The effect of heavy metals on differentiated neuronal and glial cells by Lawton, M
  
 
 
 
The Effect of Heavy Metals on 
 
Differentiated Neuronal and Glial  
 
Cells. 
 
 
 
 
 
Michelle Lawton 
 
 
 
 
 
A thesis submitted in partial fulfilment of the 
requirements of Nottingham Trent University 
for the degree of Doctor of Philosophy 
 
 
December 2007 
 I 
Table of contents 
 
 
List of Figures………………………………………………………………...IV 
List of tables……………………………………………………….…………..X 
List of Abbreviations…………………………………………………………XI 
Acknowledgments……………………………………………….…………..XII 
Declaration………………………………………………………………….XIV 
Abstract…………………………………………………...………………….XV 
1: Introduction 
1.1: Heavy metals 
1.1.1: Mercury and methylmercury…………………………......................1 
1.1.2: Thimerosal…………………………………………………………..5 
1.1.3: Lead…………………………………………………………………6 
1.1.4: Cadmium……………………………………………………………8 
1.1.5: Zinc………………………………………………………………….9 
1.2: Cellular Responses to Heavy Metals...................................................…...10 
1.3: The developing nervous system………………………………..…………11 
1.4: Potential mechanisms of heavy metal toxicity …………………..……….13 
1.4.1: Oxidative stress …………………………….………….…………..13 
1.4.2: Interaction with the cytoskeleton…………………………………..14 
 1.4.2.1: Microtubules………………………………………………14 
 1.4.2.2: Microfilaments……………………………….……………16 
                  1.4.2.3: Neurofilaments……………………………………………17 
1.5: The Role of Calcium in Heavy Metal Toxicity…………………………...19  
1.6: The Effect of Heavy Metals on the Mitogen Activated Protein Kinase 
Signalling Pathways……………………………………………………….…. 25 
1.7: Neuronal and glial cells…………………………………………………...27 
1.8: Cellular models……………………………………………………………27  
1.8.1: Neuroblastoma (N2a) cell line……………………………………...28 
1.8.2: C6 Glial cell line……………………………………………………29 
1.9: Putative mechanisms of mercury toxicity…………………………………..30 
Aims………………………………………………...………………………….32 
2: Materials………………………………………………………………….…33 
2.1.1. Specialised Reagents…………………………………….…………33 
 II 
2.1.2. Antibodies…………………………………………………………..33 
2.1.3. Tissue Culture Plastic-ware……………………………………………..33  
2.1.4. Reagents………………………………………………………………...34 
2.1.5. Cell Lines………………………………………………………………..34 
2.2: Methods…………………………………………………………………...34 
Cell culture and maintenance……………………………………………..34 
Cryopreservation of cell lines…………………………………………….34 
Restoration of cells stored in liquid nitrogen……………………………..35 
Seeding of cells for experiments………………………………………….35 
Cell differentiation………………………………………………………..36 
Exposure of cells to heavy metals………………………………………...36  
Methyl blue tetrazolium (MTT) reduction assays………………………...37 
Quantification of neurite outgrowth………………………………………37 
 Preparation of cell lysates………………………………………………...37 
Mini-Lowry assay to determine protein concentration in cell extracts……38 
SDS-PAGE and  electrotransfer of cell lysates……………………………38  
Staining of Western blots………………………………………………….39 
Immunoprobing of nitrocellulose blots……………………………………39 
Immunofluorescence staining of cells……………………………………..43 
BODIPY dye staining……………………………………………………...43 
Calpain Assay……………………………………………………………...44 
3: Chapter 3 : Effects of heavy metals on cell growth and  
    Differentiation………………………………………………………………..45 
3.0: C6 and N2a cell morphology…………………………………………...47 
3.1: The effect of zinc chloride on MTT reduction and neurite outgrowth…48 
3.2: The effect of lead chloride on MTT reduction and neurite outgrowth…53 
3.3: The effect of cadmium chloride on MTT reduction and 
 neurite outgrowth…………………………………………………………..59 
3.4: The effect of mercury chloride on MTT reduction  
and neurite outgrowth…………………………………………..…………..65 
3.5: The effect of thimerosal on MTT reduction and neurite outgrowth…...72 
3.6: Effect of methylmercury chloride on MTT reduction  
and neurite outgrowth………………………………………………………77 
 
 III 
3.7: Dose response curves……………………………………………………....84 
3.8: Discussion……………...…………………...………………………..…….89   
4: Chapter 4: Effects of organic mercury compounds on the  
neuronal and glial cell cytoskeleton…………………………………………….95 
4.1: Effects of organic mercury compounds on the levels and distribution  
of microtubule protein in differentiated C6 cells ……………………………97 
4.2: Western blot analysis and immunofluorescent staining of  
microtubule and neurofilament proteins in N2a cells treated with  
thimerosal and methylmercury chloride……………………………………..105 
4.3: Discussion…………………………………………….…………………123 
5: Chapter 5: Effects of organic mercury compounds on cell signalling  
 pathways in differentiating N2a and C6cells………………..………………….130 
5.1: The effect of thimerosal and methylmercury chloride on the levels  
and activation of ERK1/2 in C6 cells………………………………………..132 
5.2: The effect of thimerosal and methylmercury chloride on ERK  
and phosphorylated ERK in N2a cells………………………………………136 
5.3: Effects of thimerosal and methylmercury chloride on  
the levels of phosphorylation in serine and threonine residues……………..139 
5.5: Discussion………………………………………………………………149 
6: Chapter 6: The effect of thimerosal and methylmercury chloride on the  
organisation of the cell and calpain activity…………………………..……..154 
6.2 Discussion……………………………………….……………………….175 
7: General discussion and future work………………………………………….180 
7.1: Cytotoxicity and cell differentiation assays……………………………..180 
7.2: Cytoskeletal studies……………………………………………………...181 
7.3: Cell signalling studies……………………………………………………183 
7.4: Ca2+ homeostasis and calpain activity…………………...………………185 
7.5: Future work………………………………………………………………188 
 
 IV 
References and appendix…………………………………...………………..191 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 V 
Abstract 
 
Heavy metal poisoning poses a serious health risk among populations worldwide. The 
symptoms presented by exposure are varied and depend upon the species of the metal, the age 
of the individual and the exposure dose. All heavy metals have debilitating effects on the 
CNS. Children are especially sensitive to the neurological effects due to the intense growth 
and activity of a developing nervous system and inadequately developed defences.                       
The aims of this study were to determine the effects of sub-lethal concentrations of numerous 
heavy metals on neuronal and glial cell differentiation. Using established cellular models, the 
toxicity of zinc, lead, mercury, methylmercury and thimerosal were investigated using assays 
of cell viability and morphology on differentiating N2a and C6 cells. Initial research revealed 
thimerosal, methylmercury and cadmium to be the most toxic compounds tested, in terms of 
their ability to inhibit the outgrowth of neurites in both cell lines at sub-lethal concentrations.   
 
Although cadmium chloride showed similar patterns of toxicity to the mercury compounds, 
thimerosal and MeHgCl were chosen for further investigation at a molecular level. 
Methylmercury chloride a common environmental pollutant and thimerosal; a preservative 
found in many medicines, were chosen for further investigation, as previous work has 
demonstrated the health risks posed by the two organic mercury compounds but little is 
known about non-lethal changes that occur in the nervous system, especially with thimerosal. 
 
Both thimerosal and MeHgCl inhibited MTT reduction and neurite outgrowth after 4 and 24 
hours exposure at sub-lethal concentrations (0.1 and 1 µM). The inhibition of neurite 
outgrowth by sub-lethal concentrations of MeHgCl and thimerosal was accompanied by 
cytoskeletal changes in the cells. At 4 hours in C6 cells there was no change in the levels of 
tyrosinated α-tubulin, whereas in N2a cells the level of tubulin tyrosination was shown to be 
reduced compared to the control. Both cell lines exhibited a fall in total α-tubulin, tyrosinated 
α-tubulin and total β-tubulin after 24 hours of exposure to organic mercury compounds, 
indicating proteolysis and/or reduced synthesis of the tubulin subunit.  N2a cells also showed 
a decrease in the levels of phosphorylation in the neurofilament heavy chain after 4 hours of 
exposure to thimerosal and MeHgCl, whereas after 24 hours there appeared to be proteolytic 
degradation, as the total neurofilament heavy chain levels were reduced compared to the 
untreated controls. Reduced levels of tubulin and NFH were confirmed by 
immunofluorescence staining of fixed cell monolayers.  
 
Western blotting analysis also indicated increased ERK activation in glial cells incubated with 
0.1 and 1 µM thimerosal for 4 hours, followed by reduced activation after 24 hours exposure, 
whereas exposure to MeHgCl decreased the levels of ERK activation at both time points. In 
the neuronal cell line ERK activation was suppressed at both 4 and 24 hours and with both 
concentrations of the organic mercury compounds. As ERK activation plays a key role in the 
regulation of neurite outgrowth and NFH phosphorylation, both of which were inhibited by 
the addition of thimerosal and MeHgCl, the findings are consistent with a role for disrupted 
ERK signalling in the sub-lethal toxicity of these compounds.  
          
Both thimerosal and MeHgCl caused redistribution of SERCA and ryanodine receptors, both 
of which are mechanisms by which intracellular Ca2+ concentrations are maintained. As the 
endoplasmic reticulum (ER) houses both SERCA and ryanodine receptors, the reorganisation 
may indicate that organic mercury compounds cause redistribution of the ER. Such disruption 
may lead to sustained increases in intracellular Ca2+, causing elevated activity in Ca2+ 
dependant enzymes. Indeed, western blotting analysis and enzyme assays showed that calpain 
activity (particularly calpain 1) increased in response to sub-lethal concentrations of the 
organic mercury compounds. As calpains target cytoskeletal proteins, the increased activity 
may be at least partly responsible for reduced levels of tubulin and NFH.   
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1.1: Heavy Metals   
          
              Heavy metals can be broadly defined as metallic elements that have a 
molecular weight greater than 50 Daltons and are able to form polyvalent cations. 
These cations are extremely reactive and many of them have an affinity for sulphydryl 
groups (Foulkes, 2000). Heavy metals can not be metabolised by the body and if they 
accumulate in tissues faster than the body can eliminate them, they will gradually 
reach toxic levels and cause numerous and severe health problems. Heavy metal 
elements can be assigned to four distinct classes; Class A metals are essential for life 
in high concentrations (e.g. iron). Class B has no clear biological role and in low 
concentrations is not toxic, (e.g. strontium). Class C metals are essential in trace 
amounts for some living systems (e.g. zinc and copper), but can be toxic at higher 
concentrations. Class D have no recognised biological role and are toxic even at low 
concentrations (e.g. lead, cadmium and mercury amongst others) (Foulkes, 2000). The 
metals investigated in this thesis were lead and the transition metals cadmium, 
mercury and zinc. 
            In the environment, toxic metals can originate from natural sources and 
industrialisation. Heavy metals such as mercury, lead, cadmium and zinc are common 
environmental pollutants and can accumulate in biological systems. The symptoms of 
heavy metal poisoning vary according to the heavy metal, the age of the individual 
and whether the dose of the metal was acute or chronic (Redwood, 2001). The toxicity 
produced by exposure to heavy metals tends to involve neurotoxicity, hepatotoxicity 
and nephrotoxicity (Stohs & Bagchi, 1995).   
 
1.1.1: Mercury and Methylmercury 
 
            Since mercury is present in the environment from the normal degradation of 
the earths crust, everyone is exposed to tiny amounts of background mercury. 
However, industrial accidents, consumption of contaminated food and exposure in the 
workplace can result in individuals and populations being exposed to a higher than 
normal dose. For example, the earliest recorded use of mercury as a preservative was 
in Spain 5000 years ago where it was used in embalming (Myers et al., 2000). In the 
1800s it was common practice in the hat making industry to use a mercury solution in 
the process of turning fur into felt. The symptoms of mercury poisoning suffered by 
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the workers became known as ‘mad hatter’s disease’. Mercury was also widely used 
as a treatment for syphilis (Baldwin & Marshall, 1999). More recently in Minamata 
bay in Japan in the 1950s residents ingested seafood that was contaminated with 
methylmercury from a local industrial plant (Castoldi et al., 2001). Toxic effects 
including damage to areas of the brain controlling motor function and mental 
impairment were observed in adults and in infants born after the industrial accident. It 
was later found that methylmercury was able to induce congenital poisoning via 
transplacental transfer (Castoldi et al., 2001). In the 1970s another incidence of 
methylmercury poisoning occurred in Iraq, when grain that had been treated with a 
methylmercury fungicide was used to make bread (Myers et al., 2000).  
             There are three forms of mercury (Hg), organic, inorganic and elemental. 
Elemental mercury occurs naturally, is liquid at room temperature and vaporises when 
heated. Elemental Hg is released during volcanic eruptions in the form of vapour. 
Contact with excessive amounts of the metal can also arise from human activities, 
such as the burning of fossil fuel or exposure to dental amalgams. Mercury tends to be 
more hazardous as vapour; exposure can cause a variety of symptoms, including 
pleuritic pain, shortness of breath, fever, tiredness, tremors and delusions (Baldwin & 
Marshall, 1999). Children and adults show similar symptoms but poisoning of infants 
is extremely rare in modern society (Counter & Buchanan, 2004).  
               Exposure to inorganic mercury or mercury salts can come from soaps, skin 
creams, and traditional Chinese and Indian medicines. There have even been cases of 
infants presenting with classic signs of mercury poisoning linked to a teething powder 
containing mercury (Counter & Buchanan, 2004). The symptoms of inorganic Hg 
exposure are not dissimilar to the symptoms presented with the other forms of Hg 
poisoning. 
          The organic form of methylmercury is considered the most dangerous and 
common source of mercury toxicity (Gopal, 2002). However it is far from clear why 
organic mercury compounds like methylmercury are much more toxic than the 
inorganic mercury species. The difference in toxicity of inorganic mercury and 
organic mercury compounds should be related to alterations in their chemical 
structure and reactivity. The principal feature of organic mercury is the presence of 
both the metal centre (Hg) and the organic moieties covalently bonded to the mercury 
atom in their molecules (Milaeva, 2006). The organic group attached to the mercury 
makes the compound more lipid soluble, which makes transport into cells easier. 
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Nowadays, widespread exposure to methylmercury is rare, however methylmercury 
remains a significant threat, mainly from low dose exposure as a result of the 
consumption of contaminated sea food (Atchison, 2005). Inorganic mercury deposits 
are converted to methylmercury in the aquatic environment by microorganisms, 
which are then ingested by larger species leading to methylmercury accumulation in 
the food chain (Counter & Buchanan, 2004). In humans 90-100% of methylmercury is 
absorbed through the gastrointestinal (GI) tract and into the bloodstream, where it is 
then transported round the body. Methylmercury can cross the blood-brain barrier via 
the neutral amino acid transport system L as a MeHg-L-cysteine complex. There it is 
partially demethylated to inorganic mercury (Allen et al., 2002). Once in the brain 
methylmercury induces loss of neurons and has been shown to accumulate within 
astrocytes (Allen et al., 2002). In adults, the main symptoms of methylmercury 
poisoning are the loss of sensory, visual and auditory functions, weakness and damage 
in areas of the brain controlling motor function. Neurological disturbances have been 
report in populations with a high consumption of seafood at Hg concentrations as low 
as 50 µg/g (Zahir et al., 2005). In prenatal exposure, the main symptoms are severely 
impaired motor and mental development, general paralysis and cerebral palsy 
(Jacobson, 2001; Sanfeliu et al., 2001). Epidemiological data has correlated Hg 
concentrations in maternal blood with impaired neurological development of 
neonates. Mothers with blood concentrations of 24 µg/l reflected in neurological 
impairment in the child (Grandjean et al., 1994). Treatment for all mercury species 
involves the use of dimercaprol, oral penicilliamine and the newer chelating agent 
2,3-dimercapto-1-propansufonic acid (DMPS) (Baldwin & Marshall, 1999). The 
minimum risk level for mercury consumption was established by the Agency for 
Toxic Substances and Disease Registry as 0.3 µg/kg per day in children (Castoldi et 
al., 2001). 
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Table 1.1: A comparison of the different forms of mercury 
 
 
Elemental Mercury Inorganic mercury Organic Mercury 
(Methylmercury) 
Sources of 
exposure 
Dental amalgams, 
occupational exposure, 
Caribbean religious 
ceremonies, fossil fuels, 
incinerators. 
Oxidation of elemental 
mercury or 
demethylation of MeHg; 
exposure to HgCl2. 
Fish, marine mammals, 
crustaceans, animals and 
poultry fed fish meal. 
Biological 
monitoring 
Urine and blood. Urine and blood. 
 
Hair, blood, cord blood. 
Toxicokinetics Is readily absorbed when 
inhaled. 
Absorption via the GI tract 
is poor. Can also enter the 
body from skin contact. 
 
 
 
 
Exposure can occur in 
the form of aerosols, 7-
15% of the ingested dose 
of HgCl2  will be 
absorbed in the GI tract 
whilst 2-3% of applied 
dose can be taken up via 
the dermal route. 
Methylmercury vapours 
can be inhaled. 
Poisoning can occur from 
diet, particularly a diet rich 
in sea food, where organic 
mercury is absorbed in the 
GI tract and can be 
absorbed via contact with 
the skin. 
Distribution Rapidly distributed 
throughout the body since it 
is lipophilic. 
Half-life in blood, 45 days 
(slow phase); half-life 
appears to increase with 
increasing dose 
Readily crosses blood– brain 
and placental barriers 
Highest accumulation in 
kidney 
Half-life in blood, 19.7–
65.6 days; 
Does not readily 
penetrate blood– brain or 
placental barriers. 
Distributed throughout 
body since lipophilic; 
approximately 1–10% of 
absorbed oral dose of 
MeHg distributed to blood; 
90% of blood MeHg in red 
blood cells Half-life in 
blood, 50 days; Readily 
crosses blood–brain and 
placental barriers. 
Biotransformation Hg in tissue and blood 
oxidized to Hg2+ by catalase 
and hydrogen peroxide.  
Vapor  is exhaled 
following oral 
administration of 
mercuric Hg. Mercuric 
Hg is not methylated in 
body tissues but GI 
micro-organisms can 
form MeHg. 
 
MeHg slowly 
demethylated to mercuric 
Hg (Hg2+).Tissue 
macrophages, intenstinal 
flora, and foetal liver are 
sites of tissue 
demethylation.  
 
Excretion Excreted as Hgo in exhaled 
air, sweat and saliva, and as 
mercuric Hg in faeces and 
urine 
Half life elimination: 58 
days. 
 
Excreted in urine and 
faeces; also excreted in 
saliva, bile, sweat, 
exhaled air, and 
breast milk 
Half life elimination: 1– 
2 months. 
 
Major route is bile and 
faeces; 90% excreted in 
faeces as Hg2+; 10% 
excreted in urine as Hg2+ 
Half-life elimination: 
(Whole body) 70– 80 days.  
 
Toxicodynamics brain and kidney. Kidney. Brain, adult and foetal. 
 
Table 1.1 Differences between organic, elemental and inorganic mercury, from 
sources of exposure to excretion (Counter & Buchanan, 2004). 
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1.1.2: Thimerosal 
 
        The organic ethyl mercury compound Sodium ethylmercuri-thiosalicylate  
(thimerosal), is the sodium salt of the complex formed between thiosalicylic acid and 
ethylmercuric ion (Tan & Parkin, 2000). It has both antifungal and antibacterial 
properties and is widely used as an antiseptic agent and preservative in cleaning 
solutions for contact lenses, cosmetics, eye drops, topical medicines and vaccines  
(Elferink, 1999). Part of the physiological response to thimerosal is due to its ability 
to bind to SH and disulphide groups in various proteins (Nishio, 1996). Whilst not 
much is known about the metabolism, excretion or toxicity of thimerosal it’s use in 
some infant vaccines as a preservative is of concern.  
 
Figure 1.1. The structure of thimerosal. The ethylmercury radical is highlighted with 
the dashed line (Van't Veen, 2001).  
 
In 1999, the US Public Health Service and the American Academy of Pediatrics 
(AAP) called for the reduction or elimination of thimerosal from vaccines due to the 
amount of mercury that children were exposed to and a potential link to autism 
(Blaxill et al., 2004).  However the World Health Organisation (WHO) in 2002 
recommended the continued use of vaccines containing thimerosal, as they stated that 
the benefits of immunization out way any theoretical risks (Knezevic et al., 2004).  At 
present the connection between autism and mercury toxicity from infant vaccines is 
controversial since there appears to be little evidence to either confirm or refute these 
links.  
           Vaccines containing thimerosal have been reported to cause sensitivity 
reactions in some recipients, such as dermatitis and conjunctivitis (Van't Veen, 2001). 
COONa 
S
 
Thimerosal 
Hg-CH2 CH3 
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There is also evidence to suggest that exposure to large amounts (ranging from 3-
several hundred mg/kg) of thimerosal causes toxicity and death in humans (Ball et al., 
2001; Redwood, 2001). Various studies indicate that thimerosal has similar effects to 
methylmercury on biological events such as calcium homeostasis (Wiktorek et al., 
1996; Elferink, 1999; Ucha-Ishibashi et al., 2004). It is thought that thimerosal is 
converted in to inorganic mercury in vivo, but does not have the same transport 
mechanism across the blood-brain barrier as methylmercury (Van't Veen, 2001). In 
addition ethylmercury (of which thimerosal is an example) has a larger molecular 
weight and faster decomposition rate than methylmercury (Counter & Buchanan, 
2004).  
              
 
1.1.3: Lead 
 
                     Lead is a potential neurotoxin to which most people are exposed, albeit 
at differing concentrations (Erdahl et al., 2000). Lead is found in mineral deposits and 
therefore naturally released into the environment. The toxicity of lead has been known 
since roman times, when it was common practice to use lead in wine and food 
because of its sweet taste (Toscano & Guilarte, 2005). Lead is also used in a variety of 
industrial activities, and was until recently, commonly used in petrol and paint. 
General marketing of lead in petrol was banned in January 2000 in the UK 
(Papanikolaou et al., 2005), and the use of leaded paint ceased in 1992 (Toscano & 
Guilarte, 2005). Lead exposure comes from a variety of sources including cigarette 
smoke, occupational exposure and old lead water pipes. Lead gains entry to the body 
via inhalation, through the skin or by direct swallowing and ingestion, after which it is 
absorbed and transported by the blood stream to various organs and tissues. Lead can 
accumulate in three areas; blood, soft tissue and bone. Lead excretion is low, with a 
half life of approximately 10 years. However, the use of chelating agents such as 
dimercaprol can increase the rate of lead excretion (Papanikolaou et al., 2005).      
             At low levels lead poisoning does not produce obvious symptoms but can 
cause long term impairment of cognitive function (Mike et al., 2000). In an adult 
central nervous system lead crosses the blood-brain barrier rapidly in the form of a 
Pb-OH+ complex and through cation channels (Mazzolini et al., 2001) The earliest 
lead induced neurological damage is seen within the endothelial cells of microvessels, 
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which form the major structural component of the blood-brain barrier (Finkelstein et 
al., 1998). Once in the brain lead accumulates within astrocytes, which appear to 
sequester lead away from the mitochondria, thereby protecting their respiration and 
potentially that of neighbouring neurons (Mazzolini et al., 2001). Lead is thought to 
initiate apoptosis by depolarising the mitochondrial membrane leading to the opening 
of the permeability transition pore. This then allows the release of cytochrome c, 
resulting in the activation of the caspase cascade and cell death (Pulido & Parrish, 
2003). Apoptotic cell death is a regulated process that involves a series of molecular 
events, such as cell shrinkage, chromatin condensation, membrane blebbing, caspase 
activation and the formation of apoptotic bodies (Wang et al., 2005). Caspases are 
aspartate-specific cysteine proteases that initiate and ensure the efficacy of apoptosis. 
The family can be grouped into the initiator caspases, such as caspase 8, 9 and 10. 
This group initiates and amplifies cellular death signals from receptors such as the 
tumor necrosis factor receptor (TNFR) and Fas (Wang, 2000). Effector caspases such 
as caspases 2, 3, 6 and 7 degrade vital cellular components (Wang et al., 2005). 
             Lead effects numerous biological systems such the reproductive, nervous, 
gastrointestinal, immune, renal, cardiovascular, skeletal, muscular and hematopoetic 
(Bouton et al., 2001). The adverse affects of lead can be seen with concentrations as 
low as 10 µg/dl (Papanikolaou et al., 2005) The symptoms of lead exposure include 
paralysis, seizures (Dai et al, 2001), restlessness, irritability, headaches, muscle 
tremors abdominal cramps and loss of memory at concentrations of around 100-120 
µg/dl (Papanikolaou et al., 2005). Impaired hearing has been reported with blood lead 
concentrations of around 10-20 µg/dl (Staessen et al., 1994). Lead has been shown to 
inhibit myelination processes in brain tissue and alter the number of synapses per 
neuron, thus disrupting signal propagation in the CNS (Crumpton et al, 2001).  Lead 
may also have the ability to cause cancers in humans, since epididemeological data 
indicates that individuals with a blood lead concentration of 20µg/dl and above have 
an increased risk of cancer and heart disease. The carcinogenic properties of lead have 
not yet been fully elucidated but it may be by inhibiting DNA repair mechanisms or 
by replacing zinc in DNA binding proteins (Silbergeld, 2003). In addition it may 
factor in diseases such as Alzheimer’s that effect the aged as during osteoporosis, lead 
is released from bone storage (Bressler et al., 1999). The Centres for Disease Control 
and Prevention defined elevated levels of lead as > 10 µg/dl and recommended 
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treatment for concentrations greater than >15 µg/dl in adults and >10 µg/dl in children 
(Toscano & Guilarte, 2005). 
 
1.1.4: Cadmium 
 
               Cadmium is a significant industrial and environmental toxin and is ranked 
sixth out the top ten hazardous substances (Hinkle & Osborne, 1994; Lau et al., 
2006). Exposure to cadmium can occur via cigarette smoke, contaminated food, 
drinking water, soil. It is used in various industrial processes, for example in the 
production of certain pigments in paints and plastics and in the production of nickel-
cadmium batteries. The importance of cadmium as a compound detrimental to 
humans was evident at the Jinzu River in Japan where the out break of a severe 
disease known as Itai-Itai disease was linked to cadmium contaminated food. The 
disease caused bone pain, fractures, proteinuria and ostoemalacia (Waisberg et al., 
2003).  
           Cadmium can produce genotoxic and mutagenic events at high concentrations 
of 10-40 µM (Waisberg et al., 2003). In 1993 cadmium was classified as a human 
carcinogen by the International Agency for Research on Cancer. The exact 
mechanism by which cadmium causes malignancies is not yet known. It has been 
proposed that it may interfere with the expression of early genes like c-jun or the 
tumour suppressor gene p53 (Waisberg et al., 2003). Cadmium toxicity is thought to 
occur in numerous ways. Like other heavy metals, cadmium has an affinity for SH 
groups and is able to bind tightly to proteins. It is also able to replace calcium in 
calmodulin and a variety of calcium binding enzymes; as well as substituting for zinc 
in zinc containing enzymes (Hinkle & Osborne, 1994). Cadmium can enter cells via 
calcium channels and can also block calcium uptake by cells (Hinkle & Osborne, 
1994). It can also affect gene expression through metal-responsive upstream 
regulatory elements (Watjen, 2001). It can also produce reactive oxygen species 
(ROS) leading to cell death in neurons via the caspase pathway (Lopez et al., 2006). 
The susceptibility of cells to cadmium mediated apoptosis is however dependent upon 
levels of metallothionein. This protein binds to cadmium thereby restricting 
intracellular availability and reducing toxicity (Pulido & Parrish, 2003). The 
mitochondria are possibly the initial target for cadmium induced apoptosis, studies 
have shown that the disruption of the mitochondrial membrane causes the release of 
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cytochrome c and the subsequent activation of caspase 9 (Habeebu et al., 1998). The 
kidney is the critical target organ for cadmium toxicity (Lermioglu & Bernard, 1998), 
but exposure to cadmium may result in damage to numerous organs, bone, lungs, 
reproductive organs and the central nervous system. The neurological symptoms of 
cadmium poisoning include cerebral bleeding and edema, hyperactivity, 
aggressiveness and decreased ability to learn (Lopez et al., 2006). 
 
1.1.5: Zinc 
 
             Unlike the other heavy metals mentioned earlier, zinc is an essential element. 
It is the second most prevalent metal in the body (Weiss et al., 2000), and whilst an 
excess of zinc is toxic, zinc deficiency is also deleterious to health. (Maret & 
Sandstead, 2006) estimated that over 25% of the world’s population is at risk from 
zinc deficiency.  The normal zinc concentration within a healthy adult range from 2-
3g throughout the body and daily intake is recommended at 0.25 mg/kg (Sandstead, 
1993). Zinc is an important catalytic and structural component of hundreds of 
enzymes involved in metabolism and gene expression (Turan et al., 1997). It is 
essential for normal growth and development and is involved in cellular proliferation, 
differentiation and apoptosis (Ross et al., 1997). The immune system, metabolism, 
reproduction, vision, taste and behaviour all essentially require zinc (Fraga, 2005). In 
addition zinc has a role neuronal growth and transmission (Maret & Sandstead, 2006). 
The brain has the highest zinc content around 10 times higher than the concentration 
found in plasma. The vast majority of zinc in the brain is bound to zinc 
metalloproteins, around 10% of zinc is free or loosely bound and is found mostly in 
certain synaptic vesicles (Mathie et al., 2005). These zinc rich vesicle are only found 
in glutamatergic neurons (Frederickson & Bush, 2001) at a concentration estimated to 
be around 300 µM (Takeda et al., 2003). Zinc is present in vesicles within excitatory 
nerve terminals and when released in a calcium dependent manner, can reach 
concentrations of 100 µM in the extra cellular space (Gee et al., 2002). Synaptically 
released zinc can then modify the activity of certain proteins such as glutamate and γ-
aminobutyric acid (GABA) receptors (Frederickson & Bush, 2001; Mathie et al., 
2005). 
               However an excess of extra cellular zinc is damaging and is implicated in 
cell death following an ischemic period or seizure (Park & Koh, 1999; Kim et al., 
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2000). An excess of zinc during pregnancy can be teratogenic and sometimes lethal. 
Toxic doses in adults of around 325-650 mg causes nausea, abdominal pain, vomiting 
and diarrhoea (Maret & Sandstead, 2006). Changes in zinc homeostasis within the 
brain has been linked to the occurrence of seizures in epileptics, this is part due to the 
discovery that prior to a seizure zinc concentrations are higher in the brains of 
epileptic mice than in control mice (Mathie et al., 2005).    
 
1.2: Cellular Responses to Heavy Metals 
 
            Once heavy metals have entered the body, the cellular machinery attempts to 
detoxify and/or remove them from the cell via a combination of processes collectively 
known as metalloregulation (Castiglioni et al., 2001). This is mediated by metal 
chelating proteins such as metallothioneins. Other detoxification pathways involve 
removal of the metal from within the cell via diffusion, or through the action of P-type 
ATPases. These are energy dependant pumps which extrude cations into or out of the 
intracellular matrix or intracellular compartments, thereby protecting internal cellular 
mechanisms from heavy metal damage (Lutsenko & Kaplan, 1995). In addition toxic 
metals can also be mineralised within mitochondria or lysosomes (Castiglioni et al, 
2001). Another mechanism of detoxification in marine invertebrate has been 
speculated and it is the formation of insoluble metal-calcium precipitates (Mason & 
Nott, 1981). Metallothionein is a highly conserved low molecular weight intracellular 
protein. It is known to be important in the detoxification of heavy metals and can bind 
to at least 18 different elements including zinc, cadmium and mercury (Baldwin & 
Marshall, 1999). Metallothioneins store and release essential metals such as zinc and 
copper; thus maintaining the low intracellular concentration of free essential metals. 
Metallothioneins have a regulatory capacity and influence transcription, replication, 
protein synthesis, metabolism, as well as other zinc-dependent biological processes. 
Increasing cellular expression of metallothionein protects the cell from heavy metal 
damage (Yao et al., 1999). Lead and mercury exposure gives rise to insoluble protein 
bodies in the kidneys, however the precise nature of these protein inclusions remains 
uncertain, they could be an excretory process or passive shedding of cells (Baldwin & 
Marshall, 1999).  If the exposure of the individual reaches pathological levels heavy 
metals can be deposited into tissue. An example of this is mercury which can be found 
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deposited in a wide variety of body tissue, which would account for the variety of 
symptoms that accompany mercury poisoning.  
            The central nervous system is extremely susceptible to heavy metal toxicity. 
The brain already contains significant amounts of zinc, iron, copper and magnesium 
(Castiglioni et al. 2001). Normal copper concentrations in the brain are around 0.2-1.7 
µM but can exceed this level at the synaptic cleft; reaching concentrations of 200 µM. 
Compared to all other organs the brain has the highest concentration of zinc at 
concentrations of 100-150 µM. Therefore the brain needs effective protective 
mechanisms in order to allow these metals to exist in the nervous system without 
causing any damage. One such protective system is glial cell activity. Astroglia have 
high levels of metallothioneins I, II and type III; which is unique to the CNS. 
Neuronal cells have been shown to express very low levels of metallothioneins, 
making them susceptible to heavy metal damage. Glial cells express levels of 
metallothionein I 10 times greater than that of neuronal cells, 538 pg metallothionein 
I/µg protein in glial cells compared to just 49 pg/µg protein in neuronal cells (Hidalgo 
et al., 2000).  Metallothioneins are cysteine rich proteins with a high affinity for metal 
ions, which may allow glial cells to chelate heavy metals. Exposure to heavy metals 
induces metallothionein synthesis in astrocytes. Zinc exposure of 50 µM increased 
metallothionein I concentrations by 3.5 fold in neurons and 2.5 in astrocytes (Hidalgo 
et al., 2000). Astrocytes protect neighbouring cells including neurons from oxidative 
damage. They are rich in glutathione (GSH), which is a powerful anti-oxidant and in 
addition they provide GSH precursors to neurons (Takuma et al., 2004). GSH 
concentration within mature astrocytes is around 2 mM (Castiglioni & Qian, 2001). 
Glial cells provide protection to neurons against excitotoxicity, caused by an excess of 
the neurotransmitter glutamate (Glu). Exposure to heavy metals reduces the ability of 
astrocytes to take up Glu (Aschner, 1996).  Since glial cells line the ventricles of the 
central nervous system they are the first cells that come into contact with metals 
crossing the blood-brain barrier. Hence, despite their protective roles, the heavy 
metals may overwhelm the regulatory capacity of the glia (Castiglioni & Qian, 2001).  
 
1.3: The developing nervous system  
 
               Children tend to be more susceptible to the toxic effects of heavy metals 
since their nervous system is still developing (Choi et al, 1989, Castoldi et al, 2001). 
 12 
Hence exposure to heavy metals can have a devastating effect on the normal 
development of an infant. Many studies have reported that even very low doses of  0.1 
µM lead and methylmercury can affect growth and development (Crumpton et al., 
2001; Moreira et al., 2001). Both metals can cross the placenta. The concentration of 
heavy metal in foetal blood is assumed to be proportional to that in maternal blood. In 
adult brain tissue mercury damage tends to be restricted to areas of anatomical 
importance such as the visual cortex but in a developing CNS the damage is more 
extensive (Castoldi et al., 2001). The major difference between a mature CNS and a 
developing one is the intense cellular proliferation that occurs during development. 
The toxicity of methylmercury, mercury and lead occurs by the compounds 
interfering with normal biological processes, such as calcium homeostasis, interaction 
with the cytoskeleton and/or protein SH groups in enzymes. Cytoskeletal proteins like 
tubulin are important in a developing nervous system since it is subject to intense 
cellular proliferation and differentiation. Any interference in these processes are liable 
to damage the CNS. In addition mercury affects microtubule formation during the cell 
cycle (Miura et al., 1999). It has also been suggested that methylmercury has an 
inhibitory effect on axon formation and that the inhibition is partly responsible for the 
resultant developmental problems seen in cases of mercury poisoning (Heidemann et 
al., 2001).  
            Lead is known to impair the cytoarchitectural development of the nervous 
system, particularly an immature CNS (Erdahl et al., 2000), infants have an 
inadequate blood-brain barrier (Moreira et al, 2001). In addition there is evidence that 
children do not form lead-protein complexes, a protective process that is used to bind 
lead in adult brain (Moreira et al, 2001). The plasma lead concentration of children 
should remain below 10µg/dl. The Centre for Disease Control (CDC) recommends 
treatment for levels over 20µg/dl, while 70µg/dl is considered a medical emergency 
(Kaufman, 2001). Data from a national health and nutrition survey indicated that 
blood lead levels had an inverse correlation with height, weight and chest 
circumference in children in the U.S.A (Tonner & Heiman, 1997). It was found that 
lead exposure reduced the secretion of  both the thyroid hormone and growth 
hormone, which would account for the reduction in height, weight and chest 
circumference seen in that survey (Huseman et al., 1992).  Lead has been shown to 
alter the expression of various receptors on the cell surface, altering normal signalling 
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pathways. It can inhibit NMDA receptor-receptor ion channel function which is 
thought to be involved in learning and memory, which is a classic indication of lead 
toxicity (Finkelstein et al., 1998). Like mercury, lead is also able to cross the placental 
barrier. Concentrations in the umbilical cord were found to be 80-100% of that found 
in maternal blood. During pregnancy bone turnover can increase, which can release 
the lead taken up by bone potentially leading to chronic lead toxicity in both mother 
and baby (Papanikolaou et al., 2005).   
 
1.4: Potential mechanisms of heavy metal toxicity 
 
1.4.1: Oxidative stress  
 
             Oxidative stress is caused by an imbalance between the production of reactive 
oxygen species (ROS) and the anti-oxidant defences of the cell. Normal metabolism 
in a healthy CNS is high and generates large amounts of ROS. This is counteracted by 
high concentrations of antioxidants, such as reduced glutathione (GSH). The increase 
in levels of ROS can damage cellular components including proteins, membrane 
lipids and nucleic acids (Halliwell and Gutteridge, 1989). When the anti-oxidant 
defences are overwhelmed, ROS can cause catastrophic damage to cellular 
components leading to necrosis or apoptosis. (Yee & Choi, 1996.) suggested that the 
mitochondria is one of the earliest sites of heavy metal accumulation. Disruption to 
the mitochondrial electron transport chain is possibly a major cause of free radical 
production, which would deplete the cell’s energy levels. 
           Production of free radicals is a common toxic mechanism for many heavy 
metals including lead, cadmium and mercury. Cadmium does not appear to generate 
free radicals but lipid peroxidation in an earlier indicator of cadmium exposure 
(Manca et al., 1991). In the case of cadmium exposure ROS damage could occur via 
depletion of anti-oxidant systems rather than the creation of the radicals themselves as 
glutathione levels have been shown to be depleted (Li et al., 1993). In contrast zinc 
appears to prevent the formation of ROS by protecting sulphydryl groups from 
oxidation (Bray & Bettger, 1990). Lead, mercury and other heavy metals have high 
affinities for sulphydryl (SH) groups in proteins. The binding of heavy metals to SH 
groups in anti-oxidant enzymes, such as superoxide dismutase (SOD) and GSH would 
seriously affect the ability of cells to cope with the ROS. It would also leave cells 
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more susceptible to further oxidative damage (Hsu & Guo, 2002). For example 
methylmercury has high thiol reactivity, which would render GSH ineffective as an 
anti-oxidant (Gatti et al., 2004). 
            The generation of ROS may also be one of the mechanisms thorough which 
heavy metals affect calcium homeostasis.(Burlando et al., 1997b) demonstrated that 
increased levels of free radicals can lead to a massive release of calcium from the 
sarcoplasmic reticulum stores via the ryanodine receptor. The evidence for ROS 
playing a part in metal toxicity is supported by the observation that the addition of 
certain anti-oxidants like vitamin E, C, B6 and selenium, can increase the protection 
for cells that have been exposed to heavy metals (Stohs & Bagchi, 1995; Dare et al., 
2000; Gurer & Ercal, 2000).  
               Numerous studies suggest that oxidative stress is an important mechanism of 
damage for all of the metals that are of interest to this research. There are however 
other pathways that are also relevant 
                               
 
1.4.2: Interaction with the cytoskeleton 
 
             The neuronal cytoskeleton is a complex and dynamic structure that extends 
through the cell cytoplasm. The main components of the cytoskeleton within the cells 
of the central nervous system are microtubules, microfilaments and intermediate 
filaments. Together these components are responsible for cellular organisation, 
communication, transport and cell stability. Each component of the neuronal 
cytoskeleton has different biochemical properties and functions within the cell.   
 
1.4.2.1: Microtubules 
 
              Both neuronal and glial cells contain microtubules. Microtubules are hollow 
cylindrical organelles, approximately 25nm in diameter. They are labile polymers 
assembled from heterodimeric subunits of α- and β-tubulin, each with a molecular 
weight of around 50 kDa (Graff et al., 1997). Tubulin is an acidic protein of which 
there are two main isotypes, α- and β-tubulin. The heterodimeric subunit comprised of 
these two isotypes is the principle constituent of microtubules. Microtubule formation 
occurs via the binding of the α/β-subunit to two molecules of GTP. One molecule of 
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GTP binds to α-tubulin and the other is reversible bound to β-tubulin and is 
hydrolysed during microtubule formation (Hargreaves, 1997). Tubulin synthesis is 
regulated by the pool of unpolymerised tubulin, for example when microtubule 
assembly is high the pool lowers and tubulin synthesis is increased so that the pool of 
unpolymerised tubulin remains the same and when microtubule assembly is low the 
opposites occurs (Dhamodharan & Wadsworth, 1995). 
                Microtubules are made up of 13 longitudinally arranged polar 
protofilaments (Figure 1.2). The polarity allows the ends of the protofilaments to 
display differences in subunit addition and loss. Polymerisation occurs via the 
addition of tubulin subunits to the polar end or plus end of the microtubules until 
equilibrium is reached, where the gain of tubulin subunits at the plus end is equal to 
the loss of subunits from the minus end (Hargreaves, 1997). Microtubules are 
dynamic in most interphase cells. Tubulin subunits are constantly polymerising and 
depolymerising. However some cell types, like neuronal and glial cells contain 
microtubules that are able to resist depolymerisation and are termed stable. Stable 
microtubules have a role in maintaining cell polarity and the complex architecture in a 
mature brain (Graff et al., 1997). Microtubule stability is achieved via 
posttranslational modification of the α-tubulin subunit, modification such as 
detyrosination and acetylation (Gundersen & Bulinski, 1986). The detyrosination of 
microtubules involves the removal of a tyrosine residue from the C-terminal of the α-
tubulin subunit; the subunit can also be acetylated on the lysine side chain. The 
addition of various microtubule associated proteins (MAPs) such as Tau can further 
stabilise microtubule networks within cells (Bunker et al., 2004).  
                           The integrity of the microtubule network is vital in neuronal 
migration. Studies have shown that concentrations ranging from 0-10 µM of MeHg 
inhibit the migration of external granule cells toward the internal granule layer in a 
concentration dependant manner (Kunimoto & Suzuki, 1997). Methylmercury can 
disrupt the cell cycle by interfering with microtubules and, through its interaction with 
the microtubules, cause the induction of apoptosis (Miura et al., 1999). In vitro 
studies have indicated that MeHg produces this effect by binding to tubulin SH 
groups, which either depolymerises the microtubules or prevents the polymerisation 
of tubulin (Vogel et al. 1985; Sager, 1988; Graff et al. 1997). The sensitivity of 
neuronal cells to mercury toxicity may be related to the high concentration of tubulin 
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and microtubules in vertebrate brain, which is primarily due to their high density in 
axons where they mediate the process of axonal transport. 
 
  
 
Figure 1.2 Microtubule structure  
 
Microtubules are comprised of 13 longitudinally arranged protofilaments. Each protofilament 
contains alternate α and β subunits. Subunits are constantly added and removed from the 
microtubule structure during the steady state. When the microtubule is elongating there is no 
removal of subunits only additions. 
 
1.4.2.2: Microfilaments 
 
             Another important cytoskeletal component is microfilaments, which are 
composed of the 42 kDa protein actin. Actin has a bi-lobal structure and is arranged 
helically during polymerisation (Hargreaves, 1997). F-actin is the finished filament; it 
has an outer diameter of 5-7 nm and appears to be comprised of twisted beads due to 
the helical arrangement of the actin protein. Actin is abundant in muscle cells where it 
forms stable thin filaments that enable muscle contraction; it also forms labile 
microfilament structures in non-muscle cells in the form of stress fibres, lamellipodia 
and other networks. F-actin formation occurs by a nucleated condensation mechanism 
in which polymerisation occurs via the addition of monmeric actin subunits, known as 
Protofilament 
Tubulin subunit 
comprising of one α 
and one β molecule.  
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G-actin at the positive end of F-actin filaments (Hargreaves, 1997). Actin is important 
in the process of axon branching where it forms filopodia and lamellipodia in the axon 
growth cone (Gitler & Spira, 1998). Actin filament undergo rapid cycles of 
polymerisation and depolymerisation that enable filopodia to probe the extracellular 
space (Kornack & Giger, 2005)  
 
 
1.4.2.3: Neurofilaments 
 
Apart from microtubules and microfilaments, neuronal and glial cells also 
contain a number of unique intermediate filaments. Glial cells contain glial fibrillary 
acidic protein (GFAP) and neuronal cells contain neurofilaments, of which there are 
three main types in mammals, neurofilament light chain (NF-L) with a molecular 
weight of around 60 kDa, neurofilament medium chain (NF-M), molecular weight of 
around 102 kDa and neurofilament heavy chain (NF-H) which has a molecular weight 
of approximately 112 kDa (Ackerley et al., 2003). All NF subunits consist of a 
globular amino-terminal ‘head’ domain, an α-helical rod domain and a globular 
carboxy-terminal ‘tail’ domain (Figure 1.3). The central rod domain consists of 310 
amino acid residues and is consistent between the three main NFs, so the differences 
in molecular weight are primarily down the differences in the head and tail domains. 
The central rod domain of the NF subunits is intertwined in order to form dimmers 
which then form tetramers, the tetramers combine to form protofilaments, which 
finally assemble to produce the NF (Figure 1.4). 
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Figure 1.3 Structure of the neurofilament protein  
 
NF-H is one of the most extensively phosphorylated neurofilaments it contains 
over 50 acceptor serine/threonine sites in the KSP region within the C-terminal 
(Ackerley et al., 2003). Neurofilament phosphorylation is associated with axonal 
stability, the neurofilament proteins extend along the axon and are the primary 
component of its cytoskeleton and in addition to the stabilisation of axons, NF-H also 
controls axon girth (Williamson, 1996). NFH phosphorylation is also involved with 
neurofilament transport within the axons (Pant et al., 2000).  
Although there is evidence that methylmercury affects axon production 
(Gopal, 1995) there are very few in vivo or in vitro studies that have assessed the 
effects of non-lethal doses of methylmercury on axon outgrowth and the proteins 
involved in axon stability (Heidemann et al., 2001). Most investigations have simply 
determined the mechanism by which lethal doses cause cell death. One of the aims of 
this study is to determine whether sub-lethal concentrations of various heavy metals 
affect neurite outgrowth in differentiating N2a and C6 cells and the levels of proteins 
known to be important in the outgrowth and maintenance of axons formed by mouse 
neuroblastoma (N2a) cells and processes formed by a rat glioma (C6) cells. 
 
α-helical rod domain containing heptad repeats 
Carboxyl terminus 
Amino terminus 
 19 
Figure 1.4: Neurofilament Assembly. 
The central rod domain of the NF subunits is intertwined in order to form dimers. The dimers 
are sorted in an anti-parallel fashion and form tetramers. Tetramers combine to form 
protofilaments, which finally assemble to produce the 10 nm thick NF. Diagram adapted from 
(Petzold, 2005). 
 
1.5: The Role of Calcium in Heavy Metal Toxicity  
 
               Numerous studies have shown that toxic concentrations of heavy metals 
have an effect on calcium homeostasis (Viarengo et al, 1999; Nathenson et al, 1995; 
Szucs et al, 1997; Leonhardt et al, 1996). These imbalances in calcium can then affect 
cell signalling mechanisms and impair the activity of calcium dependent enzymes 
(Panfoli et al, 2000; Watjen et al, 2001).            
                   Calcium is known to be involved in the regulation of many physiological 
processes (Saino et al., 2002). It is also widely used as an intracellular signalling 
molecule. The concentration of free calcium within the cytosol is approximately 
0.1µM, whereas the extracellular calcium concentration is around ten thousand fold 
higher. This difference in calcium concentration creates a chemical gradient greater 
dimer 
NF subunit 
Tetramer 
Protofilament 
Assembled NF 
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than that of any other ions. In addition, the negatively charged interior of the axonal 
plasma membrane forms an electrical gradient that together creates a large 
electrochemical force for the entry of calcium into the cell. The electrochemical 
gradient for calcium entry is opposed by Ca2+ATPases. These are ATP dependant 
Ca2+ pumps that actively remove Ca2+ from the cytosol by pumping it into the extra 
cellular medium or sequester Ca2+ into various organelles such as the mitochondria 
and the endoplasmic or sarcoplasmic reticulum. Thus, when the calcium concentration 
within the cytosol increases by the entry of Ca2+ through voltage gated Ca2+ channels, 
when the cell membrane is depolarised or by the binding of an extra cellular 
signalling molecule to a cell surface receptor, it generates an intra cellular response 
such as the activation of inositol triphosphate (see Figure 1.5 for diagram of calcium 
signalling). With the subsequent stimulation of Ca2+ release, Ca2+ dependent pathways 
are then activated within the cell. In the nervous system, Ca2+ is involved in the 
transmission of action potentials across synaptic junctions. When the action potential 
reaches the pre-synaptic terminal calcium ions enter the depolarised pre-synaptic 
terminal via voltage gated Ca2+ channels and activate the exocytotic pathways 
resulting in the release of a neurotransmitter into the synaptic cleft (Kostyuk & 
Verkhrastsky, 1995).  
         The alteration of calcium homeostasis in cells due to heavy metal exposure has 
been noted by a number of different studies (Hare et al., 1993; Abramson et al., 1995; 
Marchi et al., 2000). This rise in intracellular Ca2+ is generally caused by the opening 
of Ca2+ channels in the cell membrane (Burlando et al., 1997a; McNulty & Taylor, 
1999; Gopal, 2002). The opening of the voltage gated Ca2+ channels may be due to 
the binding of the metals to the SH groups within the channels proteins (Atchison & 
Hare, 1994). The rise in Ca2+ would be further augmented by any interaction between 
the metals and the SH groups within both the plasma membrane and SERCA Ca2+ 
ATPases (SERCA Ca2+ ATPases are calcium pumps that remove calcium ions from 
the cytoplasm into the ER or SR). The cell would then have a reduced ability to 
remove Ca2+ entering via the open channel (Canesi et al., 2000). Methylmercury has 
been shown to increase intracellular calcium via an influx from the extracellular 
medium as well as from intracellular stores. In contrast mercury caused an influx from 
the extracellular medium alone. Hence although the outcome of increased intracellular 
calcium was the same, the mechanisms by which it was achieved was different for 
organic and inorganic mercury (Stohs & Bagchi, 1995). The resultant change in Ca2+ 
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concentrations would affect Ca2+ dependent enzymes within the cell. Methylmercury 
induced rises in [Ca2+]i can cause the spontaneous release of the neurotransmitter by 
depolarising the plasma membrane, causing it to become more permeable to calcium 
ions (Atchison & Hare, 1994). Limited research shows that thimerosal also increases 
[Ca2+]i  though not as potently as methylmercury (Nishio, 1996; Ucha-Ishibashi et al., 
2004).  
 
 
Figure 1.5: Calcium homeostasis  
Diagram shows Ca2+ homeostasis in a glial cell. Extracellular calcium can enter the cell via 
voltage activated calcium channels (VOCC). Calcium can also be released from intracellular 
stores via the binding of an extracellular signalling molecule such as glutamate to a cell 
surface receptor such as the glutamate receptor (mGluR). This generates  the hydrolysis of PI 
4, 5-bisphosphate (PIP2) to inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 leaves 
the cell membrane and diffuses through the cytosol, where it interacts with an inositol 
triphosphate receptor (IP3R) on the membrane of the endoplasmic reticulum (ER) causing the 
release of calcium. Ca2+ can be released from the ER via the ryanodine receptor (RyR). RyR 
are regulated by positive feedback, where the binding of Ca2+ to the receptor increases Ca2+ 
release. Stores within the mitochondria (mito) are released via a uniporter; which utilises the 
large negative potential to translocate calcium, through a Ca2+/Na+ exchange and through the 
calcium permeable ‘permeability transition pore’ Intracellular extrusion of calcium occurs 
through Ca2+ATPase pumps in the plasma membrane, through sarcoplasmic and endoplasmic 
reticulum Ca2+ATPases (SERCA) and through a 1Ca2+/3Na+ exchange. Diagram adapted from 
(Deitmer et al., 1998)                        
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                      Lead can mimic calcium in cells. It enters cells via the calcium channel 
and can activate protein kinase C (Loikkanen et al., 1998; Raunio & Tahti, 2000). 
Lead functions as a substitute for calcium in its interaction with other proteins, such 
as calmodulin and the synaptic vesicle protein synaptotagmin 1. This can lead to an 
abnormally functioning protein, with potential deleterious effects on cell pathways 
and gene transcription (Bouton et al., 2001). Lead is so effective as a substitute for 
calcium, that on most protein targets the affinity of the binding sites is greater for lead 
than for calcium (Mike et al., 2000).    
            Alterations in calcium homeostasis, would effect the regulation of calcium 
dependent enzymes within the cell. Calpains are calcium dependent intracellular 
cysteine proteases. Since the discovery of the calpain family 14 members have been 
identified, some of which are tissue specific whilst others are ubiquitously expressed 
(Nixon, 2003). Calpains are comprised of large 80 kDa catalytic subunit and a small 
30 kDa regulatory subunit (Sorimachi et al., 1997). The two most widely distributed 
isoforms are µ-calpain and m-calpain, sometimes known as calpain 1 and calpain 2. 
These two forms have virtually identical substrates and are so far only distinguished 
by their calcium requirements for activation and tissue distribution (Nixon, 2003), 
calpain 1 requires 5-50 µM and 2 requires 200-1000 µM of calcium (Reverter et al., 
2001). Once activated it has been suggested that calpains are modulated by a protein 
inhibitor called calpastatin (Nixon, 2003). 
                Calpains exist in an inactive state that requires a conformational change to 
align the active site residues to form the catalytic centre. Calpain activation is 
dependent upon the binding of calcium to several areas, translocation to the cell 
membrane and autoproteolysis, upon activation the regulatory subunit is cleaved 
(Huang & Wang, 2001).  
          Calpains act on various cytoskeletal proteins, and are involved in the regulation 
of cell adhesion, cell spreading or migration and process outgrowth (Khorchid & 
Ikura, 2002).  Calpains interact with various microtubule associated proteins (MAP) 
such as tau and MAP 2. As MAP’s are important in the stabilisation of microtubules, 
then their degradation by calpain or abnormal phosphorylation by the cdk5-p25 
complex would result in disruption of the microtubule network. Calpains are also 
involved in the processing of p35 to p25. This then forms the cdk5-p25 complex that 
is involved in the phosphorylation of many proteins including tau and neurofilaments 
(Sakaue et al., 2005). 
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          Limited research into heavy metal influence on calpain activation indicates that 
methylmercury exposure increases calpain activation in cell culture systems (Zhang et 
al., 2003; Sakaue et al., 2005). Abnormal calpain regulation is probably caused by the 
changes in calcium homeostasis induced by exposure to heavy metals. 
          A possible pathway for the over activation of calpain is via excessive glutamate 
build up (see Figure 1.6). Glutamate (Glu) is a common neurotransmitter, but an 
excess can lead to over stimulation of cells, resulting in cell death. In nerve terminals 
Glu arises from glucose, through the Krebs cycle and is also secreted by astrocytes. 
Stimulation of the glutamate receptor (GluR) causes an influx of calcium and 
depolarisation of the cell. Astrocytes are also responsible for facilitating the removal 
of Glu from the extracellular matrix. Both mercury and lead affect Glu transmission 
but in different ways. Mercury causes an increase leading to excitotoxicity. It has 
been suggested that the increase in Glu is due to the inhibitory effect that mercury has 
upon astrocytes to clear the extracellular space of Glu. Conversely lead decreases Glu 
release by acting as a non competitive inhibitor for the receptor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24 
  
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Methods by which heavy metals may compromise cell function via 
calpain activation. 
Figure 1.6 shows the mechanism by which exposure to heavy metals may cause cell death via 
elevations of calcium concentrations and activation of calpains. Exposure to heavy metals 
such as mercury causes a build up of the neurotransmitter Glu. This leads to over stimulation 
of the cell, which is known as excitotoxicity. The resultant excessive build up of glutamate 
over activates ionotropic glutamate in the postsynaptic membrane and causes a sustained 
influx of Ca2+ through these receptors. Because of membrane depolarization, voltage-gated 
Ca2+ channels open, enabling Ca2+ to enter, resulting in a massive calcium overload. This then 
activates several calcium-dependent enzymes, especially calpain 1 and 2. Over activated 
calpain could lead to uncontrolled degradation of cytoskeletal proteins, cytosolic and nuclear 
enzymes and, ultimately, neuronal death (Huang & Wang, 2001).  
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1.6: The Effect of Heavy Metals on the Mitogen Activated Protein Kinase Signalling 
Pathways 
 
              The Mitogen activated protein kinases (MAPKs) are serine/threonine kinases 
that are ubiquitous enzymes of signalling pathways. They were first discovered in the 
1980’s in the pheromone-induced mating pathway in yeast (Callaway et al., 2005) and 
were later found to be involved in cell cycle progression, proliferation and 
differentiation in all organisms. They are activated via reversible phosphorylation and 
are vital in connecting cell surface receptors to various targets within the cell (Hirsch 
& Stork, 1997). Most cell surface receptors involve one or more of the MAPK 
cascades in signal transduction. MAPKs are under the control of G-protein-coupled, 
growth factor and cytokine receptors (Werry et al., 2005). The MAPK family consists 
of three main groups, the extracellular-signal related protein kinases (ERK), the 
stress-activated protein kinases (SAPK) p38, and the SAPK c-jun N-terminal kinases 
(JNK) (Chang & Karin, 2001). The signalling cascades for these enzymes are quite 
complex and are not understood. Each MAPK is activated by a specific Mitogen 
activated protein kinase kinase (MAPKK), MEK1/2 activates ERK1/2, MKK3/6 
activates p38 and MKK4/7 for JNKs. However each MAPKK can be activated by 
more than 1 MAPKKK (Robinson & Cobb, 1997).  
             JNK and p38 pathways are involved with cellular responses to stress. The 
activity of these pathways respond to inflammatory cytokines and stress and have 
been linked to apoptosis (Wang et al., 1998). ERK activity is controlled by mitogens 
and growth factors to stimulate cell survival and differentiation, and is suppressed in 
many events leading to apoptosis (Jin et al., 2002). In recognition of the variety of 
biological processes that involve the MAPK signalling, a large numbers of studies are 
being carried out on the potential of the signalling cascades as therapeutic targets.              
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Figure 1.7 schematic diagram of the ERK, JNK and p38 signalling pathways              
The diagram shows the complexity of the signalling cascades. Not only can the MAPKs 
become activated by their traditional pathway, there can also activation via cross talking from 
other pathways, for example Raf can be activated by Ras in the ERK pathway and Rac/Cdc42 
from the JNK pathway. Heavy metals can interfere with ERK1/2 activity, either inhibiting or 
stimulating the pathway depending on the concentration of the metals. In addition heavy 
metals have been shown to stimulate the stress activated pathways. Diagram adapted from 
(Robinson & Cobb, 1997). 
 
 
 
            Heavy metals affect various signalling pathways including the MAPK 
signalling cascade shown in figure 1.7. A low exposure to cadmium decreases ERK 
activity, whilst high concentrations have been shown to increase ERK activity. In 
contrast p38 is increased by both high and low cadmium concentrations (Pulido & 
Parrish, 2003). Non toxic concentrations of methylmercury also inhibit ERK 
activation (Parran et al., 2004). Exposure to zinc and lead caused activation of ERK at 
concentrations ranging from 1-10 µM (Seo et al., 2001; Cordova et al., 2004). JNK 
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activation has been found to increase during mercury exposure (Matsuoka et al., 
1999; Drzewiecka et al., 2005). However, a separate study found no change in JNK 
activation (Barnes & Kircher, 2005), indicating that JNK plays an inconsistent or a 
duel role  during exposure to mercury compounds.  
             
1.7: Neuronal and glial cells 
 
            Due to the complexities of the kinetics of heavy metals, and the issues of 
absorption, distribution, metabolism and excretion that occur in a multi organ system, 
many studies have utilised cellular models. It is therefore of value to outline the 
rationale and properties of the cells lines used in this project. 
            Neuronal and glial cells are both generated by neural stem cells that are 
present in both an adult and developing CNS (Tamm et al., 2006). Neuronal and glial 
cells have very different functions in the nervous system. Neuronal cells are 
responsible for the perception of stimuli and the responses to that stimulus. Neurons 
are argued to be the most polarised cell in the human body, they form two distinct 
types of processes, axons and dendrites (Barres & Barde, 2000). Glial cells represent 
the most numerous group within the brain (Bezzi & Volterra, 2001). It includes 
astrocytes and oligodendrocytes in the CNS (Aschner, 1996). They provide structural, 
metabolic and trophic support to neurons. It is only recently that the role of glial cells 
has been uncovered. It was originally believed that neurons were the excitable cells 
within the CNS, it has now been discovered that glia have active properties and may 
communicate with neurons during synaptic transmission (Scemes, 2001). Astrocytes 
respond to neuronal activity by an increase in intracellular calcium concentrations, 
which trigger the release of chemicals which can then influence neuronal cells (Barres 
& Barde, 2000). By using both neuronal and glial cells this study will determine the 
importance of cell specific toxicity. 
 
1.8: Cellular models  
 
                Whilst cultured cell lines are useful in the study of heavy metal toxicity, the 
mechanism of toxicity of such compounds at sub-lethal concentrations is still poorly 
understood. This study utilised differentiating N2a (mouse neuroblastoma cell line) 
and C6 cells (a rat glial cell line) in order to investigate the toxic action of heavy 
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metals on the nervous system. Both N2a and C6 cells are widely used to investigate 
the cellular mechanisms of neurotoxicity (Castiglioni, 1993; Flaskos et al., 1998; 
Allen et al., 2001; Fowler et al., 2001; Sachana et al., 2001; Sachana et al., 2003).  
 
1.8.1: Neuroblastoma (N2a) cell line 
 
                 The N2a cell line was derived from the C1300 neuroblastoma (Klebe & 
Ruddle, 1967). N2a cell morphology is typically round when in suspension or 
undifferentiated. However, when attached to a suitable surface N2a cells undergo a 
striking morphological changes, the most prominent being cellular extrusions. Cells 
produce one to four processes known as neurites and show an increase in the size of 
the nucleus and perikaryon (Haffke & Seeds, 1975). These neurites contain large 
numbers of neurofilaments, which are characteristic of mature neurones. The growth 
of the neurite can be further augmented by serum withdrawal and the addition of 
dibutyryl cyclic 3’, 5’-monophosphate (dbcAMP). Serum withdrawal causes a 
reduction in cell division and promotes differentiation and dbcAMP mimics the effect 
of cAMP to promote differentiation. Together both these processes cause N2a cells to 
differentiate morphologically and biochemically to mimic a mature phenotype (Prasad 
& Sinha, 1976).  
           In addition to the changes in morphology, N2a cells can also develop some 
other biochemical characteristics of mature neurones. For example they are capable of 
spontaneous and repetitive depolarisation, as well as the ability to generate action 
potentials in response to stimulation (Haffke & Seeds, 1975). 
              Biochemically, N2a cells are classed as an adrenergic neuroblastoma cell line 
containing high concentrations of tyrosine hydroxylase. This enzyme is involved in 
the production of catecholamines and shows increased levels when N2a cells are 
differentiated via the addition of dbcAMP (Waymire et al., 1972). N2a cells have also 
been shown to express dopamine, norepinephrine and serotonin in low concentrations 
(Narotzky & Bondareff, 1974). 
              All heavy metals have been reported to cause neuronal death and N2a cells 
display characteristics of primary neuronal cells. Methylmercury in particular has 
been reported to effect cytoskeletal proteins; thus due to the ability of N2a cells to 
produce neurites, rich in cytoskeletal proteins such as neurofilaments makes them an 
ideal cell line by which to investigate the toxicity of heavy metals. 
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1.8.2: C6 Glial cell line 
 
              The C6 cell line was cloned from a wistar rat glial tumour. This cell line 
possesses antigens and enzymes characteristic of astrocytes and oligodendrocytes in 
vivo and in primary cultures; enzymes such as glutamine synthetase, glycerol 
phosphate hydrogenase and lactate dehydrogenase, that are thought to be involved in 
myelination and ammonia detoxification (Kumar et al., 1984). The cell line also 
produces the S-100 protein, which is unique to brain glial tissue in vertebrates, it has 
also been found in brain tumours of humans and animals. C6 cells have been 
employed in a variety of studies into neurotoxicology where they have shown similar 
responses to primary cells (Cookson et al., 1995). Morphologically C6 cells are 
astroblastic in appearance; they are epitheliod in shape with spherical nuclei. Like 
N2a cells they can also be induced to differentiate using serum withdrawal and the 
addition of sodium butyrate which causes reversible changes in morphology, growth 
and enzyme activities (Kruh, 1982). The compound causes cells to flatten, a process 
associated with the distribution of the cellular cytoskeleton. The compound induces 
hyperacetylation of chromatin proteins, which can be associated with gene expression 
and protein synthesis (Kruh, 1982). When differentiated C6 cells develop short 
processes and increased expression of a spectrin-like protein related to fodrin which; 
it has been speculated, is involved in the organisation of the cytoskeleton within these 
processes (Cookson et al., 1995) 
            Glial cells are thought to be an important target for heavy metals as research 
has indicated that the cells accumulate metals and may play a role in the death of 
neuronal cells, these features taken together make C6 cells a useful investigative tool 
that have been utilised by previous researchers in their investigation of heavy metals 
(Cookson & Pentreath, 1996). The use of both cell lines will enable a comparison to 
be made on their relative susceptibility to metal toxicity.  
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Putative mechanisms of mercury toxicity 
 
           Figure 1.8 is a diagrammatic representation of possible mechanisms of mercury 
toxicity. It is expected that at non-lethal concentrations the organic mercury 
compounds selected for further investigation will cause disturbances to the neuronal 
and glial cytoskeleton, as well as changes to the signalling cascades that control 
cytoskeletal organisation within the cells. In addition it is thought that the heavy 
metals will alter calcium homeostasis within the cells causing an increase in the 
activity of the calcium dependant enzymes, calpain. Calpain activation via increases 
intracellular calcium may occur through the action of ROS damaging cell membranes 
allowing the inflow of calcium. An increase in calcium can also occur through a build 
of glutamate causing over activation of the glutamate receptor and increases in 
calcium concentrations. Damage to membrane pumps and receptors involved in the 
control of calcium homeostasis may also contribute to calcium overload within the 
cell. 
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Figure 1.8: Possible mechanisms of Mercury toxicity. 
Hg+ enters the cell via the Ca2+ channel, MeHg diffuses across the cell membrane as does 
Hg0. Once inside the cell the metal can cause the production of ROS which attacks the 
mitochondrial membrane (mito) leading to the release of cytochrome c and the initation of the 
caspase pathway leading to cell death. Mercury exposure has also been shown to interfere 
with cytoskeletal proteins leading to disruption in the architecture of the cells. This 
interference may be caused by direct interaction of the metal with protein SH groups or via 
ROS production. In addition to stimulating ROS production, heavy metals like mercury can 
also inhibit cellular defences against free radicals, further exacerbating the damage caused by 
ROS. Exposure to heavy metals has also been shown to disrupt the uptake of glutamate by 
glial cells, which can lead to the death of neuronal cells by excitotoxicity. 
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AIMS 
 
 
To determine the effects of heavy metals on the growth, viability and differentiation of 
N2a and C6 cells using MTT reduction assays and morphology studies. Using established 
methods the sub-lethal concentrations of the selected heavy metals will be investigated to 
enable the selection of compounds for further study in to the sub-lethal effects of the 
chosen metals. 
 
To establish the molecular changes in the cytoskeleton associated with any sub-lethal 
changes in morphology that was highlighted by the morphology studies. The sub-lethal 
effects would be carried out on two compounds selected from the range of heavy metals 
investigated in the initial studies into cytotoxicity. Western blotting and confocal 
microscopy will be used to highlight any changes in the levels and distribution of 
cytoskeletal proteins such as tubulin and neurofilament proteins. 
 
Using western blotting the signalling pathways that control the regulation of the cell 
cytoskeleton is to be investigated to determine whether any alterations in the levels and 
distribution of cytoskeletal proteins are preceded by changes to the normal signalling 
pathways.   
 
Previous studies have shown that treatment with heavy metals impairs the cells ability to 
regulate intracellular calcium concentrations. Sustained elevations in intracellular calcium 
concentrations would cause unregulated activation of calcium dependant enzymes such as 
calpains. Calpains are known to target cytoskeletal proteins for degradation, so the fourth 
aim of this thesis was to investigate changes in calpain activity, in an attempt to explain 
the degradation of the cytoskeleton. The distribution of certain proteins essential for 
calcium homeostasis will also be looked at using confocal microscopy. 
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2.1: Materials 
 
2.1.1. Specialised Reagents 
Dulbecco’s modified Eagle’s medium (DMEM) and foetal calf serum (BioWhittaker, 
Wokingham, UK) 
Glutamine/penicillin/streptomycin was purchased from Sigma-Aldrich (Poole, UK). 
Bodipy thapsigargin, Bodipy ryanodine, calpain substrate and ER tracker were from 
Invitrogen, (Paisley, UK).  
Vectashield mounting medium was supplied by Vectalabs, (Peterborough, UK). 
. 
2.1.2. Antibodies 
Mouse monoclonal antibodies to NF-H (N52), total α-tubulin (B512), tyrosinated α-
tubulin (T1A2), β-tubulin (Tub 2.1), anti-phosphorylated serine (PSR-45) and anti-
phosphorylated threonine (PTR-8) were supplied by Sigma-Aldrich (Poole, UK) 
The mouse hybridoma cell line producing antibody against phosphorylated NF-H 
(RT97) was originally purchased from The Developmental Hybridoma Bank and 
culture supernatant produced ‘in house’. 
Mouse monoclonal anti-phosphorylated NF-H (SMI-34) was from Sternburger 
Monoclonals, Ltd. (Maryland, USA)  
The goat polyclonal anti-calpain 1 antibody (C-20) and mouse monoclonals anti-JNK 
(D-7) and anti-phosphorylated JNK (G-7) and anti-GRASP 65 were purchased from 
Autogen Bioclear (Wiltshire, UK) 
Alkaline phosphatase-conjugated polyclonal rabbit anti-mouse, TRITC-conjugated 
polyclonal rabbit anti-mouse and horse radish peroxidase-conjugated goat anti-rabbit 
were all purchased from DakoCytomation (Ely, UK).  
 
2.1.3. Tissue Culture Plastic-ware  
All sterile tissue culture plastics were of the highest quality and purchased from 
Scientific Laboratory Supplies (Nottingham, UK) 
 
 
 
 
 
 34 
2.1.4. Reagents 
 
All general chemical reagents were purchased from Sigma-Aldrich (Poole, UK) or 
BDH (Leicester, UK), unless otherwise stated in the text. 
 
2.1.5. Cell Lines 
Rat C6 glioma cells and mouse N2a neuroblastoma cell lines were obtained from 
Flow Laboratories (Irvine, UK) 
 
2.2: Methods 
 
2.2.1: Cell culture and maintenance 
N2a cells and C6 cells were both maintained as monolayers in T25 flasks containing 
DMEM supplemented 10 % foetal bovine serum (FBS) and 2 mM L-glutamine, 100 
units/ml penicillin and 100 µg/ml streptomycin (Growth medium). They were 
incubated at 37 oC in a humidified atmosphere of 5 % CO2 / 95 % O2. Both cell lines 
were maintained in the logarithmic growth phase and passaged every 3-4 days, when 
the monolayer was approximately 80 % confluent. The cells were detached gently 
using a sterile pasture pipette and the cell suspension was centrifuged for 5 minutes at 
300 rpm. The supernatant was discarded and the cell pellet was suspended in 1 ml of 
fresh growth medium. 1-2 drops of the cell suspension were placed in a new T25 flask 
along with 10 ml of fresh growth medium. Cells were routinely kept and used for 
approximately 30 passages following revival from liquid nitrogen storage, after which 
they were discarded and a new batch thawed.  
 
2.2.3: Cryopreservation of cell lines 
 
Cells were detached from the surface of the flask and centrifuged for 5 minutes at 300 
rpm. The supernatant was discarded and the pellet of cells was resuspended in 1 ml of 
freezing medium [69 % (v/v) DMEM, 25 % FBS, 5 % dimethylsulphoxide (DMSO), 
2 mM L-glutamine, 100 units /ml penicillin and 100 µg/ml streptomycin]. The cell 
suspension was transferred to a freezing vial and stored at -70 °C overnight and then 
into liquid nitrogen for long term storage. 
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2.2.4: Restoration of cells stored in liquid nitrogen 
 
Cells were removed from liquid nitrogen and thawed as quickly as possible in warm 
water. The freezing medium containing the cells was immediately diluted in 10 ml of 
growth medium and centrifuged for 5 minutes at 300 rpm. The supernatant was gently 
poured off and the pellet was resuspended in 10 ml of fresh growth medium. The cell 
suspension was centrifuged again and then resuspended in 1 ml of growth medium 
before being transferred to a sterile T25 flask containing approximately 5 ml of 
growth medium. The cells were left to recover for 24 hours, after this time the 
medium was replaced or if the monolayer was 80 % confluent the cells were 
passaged. Cells were considered fit for experimentation after 1-2 passages. 
 
2.2.5: Seeding of cells for experiments 
 
Both cells lines were used for experimental analysis when they were approximately 
60-80 % confluent. The cells were detached using a sterile pasture pipette and growth 
medium. The cell suspension was transferred to a ‘sterilin’ tube and centrifuged at 
300rpm for 5 minutes. The cell pellet was resuspended in 1 ml of growth medium 
using a 1000 µl Gilson pipette. A total of 20 µl of the cell suspension was removed 
and added to 180 µl of growth medium in an Eppendorf tube (1:10 dilution) and a 
haemocytometer count was carried out to determine cell density. Cells were then 
plated out at a typical cell density of 50,000 cells/ml. Cells were then incubated at 37 
°C in a humidified atmosphere of 95 % O2 and 5 % CO2 to allow recovery. Cell 
viability was determined by the general appearance of the cells and the trypan blue 
exclusion test. Trypan blue is taken up by dead cells where it stains the cytoplasm, 
causing the cells to shine blue under a light microscope. A 1:10 dilution of cell 
suspension was made in trypan blue solution (0.4 % [v/v]) typically 180 µl of trypan 
blue and 20 µl of cell suspension. 
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2.2.6: Cell differentiation 
 
Mouse N2a neuroblastoma cells 
 
N2a cells were seeded as described previously. After the recovery incubation 
overnight, N2a cells were induced to differentiate by serum withdrawal and the 
addition of dibutyrl cyclicAMP (dbcAMP) at a final concentration of 0.3 mM 
(Flaskos et al. 1998 etc). For this, the growth medium was carefully removed and 
replaced with an equal volume of serum-free DMEM supplemented with 2mM L-
glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin (serum-free medium) 
and dbcAMP.  
 
Rat C6 glioma cells 
 
C6 cells were seeded as described previously. After the recovery incubation, C6 cells 
were induced to differentiate using serum withdrawal and the addition of sodium 
butyrate at a final concentration of 2 mM. For this, the growth medium was carefully 
removed and replaced with an equal volume of serum-free DMEM supplemented with 
2 mM L-glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin (serum-free 
medium) and sodium butyrate.  
 
2.2.7: Exposure of cells to heavy metals  
 
All toxins except methylmercury chloride, which was solubilised and diluted in 
dimethyl sulphoxide (DMSO), were diluted in sterile distilled water to make a master 
stock concentration of 20 mM, from which working stock solution were prepared by 
further dilution. Cells were seeded as described previously. The growth medium was 
removed and replaced with serum free medium containing the compounds to final 
concentrations of 0.01, 0.1, 1, 10 or 100 µM. The equivalent amount of sterile 
distilled water or neat DMSO was added to the control cells (final concentration 0.5 
% v/v).  
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2.2.8: Methyl blue tetrazolium (MTT) reduction assays 
 
The MTT assay is based upon the cleavage of a yellow tetrazolium salt to purple 
formazan crystals which can then be read in a spectrophotometer by lysing the cells 
with DMSO (Mosmann, 1983). The MTT assay has been shown to be a useful 
indicator of cell viability when looking at heavy metals (Cookson et al., 1995). 
Cleavage is thought to be carried out mainly by mitochondrial dehydrogenases. Cells 
induced to differentiate in the presence and absence of heavy metals, as described 
earlier, were incubated for the final 30 minutes of the required exposure time in the 
presence of MTT (50 µl of a stock solution at 5 mg/ml in DMEM). After carefully 
removing the medium, 1 ml of dimethyl sulphoxide (DMSO) was added to each well 
to solubilise the reduced dye. The absorbance was read in a spectrophotometer at 
570nm. 
 
2.2.9: Quantification of neurite outgrowth 
 
The cells were seeded into 24-well plates and differentiated in the presence and 
absence of heavy metals. After incubated period was complete the medium was 
removed and the cells were fixed for 10 minutes at –20 oC with 0.5 ml of 90 % 
methanol in TBS (10 mM Tris, 140 mM NaCl, pH 7.4). Cells were stained using 0.5 
ml of Coomassie brilliant blue stain (1.25 g Coomassie blue-R250, 10 % (v/v) glacial 
acetic acid, 40 % (v/v) methanol, 50 % (v/v) distilled water) for approximately 2 min 
at room temperature. The Coomassie stain was removed and the wells were gently 
washed with distilled water and then allowed to air dry. Cell counts were carried out 
on an inverted microscope at x200 magnification. Five fields were counted per well; 
the counts included total number of cells and number of axons, which were defined as 
neuronal outgrowths over two cell body diameters in length in the case of N2a cells 
(Keilbaugh et al., 1991; Flaskos et al., 1998). In the case of C6 cells, all neurites were 
counted (Flaskos et al., 1998). 
 
2.2.10: Preparation of cell lysates  
 
N2a and C6 cells were differentiated for 4 h or 24 h in the presence and absence of 
two sub-lethal concentrations of methylmercury chloride or thimerosal (0.1 µM or 1 
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µM). After the required period of exposure, cells were lysed by the replacement of 
medium with 0.5 % w/v SDS in TBS, which had been pre-heated in a boiling water 
bath. The lysate was then transferred to an Eppendorf tube and boiled for 5 min. The 
protein concentration of cell lysates was determined using the assay of (Lowry et al., 
1951) modified to a microtitre plate format. 
 
2.2.11: Mini-Lowry assay to determine protein concentration in cell extracts 
 
Protein estimation was carried out using an assay first described by (Lowry et al., 
1951). The mini-Lowry assay has been used routinely in the lab. The typical r2 for the 
calibration curve was 0.9883. The protein assay has also been used in previous work 
using the same cell lines (Sachana et al., 2001). A series of standards were produced 
in triplicate using bovine serum albumin (BSA). The protein mass in the standard 
assay tubes was from 0 to 70 µg. In addition to the appropriate BSA amount, standard 
assay tubes also contained 30 µl of extraction buffer (0.5 % w/v SDS in TBS) and 
made up to 0.1 ml with distilled water. The unknown samples, which were set up in 
duplicate, contained 30 µl of cell lysate in extraction buffer and 70 µl of distilled 
water. Solution A [2 % (w/v) Na2CO3, 0.4 % (w/v) NaOH]. Solution B [1 % (w/v) 
CuSO4. 5H2O] and solution C [2.7 % (w/v) sodium potassium tartrate] were combined 
to make a working solution comprising 50 ml of solution A and 1 ml of solutions B 
and C. A volume of 1 ml of the Lowry working solution was added to the standards 
and the cell extracts, vortex mixed and left for 10 minutes at room temperature. 
Following incubation, 100 µl of Folin-Ciocalteu reagent (freshly diluted 1:1 with 
distilled water) were added, vortex-mixed and left for a further 30 min. A total of 100 
µl of each sample from the Eppendorf tubes was transferred to a 96-well microtitre 
plate and read the absorbance read at 750nm.  
 
2.2.12: SDS-PAGE and  electrotransfer  of cell lysates  
 
Lysed cell extracts with an equal protein concentration of 20-60 µg were diluted in an 
equal volume of x2 concentrated Laemmli electrophoresis sample buffer (10 % w/v 
SDS, 0.5 M Tris-HCl pH 6.8, 10 % v/v glycerol, 0.04 % w/v bromophenol blue and 
10 % v/v β-mercaptoethanol and boiled for 5 min. Samples were then loaded in to 
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sample wells using gel loading tips. Proteins from cell extracts were separated on a 
7.5 % or 10 % w/v polyacrylamide gel, the recipe for which can be seen in table 2.1, 
overlaid with a 4 % w/v polyacrylamide stacking gel (Laemmli, 1970). The samples 
were equally loaded on to the gel through electrophoresis running buffer (0.0256 M 
Tris base, 0.192 M glycine and 0.1 % w/v SDS).  
The samples were electrophoresed in parallel with Bio-Rad precision blue pre-stained 
standards in a mini Protean 3 electrophoresis cell for 10 min at 50 V and then at 200 
V until the dye front reached the bottom of the gel (which normally takes about 1 
hour). The electrophoresed proteins were then transferred to a nitrocellulose 
membrane filter using the wet blotting procedure described by (Towbin et al., 1979) 
with modifications, using a ‘tank’ buffer system. Following electrophoresis, the gel 
was immersed in continuous transfer buffer (CTB: 30 mM glycine, 48 mM Tris base, 
0.1 % w/v SDS, 20 % v/v methanol in distilled water) to allow partial removal of 
SDS. Four pieces of blotting paper (3MM Whatman chromatography paper) per gel 
were soaked in continuous transfer buffer along with a sheet of nitrocellulose (pore 
size 0.45 mm) all were cut slightly larger than the gel itself. Two pieces of blotting 
paper were placed on the sponge at the bottom of the wet blotter cassette then the 
nitrocellulose membrane filter was placed on top of the blotting paper, followed by 
the gel. The sandwich was completed by a further two sheets of blotting paper and the 
blotter sponge. Each blotting cassette was carefully assembled to minimised air 
bubbles between the individual layers. The cassette was placed in the wet blotter tank 
(nitrocellulose facing towards the positive anode). The transfer was run overnight for 
approximately 16 hours at 30 V.  
 
2.2.13: Staining of Western blots 
 
The resultant blots were stained using 0.05 % w/v copper pthalocyanine in 12 mM 
HCl to ensure that the transfer was successful and that the protein loading was indeed 
equal. Blots showing unequal protein loading were discarded or the differences in 
protein concentration within the wells were corrected for by densitometric analysis of 
the bands. Unequal protein loading was standardised against the control by adding or 
subtracting the differences in absorbance obtained for each band. The nitrocellulose 
was then destained using 12 mM NaOH, followed by neutralisation in TBS.  
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Table 2.1 Formulation of SDS-PAGE minigels 
 
 
 
 
 
 
 
 
 
 
  Resolving gel                                    Volumes for polyacrylamide gel concentrations 
(ml) 
 
                                                                    7.5 %         10 %            12 %             15 %                                                 
_____________________________________________________________________ 
40 % w/v Acrylamide stock                       1.9              2.5              3.0               3.75  
 
1.5 M Tris buffer, pH 8.8                           2.5              2.5              2.5               2.5 
 
10 % w/v SDS                                          100 µl         100 µl         100 µl          100 µl  
 
Millipore water                                            5.5             4.9              4.4              3.65 
 
TEMED                                                       10 µl         10 µl           10 µl           10 µl           
 
10 % w/v Ammonium persulphate (APS) 100 µl       100 µl         100 µl         100 µl       
         
 
Formula for  stacking gel (10 ml) 
_____________________________________________________________________ 
                                                                   Volume (ml) 
40 % w/v Acrylamide stock                         1 
0.5 M Tris buffer, pH 6.8                            2.5 
10 % w/v SDS                                              0.1 
Distilled water                                             6.4 
TEMED                                                       40 µl 
10 % w/v APS                                            100 µl                 
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2.2.14: Immunoprobing of nitrocellulose blots 
 
Unoccupied protein binding sites were blocked in 3 % w/v Marvel in TBS 
(Marvel/TBS) for at least one hour at room temperature. After blocking, the blot was 
left overnight at 4 oC in the primary antibody diluted to the appropriate concentration 
in 3 % w/v BSA or Marvel/TBS. After incubation, any unbound antibody was 
removed by 6 x 10-minute washes in TBS/Tween (0.05 % Tween-20 in TBS). After 
washing, the blot was incubated at room temp for at least 2 hours with the appropriate 
alkaline phosphatase-conjugated secondary antibody, which was used at 1/1000 
dilution in Marvel/TBS. The secondary antibody was removed by washing as for the 
primary antibody. Then the blots were incubated in the substrate buffer for at least 2 
min before the addition of developer, containing 20 ml substrate buffer (1.5 M Tris 
pH 9.5), 33 µl 5-Bromo-4-chloro-3-indolyl-phosphate disodium salt (BCIP – 50 
mg/ml in distilled water) and 44 µl nitro blue tetrazolium (NBT – 75 mg/ml in 70 % 
dimethyl formamide). Once the bands had developed on the probed blot, the reaction 
was stopped by submerging the blot in distilled water. The blot was then dried with 
filter paper and a digital image was recorded. With each use of a new antibody a non 
primary control blot was carried to ensure there was no binding of the secondary 
antibody to the electrotransfered proteins on the western blot. 
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Table 2.2 Antibodies 
 
                           Working Dilutions 
Antibody Western blotting immunofluorescence 
Anti-total neurofilament 
heavy chain (N52) 
1:1000 1:200 
Anti-phosphorylated 
neurofilament heavy chain 
(RT97) 
1:10 1:5 
Anti-phosphorylated 
Neurofilament heavy chain 
(SMI 34) 
1:1000 1:200 
Anti-calpain 1 (C-20) 1:500 - 
Anti-JNK (D-2) 1:500 - 
Anti-phosphorylated JNK 
(G-7) 
1:500 - 
Anti-ERK 1:500 - 
Anti-phosphorylated ERK 1:500  
Anti-phosphorylated serine 
(PSR-45) 
1:500  
Anti-phosphorylated 
threonine (PTR-8) 
1:500  
Anti-β- tubulin (Tub 2.1) 1:500  
Anti-total α-tubulin (B512) 1:1000 1:200 
Anti-tyrosinated α-tubulin 
(T1A2) 
1:1000 1:200 
Anti-GRASP 65 protein  1:200 
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2.2.15: Immunofluorescence staining of cells 
 
Antibody staining   
 
Cells were seeded into chamber slides at a density of 50,000 cells per ml and 
differentiated for 24 hours as before. Cells were then fixed using ice cold 90 % v/v 
methanol in TBS for 10 minutes at -20 °C. After fixing the cells were rehydrated 
using TBS for 20 minutes and then blocked in 3 % w/v BSA in TBS overnight at -4 
0C. After the blocking, the appropriate dilution of primary antibody (see table 2.2) 
was added and incubated overnight at -4 °C. All antibodies were diluted in 3 % w/v 
BSA or Marvel/TBS. Unbound primary antibody was removed by 3 x 15-minute 
washes with TBS/Tween using gentle agitation. The TRITC-conjugated secondary 
antibody was used at a dilution of 1/40 and was incubated for 2-3 hours at room 
temperature, in the dark. Unbound secondary antibody was removed as for the 
primary antibody. The slides were then dried and mounted using an anti-fade 
mountant. Once the cover slips were dry, the slides were viewed using a Leica CLSM 
confocal laser scanning microscope fitted with epifluorescence optics at a 
magnification of x 600. FITZ conjugated secondary antibodies were viewed at 488nm 
excitation and TRITZ conjugated at 532nm. 
 
BODIPY dye staining 
 
Cells were seeded into chamber slides at a density of 50,000 cells per ml and 
differentiated for 24 hours. Cells were then fixed using ice-cold 90 % v/v methanol 
for in TBS 10 min at -20 °C. After fixing the cells were rehydrated using TBS for 20 
minutes and then blocked in 3 % w/v BSA in TBS overnight at 4 °C. BODIPY-
thapsigargin was used at a concentration of 10 µM and BODIPY-ryanodine was used 
at 1 µM; both were diluted in 3 % w/v BSA in TBS. The BODIPY dye was applied 
after blocking and incubated with the fixed cells overnight at 4 °C. To prevent the 
fluorescence from fading, the slides were wrapped in foil at all times. The stain was 
removed by 3 x 15-minute washes with TBS/Tween, using gentle agitation. The slides 
were then dried and mounted using an anti-fade mountant. Once the cover slips were 
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dry, the slides were viewed at a magnification of x 600 using a Leica CLSM confocal 
laser scanning microscope fitted with epifluorescence optics at 488nm excitation. 
 
2.2.16: Calpain Assay 
 
N2a and C6 cells were seeded into T25 flasks as previously described and 
differentiated for 4 and 24 hours in the presence and absence of 0.1 and 1 µM 
thimerosal and methylmercury chloride as before. After the incubation, the medium 
was gently removed from the monolayer and replaced with the homogenisation buffer 
(20 mM Tris-HCl pH 7.2, 0.04 % v/v igepal, 2 mM EDTA pH 7.2 and 20 % v/v 
glycerol). The cells were gently removed using a cell scraper, transferred to an 
eppendorf and placed on ice. Cells were lysed by sonication, prior to the assay to 
release the contents. The calpain assay was carried out in black 96 well plate 
containing 30 µl of sample or 30 µl of homogenisation buffer for control wells, 10 µl 
of 50 mM CaCl, 40 µl of 120 mM imadizole buffer pH 7.3 and 20 µl substrate. The 
substrate was added to the wells immediately before the plate was placed in the 
machine. The assay was carried out over a period of 3 hours with readings obtained 
every 5 minutes. The fluorescence was read in a FLUOstar OPTIMA at 521nm. 
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3: Effects of heavy metals on cell growth and differentiation 
 
Introduction 
 
          Assays to determine cell viability are a valuable research tool when studying 
the toxicity of various compounds.  Previous researchers have used a variety of cell 
viability assays in order to determine the toxicity of heavy metals. Numerous cell 
viability assays exist such as the lactate dehydrogenase (LDH) assay, based upon the 
detection of the cytosolic enzyme lactate dehydrogenase (Mori et al., 1995). The 
activity of the enzyme enables conclusions to be made about membrane integrity and 
thus cytotoxicity. The propidium iodide stain can be used as a marker of dead of 
dying cells, since it is unable to penetrate the membrane of living cells (Braekman et 
al., 1997). With the CellTitre blue assay, the non fluorescent resazurin is reduced to 
resorufin by mitochondrial and cytosolic enzymes and is measured by 
spectrofluorometry (Bigl et al., 2007). The MTT assay is based upon the cleavage of a 
yellow tetrazolium salt to purple formazan crystals which can then be read in a 
spectrophotometer by lysing the cells with DMSO (Edmondson et al., 1988). 
Cleavage is thought to be carried out mainly by mitochondrial dehydrogenases. All 
these assays have their technical advantages and disadvantages and comparative 
experiments show that they may give slightly different results. A study by (Bigl et al., 
2007) looked at the LDH, CellTitre blue and MTT assay, all assays gave different 
toxicity results. This does not render these assays invalid as a research tool as long as 
the variable is controlled by the use of the same assay throughout the experiments. It 
does however make the comparison of research using different assays problematic. 
The MTT assay was used in this work as it is safer than the use of radioactive isotopes 
and gives less background. The MTT assay is also reproducible and the absorbance 
correlates strongly with cell number. It is also sensitive enough to detect low cell 
numbers. In addition the assay is also relatively quick and simple to carry out.  The 
MTT assay has also been used by previous research groups to investigate the toxicity 
of heavy metals (Cookson et al., 1995; Sanfeliu et al., 2001; Crespo-López et al., 
2006).  
            Changes in cell morphology have been reported by numerous researchers in 
both neuronal and non-neuronal cells lines during exposure to heavy metals (Schwartz 
et al., 2000; Bonacker et al., 2004). The process of neurite formation in neuronal cells 
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is essential in axonal plasticity that accompanies normal development of the CNS 
(Andrieux et al., 2002; Wall, 2005). Symptoms of neurological impairment seen with 
cases of poisoning with most heavy metals may in part by down to the effect on axon 
production, especially with developing children. Methods of looking at cell 
morphology mainly involve some form of microscopy with cell permeable stain or 
immunofluorescence.  
 
Methods 
 
          The initial aim of the research was to study the effects of the chosen heavy 
metal compounds on viability, and to establish whether sub-lethal concentrations 
affected the morphology of N2a and C6 cells. This was achieved using the established 
methods of MTT reduction assays (Mosmann, 1983; Cookson et al., 1995) and 
quantification of neurite outgrowth (Flaskos et al., 1998; Sachana et al., 2003). Cells 
were differentiated via serum withdrawal for 4, 24 and 48 hours for the viability assay 
in the presence and absence of 6 heavy metals as described in methods section. The 
concentrations of heavy metals used were 0.01, 0.1, 1, 10 and 100 µM, produced by 
serial dilution of a stock concentration of 10 mM. Each individual experiment was 
carried out in a 24 well plate containing the 4 wells of control cells and the range of 
heavy metal concentrations with 4 wells for each and each experiment was repeated 4 
times (see Methods for a detailed description). 
             Due to the inability of the cell lines used to maintain neurite stability beyond 
24 hours, the quantification of neurite outgrowth was measured at 4 and 24 hours. To 
compare early and late events that occurred with the exposure of the toxins. The cells 
were fixed using ice cold methanol and stained using Coomassie blue (see Methods). 
Quantification of neurite outgrowth used the same range of concentrations as the 
MTT assays in order to establish whether non-toxic concentrations had any effect 
upon neurite number. In N2a cells, axons were classed as processes over two cell 
body diameters in length. All processes of the qualifying length and over were 
counted and the numbers were normalised against the control cell numbers. In the 
case of C6 cells, all processes were counted and again normalised against the control 
cell number. Five fields per well were counted and there were 4 wells for each 
experimental condition. Each experiment was repeated at least 3 times. Data was 
expressed as % of control for each time point, which was calculated for each well, 
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then for each separate experiment. All data in this section are shown as mean + SEM. 
The results were analysed statistically using 2 way ANOVA to compare differences in 
data sets followed by post hoc Bonferroni’s correction for pair wise multiple 
comparisons. In the results n = x refers to the number of times the experiment was 
carried out using cells seeded on different days. 
 
3.0: C6 and N2a cell morphology 
 
Figure 3.0.1 shows typical images of healthy C6 (a) and N2a (b) cells differentiated 
for 24 hours with no heavy metals present in the media. The C6 cell line produces on 
average 2-4 processes of varying length per cell indicated by the blue arrows in image 
a. N2a cells (b) typically produce 2 to 5 processes. Not all of the processes produced 
by the N2a cells were counted; the shorter processes as indicated by the green arrow 
were not classed as axons and were excluded from the neurite counts. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.0.1: C6 and N2a control cell morphology  
C6 (a) and N2a (b) cells were induced to differentiate for 24 hours as described in Methods. 
The cells were fixed and stained with Coomassie Brilliant Blue. Blue arrows indicate cellular 
processes and the red arrows point to the cell body. Images were taken at x 400 
magnification. 
 
 
 
 
   __  
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3.1: The effect of zinc chloride on MTT reduction and neurite outgrowth 
 
Zinc chloride up to 100 µM had no effect on the ability of either C6 or N2a cells to 
reduce MTT to a coloured product measurable by a spectrophotometer (Figure 3.1.1) 
when compared to the control, differentiated under the same conditions as the cells 
exposed to zinc chloride but in the absence of heavy metal. The data was normalised 
against the control value for the corresponding time points, with typical control 
absorbance between 0.708 and 0.932, absorbance readings for cells exposed to 1 µM 
zinc chloride ranged from 0.766 to 0.850. A 2 way ANOVA test confirmed that there 
were no significant differences in either the 4 or 24 hour data sets (p value 0.94). The 
presence of zinc chloride in 1 ml of DMSO alone did not alter the absorbance of the 
spectrophotometer from that of a DMSO blank. 
 
Control cells differentiated for 4 and 24 hours (Figure 3.1.2 a & b) appear flattened as 
they are attached to the surface of the well with short processes. Treatment with up to 
100 µM of zinc chloride for 4 and 24 hours did not cause any reduction in neurite 
number or changes in cell morphology. The images shown are representative of 5 
separate experiments and reflect the effects seen in each. 
 
Similarly exposure of C6 cells to up to 100 µM zinc chloride (Figure 3.1.3) caused no 
statistically significant alterations in neurite outgrowth at any concentration or time 
point. In untreated or control cells the number of neurites was between 19 and 30 per 
100 cells and 16-18 in cells exposed to 100 µM zinc chloride. Statistics confirmed 
that there were no significant changes from the controls (p value 0.39). Statistical 
analysis of time differences was also insignificant the p value for the comparison of 4 
and 24 hours was 0.75. 
 
N2a cells differentiated in the absence of zinc chloride (Figure 3.1.4 a-b). The cells 
appeared round in shape with long axon-like processes extending outwards from the 
cell body. Treatment with 100 µM zinc chloride did not appear to cause any 
significant reduction in neurite number or changes in cell morphology. The images 
shown are representative of 4 separate experiments and reflect the effects seen in 
each. 
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Figure 3.1.1: Effects of zinc chloride on MTT reduction in differentiating C6 and N2a 
cells 
C6 (a) and N2a (b) cells were induced to differentiate for 4, 24 and 48 hours in the presence 
and absence of zinc chloride as described in Methods. The Data is expressed as mean 
percentage of the corresponding control + SEM (n = 5). Data was analysed using a 2 way 
ANOVA. 
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Figure 3.1.2: Effects of zinc chloride on differentiated C6 cell morphology 
C6 cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence (c, d) and 
absence (a, b) of zinc chloride. The cells were fixed and stained with Coomassie Brilliant 
Blue as described in Methods. Images of typical C6 cells were taken at x 200 magnification (n 
= 4). 
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Figure 3.1.3: Effect of zinc chloride on neurite outgrowth in differentiated C6 cells 
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of zinc 
chloride as described in Methods. The Data represent is expressed as mean percentage of the 
corresponding control + SEM (n = 5). Statistical analysis was carried out using 2 way 
ANOVA.  
 
 
 
Zinc chloride up to 100 µM caused no statistically significant alterations in neurite 
outgrowth at any concentration or time point (Figure 3.1.3). Typical neurite numbers 
for control cells differentiated for 24 hours were between 21 and 37 per 100 cells. 
Exposure to 100 µM zinc chloride caused no significant change in neurite number 
with neurites produced numbering between 26 and 46 neurite per 100 cells. Statistical 
analysis of the different time points was also insignificant with a p value of 0.25 when 
comparing neurite number at 4 and 24 hours. 
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Figure 3.1.4: Effect of zinc chloride on differentiated N2a cell morphology 
N2a cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence(c, d) 
and absence (a, b) of zinc chloride. The cells were fixed and stained with Coomassie Brilliant 
Blue as described in Methods. Blue arrows indicate cellular processes. Images of typical N2a 
cells were taken at x 200 magnification (n = 4). 
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Figure 3.1.5: Effect of zinc chloride on neurite outgrowth in differentiated N2a cells. 
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of zinc 
chloride as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA.  
 
3.2: The effect of lead chloride on MTT reduction and neurite outgrowth 
 
Figure 3.2.1 shows the effect of lead chloride on the ability of C6 and N2a cells to 
reduce MTT. Data is expressed as % difference from corresponding control. The 
typical absorbance obtained for controls was between 0.574 and 0.967. Lead chloride 
caused a significant increase of around 35-65 % in MTT reduction at 100 µM in both 
C6 and N2a cells at all time points (p<0.05). Actual p values were between 0.03674 
and 0.04571. Concentrations below 100 µM had no significant effect on MTT 
reduction. There was no significant difference between the values obtained for the 
different time points a comparison of the time points at gave a p value of 0.78. The 
presence of lead chloride in 1 ml of DMSO alone did not alter the absorbance of the 
spectrophotometer from that of a DMSO blank. 
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Figure 3.2.1: Effect of lead chloride on MTT reduction in differentiating C6 and N2a  
cells. 
    
C6 (a) and N2a (b) cells were induced to differentiate for 4, 24 and 48 hours in the presence 
and absence of zinc chloride as described in Methods. The Data is expressed as mean 
percentage of the corresponding control + SEM (n = 5). Data was analysed using a 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1 
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Figure 3.2.2: Effect of lead chloride on differentiated C6 cell morphology 
C6 cells were induced to differentiate for 4 (a , c) and 24 (b, d) hours in the presence (c, d) 
and absence (a, b) of lead chloride. The cells were fixed and stained with Coomassie Brilliant 
Blue as described in Methods. Blue arrows indicate cellular processes. Images of typical C6 
cells were taken at x 200 magnification (n = 4). 
 
Control cells differentiated for 4 and 24 hours have formed numerous processes and 
have differentiated together in clusters (Figure 3.2.2 a-b). Exposure to 100 µM lead 
chloride did not appear to have reduced the number of processes formed between the 
cells when compared to the control cells of the 4 hour incubation time (Figure 3.2.2 
c). In Figure 3.2.2 d the cells have been exposed to 100 µM lead chloride for 24 hours, 
it appeared that the numbers of processes were reduced when compared to the control. 
There was also evidence of cell debris (red arrows) that was not visible in Figures a-c. 
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d) 
 
__ 
10 µm 
 56 
The images are representative of 4 separate experiments and reflect the trends that 
were seen in each one. 
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Figure 3.2.3: Effect of lead chloride on neurite outgrowth in C6 cells. 
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of lead 
chloride as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
 
 
In Figure 3.2.3 neurite number is expressed as a percentage of the corresponding 
control which was calculated per well and then per experiment. Incubation with lead 
chloride had no significant effect (p < 0.05) on C6 cell morphology up to 
concentrations of 100 µM (Figure 3.2.2 c). Statistical analysis of the data obtained 
from cells exposed to 100 µM gave a p value of 0.73611. Typical neurite number in 
control cells were in the range of 13-34 processes per 100 cells. Exposure to 100 µM 
lead chloride for 24 hours caused a significant reduction of 25 % (p = 0.03429), with 
a corresponding range of neurite number of between 6 and 20 neurites per 100 cells. 
However there were no significant differences between 4 and 24 hours (p = 0.09862). 
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Figure 3.2.4: Effect of lead chloride on differentiated N2a cell morphology. 
N2a cells were induced to differentiate for 4 (a , c) and 24 (b, d) hours in the presence (c, d) 
and absence (a, b) of lead chloride. The cells were fixed and stained with Coomassie Brilliant 
Blue as described in Methods. Blue arrows indicate cellular processes. Images of typical N2a 
cells were taken at x 200 magnification (n = 4). 
 
Control cells differentiated for 4 and 24 hours in the absence of lead chloride were 
spherical in shape with long axon-like processes extending out from the cell body 
(Figure 3.2.4 a-b). The neurites were not continuous they had shorter branches along 
their length. When exposed to 100 µM lead chloride, the number of the neurites 
appeared reduced when compared to the control cells. There appeared to be no 
obvious changes in the morphology of the cell after toxin exposure. The images were 
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representative of 4 separate experiments and reflect the major trends seen in each 
separate one. 
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Figure 3.2.5: Effect of lead chloride on neurite outgrowth in N2a cells. 
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of lead 
chloride as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
 
 
Neurite number in the control cells at 4 and 24 hours was between 16 and 28 neurites 
per 100 cells. When exposed to 100 µM lead chloride for 24 hours, axon number was 
reduced in N2a cells (Figure 3.2.5). Statistical analysis using a 2 way ANOVA and 
Bonferroni’s post hoc test gave a p value of 0.023, confirming that there was a 
significant change from the control values. The actual number of neurites was 
between 10 and 17 neurites per 100 cells. There was a significant difference between 
the 4 and 24 hour time points (p = 0.026) but only in cells exposed to 100 µM lead 
chloride. After 4 hours of treatment, there were no statistically significant (p<0.05) 
events with concentrations of lead chloride up to 100 µM (p = 0.78).  
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3.3: The effect of cadmium chloride on MTT reduction and neurite outgrowth 
 
The typical absorbance for the controls was 0.879. However, exposure to 10 and 100 
µM for 4, 24 and 48 hours (Figure 3.3.1) caused a significant decrease in MTT 
reduction (p<0.01) in both C6 and N2a cells. Cadmium chloride, at concentrations 
below 10 µM for up to 48 hours had no effect on MTT reduction in either cell line. 
There were significant differences between the 4 and 24 hours data obtained from the 
exposure of the C6 cells to 10 and 100 µM cadmium chloride (p = 0.013 and 0.028 
respectively). There were no significant time differences with N2a cells (p = 0.67). 
The presence of cadmium chloride in DMSO did not alter the absorbance from a 
DMSO blank in the spectrophotometer. 
 
 
Control C6 cells differentiated for 4 and 24 hours respectively were flattened due to 
the attachment on the surface of the well. The cells differentiated in close proximity 
and appeared in clusters (Figure 3.3.2 a-b). When exposed to 1 µM cadmium chloride, 
processes formed by the cells appeared to be reduced when compared to the control 
cells of the same incubation time (Figure 3.3.2 c- d). Staining highlighted cell debris 
(red arrow) which was not evident in control cells (Figure 3.3.2 c). The images are 
representative of 4 separate experiments and reflect the trends seen in all experiments.  
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Figure 3.3.1: Effect of cadmium chloride on MTT reduction in differentiating C6 and 
N2a cells    
C6 (a) and N2a (b) cells were induced to differentiate for 4, 24 and 48 hours in the presence 
and absence of zinc chloride as described in Methods. The Data is expressed as mean 
percentage of the corresponding control + SEM (n = 5). Data was analysed using a 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
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Figure 3.3.2: Effect of cadmium chloride on differentiated C6 cell morphology 
C6 cells were induced to differentiate for 4 (a , c) and 24 (b, d) hours in the presence (c, d) 
and absence (a, b) of cadmium chloride. The cells were fixed and stained with Coomassie 
Brilliant Blue as described in Methods. Blue arrows indicate cellular processes. Images of 
typical C6 cells were taken at x 200 magnification (n = 4). 
 
Exposure to cadmium chloride caused a concentration and time dependent reduction 
in neurite outgrowth in C6 cells (Figure 3.3.3). The average number of neurites for the 
control cells was 26 after 4 hours of differentiation and 31 after 24 hours. 
Concentrations of cadmium chloride below 1 µM had no significant effect on neurite 
number when compared to the control (p = 0.0456-0.97). Exposure to 1 µM cadmium 
chloride caused a 25 % - 55 % reduction in neurite number at 4 and 24 hours (p = 
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d) 
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0.032 and 0.005 respectively). The higher concentrations of 10 and 100 µM reduced 
the number of neurites by 55-90 % at both time points. Analysis of the data using a 2 
way ANOVA test and post hoc test confirmed statistical significance; p values were 
between 0.0001 and 0.008. The 2 way ANOVA test also highlighted significant 
difference between the different time points; post hoc Bonferroni’s test confirmed that 
there were significant differences with exposure to 1-100 µM cadmium chloride (p = 
0.034 for a comparison of the 10 µM data). 
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Figure 3.3.3: Effect of cadmium chloride on neurite outgrowth in C6 cells. 
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
cadmium chloride as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1, a and b 
indicates significant differences between the 4 and 24 hour time points. 
 
 
 
Control cells differentiated for 4 and 24 hours in the absence of cadmium chloride 
were spherical in shape with long axon-like processes extending out from the cell 
body (Figure 3.3.4 a- b). When exposed to 0.1 µM cadmium chloride the number of 
the axons appeared reduced when compared to the control cells (Figure 3.3.4 c-d). 
The images are representative of 4 separate experiments and reflect the trends seen in 
each one. 
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Figure 3.3.4: Effect of cadmium chloride on differentiated N2a cell morphology 
N2a cells were induced to differentiate for 4 (a , c) and 24 (b, d) hours in the presence (c, d) 
and absence (a, b) of cadmium chloride. The cells were fixed and stained with Coomassie 
Brilliant Blue as described in Methods. Blue arrows indicate cellular processes. Images of 
typical N2a cells were taken at x 200 magnification (n = 4). 
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Figure 3.3.5: Effect of cadmium chloride on neurite outgrowth in N2a cells. 
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
cadmium chloride as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
 
Incubation with cadmium chloride caused a concentration dependent reduction in 
axon outgrowth in N2a cells (Figure 3.3.5). The average number of neurites for the 
controls cells was 17 after 4 hours of differentiation and 26 after 24 hours. The lowest 
concentration that had a statistically significant effect (p<0.05) on neurite number was 
0.1 µM. After 4 and 24 hours exposure 0.1 µM cadmium chloride caused 
approximately a 38-40 % decrease in neurite number (p = 0 .072 and 0.055 
respectively). Exposure to 1 µM cadmium chloride caused a 68-70 % decrease (p = 
0.044 and 0.047 for 4 and 24 hours). Treatment with 10 µM, cadmium chloride 
reduced neurite outgrowth by 70 – 80 % at 4 and 24 hours (p = 0.00031 and 0.00056 
respectively). Concentrations of 100 µM cadmium chloride caused a 74-88 % 
reduction at 4 hours and 24 hours. Concentrations of cadmium chloride below 0.1 µM 
had no significant effect on N2a morphology (p = 0.91). A comparison of the two 
time points showed that the data obtained at 10 and 100 µM was significantly 
different (p = 0.049). 
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3.4: The effect of mercury chloride on MTT reduction and neurite outgrowth 
 
There was a significant decrease in MTT reduction of around 55-67 % with exposure 
to 10 µM mercury chloride (p = 0.034, 0.046 and 0.019 for the 4, 24 and 48 hour time 
points respectively) and 70-85 % with exposure to 100 µM in C6 cells at 4, 24 and 48 
hours (Figure 3.4.1 a). Concentrations below 10 µM had no effect on MTT reduction 
(p = 0.45, 0.78 and 0.43 for the 1 µM concentrations of mercury chloride at the 4, 24 
and 48 time points). The average absorbance for the C6 control wells was 0.354 and 
for the N2a 0.475. In N2a cells (Figure 3.4.1 b), MTT reduction was significantly 
decreased by 43-55 % with exposure to 10 µM (p = 0.046, 0.033 and 0.022 for the 4, 
24 and 48 hours respectively). Exposure to 100 µM mercury chloride significantly 
decreased MTT reduction by 57-75 %. A 2 way ANOVA test highlighted significant 
differences between the 4 and 24 hour time points in both cell lines with a p value of 
0.045 at 100 µM in N2a cells and 0.030 in C6 cells. The presence of mercury chloride 
alone in DMSO did not alter the absorbance from a DMSO blank.  
 
 
C6 cells differentiated for 4 and 24 hours without the presence of mercury chloride 
appeared flattened due to attachment to the well and differentiated in close proximity 
to each other (Figure 3.4.2 a – b). Cells treated with 10 µM mercury chloride for 4 
and 24 hours (Figure 3.4.2 c-d) appeared similar morphologically to the control cells 
but with less processes. In Figure 3.4.2 c there appears to cell debris that is not 
evident in the images showing the control cells. 
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Figure 3.4.1: Effect of mercury chloride on MTT reduction in differentiating C6 and 
N2a cells 
 
C6 (a) and N2a (b) cells were induced to differentiate for 4, 24 and 48 hours in the presence 
and absence of zinc chloride as described in Methods. The Data is expressed as mean 
percentage of the corresponding control + SEM (n = 5). Data was analysed using a 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1, a and b 
indicates significant differences between the time points. 
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Figure 3.4.2: Effect of mercury chloride on differentiated C6 cell morphology  
C6 cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence (c, d) and 
absence (a, b) of mercury chloride. The cells were fixed and stained with Coomassie Brilliant 
Blue as described in Methods. Blue arrows indicate cellular processes. Images of typical C6 
cells were taken at x 200 magnification (n = 4). 
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Figure 3.4.3: Effect of mercury chloride on neurite outgrowth in C6 cells. 
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
mercury chloride as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
 
 
 
 
Exposure to mercury chloride induced a statistically significant (p<0.05) reduction in 
neurite number in C6 cells at concentrations of 10 µM and above (Figure 3.4.3). The 
actual numbers of neurite ranged between 12 and 23 per 100 cells in control cells and 
in cells treated with 10 µM mercury chloride the numbers were reduced to the range 
of 5 to 12 neurites per 100 cells. Incubation with 10 µM mercury chloride caused a 
reduction in neurite number of approximately 55 % after 4 hours (p = 0.042) and 49 
% after 24 hours (p = 0.022). Exposure to 100 µM mercury chloride significantly 
reduced neurite outgrowth by around 25 % at 4 and 24 hours.  Statistical analysis 
confirmed that concentrations of 0.01, 0.1 and 1 µM mercury chloride had no 
significant effect on neurite outgrowth after either 4 or 24 hours exposure time (p = 
0.98 and 0.56 for the 4 and 24 hour incubation with 1 µM). The 2 way ANOVA test 
also confirmed that there were no significant differences between the 2 time points at 
any concentration (p = 0.33 for a comparison of 100 µM).  
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N2a cells differentiated for 4 and 24 hours in the absence of mercury chloride were 
spherical in shape with long neurites extending out from the cell body (Figure 3.4.4 a 
- b). When exposed to 10 µM mercury chloride (Figure 3.1.19 c - d), the number of 
the long (axon-like) neurites appeared reduced when compared to the control cells.  
 
Exposure of N2a cells to mercury chloride induced a statistically significant (p<0.05) 
reduction in neurite number at concentrations of 10 µM and above (Figure 3.4.5). The 
average numbers of neurites in control cells was 23 neurites per 100 cells. Exposure 
to 10 µM mercury chloride caused a reduction in neurite outgrowth of 50 % after 4 
hours (p = 0.043) and 52 % after 24 hours (p = 0.033). Exposure of N2a cells to 100 
µM mercury chloride reduced neurite outgrowth by 64 % at 4 hours and 70 % at 24 
hours. Statistical analysis confirmed that concentrations of 0.01, 0.1 and 1 µM 
mercury chloride had no significant effect on neurite outgrowth after either 4 or 24 
hours exposure time (p = 0.87 for 1 µM). Analysis of the 4 and 24 hour data using the 
2 way ANOVA test confirmed that there were no significant differences in the 
toxicity of mercury chloride with the different incubation times.  
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3.4.4: Effect of mercury chloride on differentiated N2a cell morphology  
N2a cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence (c, d) 
and absence (a, b) of mercury chloride. The cells were fixed and stained with Coomassie 
Brilliant Blue as described in Methods. Blue arrows indicate cellular processes. Images of 
typical N2a cells were taken at x 200 magnification (n = 4). 
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Figure 3.4.5: Effect of mercury chloride on neurite outgrowth in N2a cells 
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
mercury chloride as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
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3.5: The effect of thimerosal on MTT reduction and neurite outgrowth 
 
Exposing C6 cells to thimerosal caused a concentration dependent decrease in MTT 
reduction after 4, 24 and 48 hours incubation (Figure 3.5.1.a). The average 
absorbance obtained for cells untreated with thimerosal was 0.645. Exposure to 10 
µM thimerosal caused a significant reduction of 78 – 90 % after 4, 24 and 48 hours of 
exposure (p<0.01). Exposure to 100 µM thimerosal caused significant reductions at 
all time points of 80-95 %. A 2 way ANOVA test confirmed that exposure to 0.01, 0.1 
and 1 µM thimerosal had no significant effect on MTT reduction (p = 0.98 for 1 µM). 
Statistical analysis also confirmed that there was a significant difference between 
MTT reduction at 4 and 24 hours with exposure to 10 µM thimerosal (p = 0.032) 
which was not seen with any other concentration. In N2a cells, (Figure 3.5.1.b.), 
exposure to 10 µM thimerosal caused a significant decrease of 79 - 92 % after 4, 24 
and 48 hours (p = 0.0034, 0.0089 and 0.0044 for 4, 24 and 48 hours respectively). 
There were no significant differences from the controls with exposure to 0.01, 0.1 and 
1 µM thimerosal after 4 for 24 hours (p = 0.67-0.94). However, after 48 hours 
incubation, 1 µM thimerosal caused a significant decrease of 34 % in N2a cells’ 
ability to reduce MTT (p = 0.043). Statistical analysis showed significant differences 
between the data obtained at 24 and 48 hours during exposure to 1 - 100 µM 
thimerosal (p = 0.033 for 1 µM). 
 
 
C6 cells differentiated for 4 and 24 hours in the absence of thimerosal are flattened 
and have formed short processes connecting individual cells in a network (Figure 
3.5.2 a-b). In Figure 3.5.2 c and d it appeared that the processes formed between the 
cells were reduced in number when compared to the control cells of the same 
incubation time.  
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Figure 3.5.1: Effects of thimerosal on MTT reduction in differentiating C6 and N2a 
cells 
C6 (a) and N2a (b) cells were induced to differentiate for 4, 24 and 48 hours in the presence 
and absence of thimerosal as described in Methods. The Data is expressed as mean percentage 
of the corresponding control + SEM (n = 5). Data was analysed using a 2 way ANOVA. * 
indicates significant differences from the control, * p < 0.5, ** p < 0.1, a, b and c indicates 
significant differences between the time points. 
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Figure 3.5.2: Effect of thimerosal on C6 cell morphology   
C6 cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence (c, d) and 
absence (a, b) of thimerosal. The cells were fixed and stained with Coomassie Brilliant Blue 
as described in Methods. Blue arrows indicate cellular processes. Images of typical C6 cells 
were taken at x 200 magnification (n = 4). 
 
 
Thimerosal caused a dose dependent effect upon neurite outgrowth in C6 cells 
untreated with thimerosal. Cells produced an average of 46 neurites per 100 cells. The 
lowest concentration that produced a significant effect on the neurite outgrowth was 1 
µM which caused a 60 % reduction in processes at both exposure times (p = 0.036 
and 0.027 for 4 and 24 hours respectively). Exposure to 10 and 100 µM thimerosal 
significantly reduced neurite numbers by approximately 95 % at both 4 and 24 hours. 
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Statistical analysis confirmed that there were no significant differences between the 4 
and 24 hour time points (p = 0.57).  
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Figure 3.5.3: Effect of thimerosal on neurite outgrowth in differentiated C6 cells 
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
 
 
N2a cells differentiated for 4 and 24 hours in the absence of thimerosal were spherical 
in shape with long axon-like processes extending out from the cell body (Figure 3.5.4 
a-b). When exposed to 1 µM thimerosal, the number and length of the neurites 
appeared reduced when compared to the control cells (Figure 3.5.4 c-d). 
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Figure 3.5.4: Effect of thimerosal on differentiated N2a cell morphology 
N2a cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence (c, d) 
and absence (a, b) of thimerosal. The cells were fixed and stained with Coomassie Brilliant 
Blue as described in Methods. Blue arrows indicate cellular processes. Images of typical N2a 
cells were taken at x 200 magnification (n = 4). 
 
The data in figure 3.5.5 shows that exposure to thimerosal had a concentration 
dependent effect upon neurite production in N2a cells. The average number of 
neurites per 100 cells after 4 and 24 hours of differentiation was 16 and 22 
respectively. After 4 hours of incubation there was no significant inhibition of neurite 
outgrowth at concentrations below 1 µM thimerosal. Statistical analysis gave a p 
value of 0.78 for a comparison of the 1 µM data. Exposure to 1 µM thimerosal 
significantly reduced the number of neurites by 55-60 % after 4 and 24 hours of 
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incubation. After 24 hours of thimerosal exposure, neurite number was significantly 
reduced at 0.1 µM by approximately 30 % (p = 0.049). Treatment with 10 and 100 
µM thimerosal inhibited neurite outgrowth by 90 %. There were no significant 
changes in neurite number between the 4 and 24 hour exposure times (p = 0.55 for 1 
µM). 
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Figure 3.5.5: Effect of thimerosal on neurite outgrowth in differentiated N2a cells 
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal as described in Methods. The Data is expressed as mean percentage of the 
corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
. 
 
3.6: Effect of methylmercury chloride on MTT reduction and neurite outgrowth 
 
Incubation with methylmercury chloride caused a concentration dependent decrease 
in MTT reduction after 4, 24 and 48 hours in C6 cells (Figure 3.6.1.a). The typical 
absorbance value obtained for control cells was 0.453. MeHgCl caused significant 
decreases (p<0.01) in MTT reduction of 80-90 % at 10 and 100 µM but no significant 
changes below those concentrations. Statistical analysis gave a p value of 0.094 after 
48 hours of incubation confirming that the cells ability to reduce MTT was not 
significantly altered from the control. Analysis of the data using the 2 way ANOVA 
test showed that there were no significant time differences. Figure 3.1.2.b. shows 
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MTT reduction in N2a cells; the cells showed no significant changes at concentrations 
lower than 10 µM after 4 and 24 hours of exposure. After 48 hours exposure, 1 µM 
MeHgCl caused a significant decrease of 33 % in MTT reduction that was restricted 
to N2a cells (p<0.05). Statistical analysis showed that there was a significant 
difference in MTT reduction between 4 and 24 time points after exposure to 10 µM (p 
= 0.016). 
 
 
Control cells differentiated for 4 and 24 hours in the absence of MeHgCl, appeared 
flattened with short neurites emanating from the ends of the cell (Figure 3.6.2 a – b). 
After treatment with MeHgCl (Figure 3.1.27 c-d), it appeared that there was a slight 
reduction in the number of neurites compared to controls. 
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Figure 3.6.1: Effect of methylmercury chloride on MTT reduction in differentiating 
C6 and N2a cells 
C6 (a) and N2a (b) cells were induced to differentiate for 4, 24 and 48 hours in the presence 
and absence of methylmercury chloride as described in Methods. The Data is expressed as 
mean percentage of the corresponding control + SEM (n = 5). Data was analysed using a 2 
way ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1, a and 
b indicates significant differences between the time points. 
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Figure 3.6.2: Effect of methylmercury chloride on differentiated C6 cell morphology   
 
C6 cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence (c, d) and 
absence (a, b) of methylmercury chloride. The cells were fixed and stained with Coomassie 
Brilliant Blue as described in Methods. Blue arrows indicate cellular processes. Images of 
typical C6 cells were taken at x 200 magnification (n = 4). 
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Figure 3.6.3: Effect of methylmercury chloride on neurite outgrowth in differentiating 
C6 cells 
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
methylmercury chloride as described in Methods. The Data is expressed as mean percentage 
of the corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
 
 
 
 
Figure 3.6.3 shows that exposure to MeHgCl produces a dose dependent inhibition of 
neurite outgrowth. The average number of neurites produced by C6 cells was around 
19 after 4 hours of differentiation and 23 after 24 hours. MeHgCl displayed no ability 
to significantly reduce process formation below 1 µM at either time point. Statistical 
analysis confirmed this with a p value of 0.075 and 0.87 for 4 and 24 hours treatment 
with 1 µM respectively. Treatment with 1 µM MeHgCl caused a significant (p<0.05) 
reduction in neurite outgrowth of 60-65 %. There was virtually complete inhibition of 
at least 90 % in process outgrowth following exposure to 10 and 100 µM MeHgCl for 
4 and 24 hours.  Statistical analysis indicated that there were no significant differences 
between the 2 incubation times.  
 
N2a cells differentiated for 4 and 24 hours in the absence of MeHgCl were spherical 
in shape with long axon-like processes extending out from the cell body (Figure 3.6.4 
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a and b). When exposed to 1 µM MeHgCl, the number of these processes appears 
reduced when compared to the control cells. There appeared to be a large number of 
shorter neurites that were not classed as axons, so were not counted (green arrows). 
 
 
 
 
 
 
                                                                                     
 
 
 
  
                                                                                     
 
 
 
 
                                                                                                       
                                                                                                
 
 
 
 
 
 
 
 
 
Figure 3.6.4: Effect of methylmercury chloride on differentiated N2a cell morphology  
N2a cells were induced to differentiate for 4 (a, c) and 24 (b, d) hours in the presence (c, d) 
and absence (a, b) of lead chloride. The cells were fixed and stained with Coomassie Brilliant 
Blue as described in Methods. Blue arrows indicate cellular processes. Images of typical N2a 
cells were taken at x 200 magnification (n = 4). 
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Figure 3.6.5: Effect of methylmercury chloride on neurite outgrowth in N2a cells. 
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
methylmercury chloride as described in Methods. The Data is expressed as mean percentage 
of the corresponding control + SEM (n = 4). Statistical analysis was carried out using 2 way 
ANOVA. * indicates significant differences from the control, * p < 0.5, ** p < 0.1. 
 
 
Methylmercury chloride exposure induced a concentration dependent reduction in 
axon number (Figure 3.6.5). After 4 and 24 hours incubation there was no significant 
reduction in neurite number at MeHgCl concentrations below 1 µM (p = 0.088). 
Exposure to 1 µM MeHgCl caused a 60 % reduction in neurite outgrowth at 4 hours 
and a 70 % reduction at 24 hours. Statistical analysis showed both reductions to be 
significant with p values of 0.042 and 0.0034 respectively. The higher concentrations 
of 10 and 100 µM significantly inhibited neurite outgrowth by 80-90 %. There were 
no significant differences between the levels of inhibition at the different time points 
(p = 0.98 and 0.72 for 0.01 and 100 µM respectively).  
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3.7: Dose response curves 
 
        All of the dose response curves contained in section 3.7 were created from the 
MTT reduction assays shown as % of corresponding control in the previous sections 
of the chapter. 
  
The dose response curves for C6 and N2a cells exposed to concentrations of zinc 
chloride up to 100 µM indicated that there was no significant effect on MTT 
reduction (Figure 7.1) (p = 0.35641-0.82984)  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7.1: Dose response curve showing C6 and N2a cells differentiated for 48 
hours in the presence and absence of zinc chloride. 
N2a and C6 cells were induced to differentiate in the presence and absence of zinc chloride 
for 48 hours, after which the MTT assay was performed as an assessment of cell viability, as 
described in Methods. Data is shown as average absorbance + SEM.  Statistical test used was 
the 1 way ANOVA, followed by post hoc Bonferroni’s correction for pair wise multiple 
analysis. 
 
 
 
Both cell lines were affected by lead chloride at the same concentration of 10 µM 
(Figure 3.7.2). MTT reduction increases in an almost identical curve for both cell 
lines. Statistical analysis using a 1 way ANOVA test indicated that the response seen 
at 10 and 100 µM were significantly different from the control (p = 0.02343 and 
0.01946 respectively). The dose response curve gave an EC50 value of 1.4x10-5 M 
for C6 cells and 1.1x10-5 M for N2a cells. 
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Figure 3.7.2: Dose response curve showing C6 and N2a cells differentiated for 48 
hours in the presence and absence of lead chloride. 
N2a and C6 cells were induced to differentiate in the presence and absence of lead chloride 
for 48 hours, after which the MTT assay was performed as an assessment of cell viability, as 
described in Methods. Data is shown as average absorbance + SEM. Statistical test used was 
the 1 way ANOVA, followed by post hoc Bonferroni’s correction for pair wise multiple 
analysis (* p < 0.05 for C6 cells, * p < 0.05 for N2a cells). 
 
 
 
The dose response curve for C6 and N2a cells differentiated for 48 hours with 
cadmium chloride shows that MTT reduction began to decrease significantly at  1 µM 
in both cell lines (Figure 3.7.3). Statistical analysis indicated that significant decreases 
occurred at 10 and 100 µM (p = 0.00895 and 0.00639 for C6 and N2a cells 
respectively at 100 µM). The dose response curve gives an EC50 value of 4.6x10-6 in 
C6 cells and 3.6x10-6 in N2a cells. 
 
 
The dose response curve in Figure 3.7.4 begins to slope down at log 1 µM for both C6 
and N2a cells. Statistical analysis using a 1 way ANOVA indicates that the ability to 
reduce MTT was not affected significantly until 10 and 100 µM (p = 0.008760 and 
0.004536 for C6 and N2a cells respectively at 100 µM). The EC50 value in the C6 
cell line was 6.6x10-6 and in N2a cells 6.5x10-6. 
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Figure 3.7.3: Dose response curve showing C6 and N2a cells differentiated for 48 
hours in the presence and absence of cadmium chloride. 
N2a and C6 cells were induced to differentiate in the presence and absence of cadmium 
chloride for 48 hours, after which the MTT assay was performed as an assessment of cell 
viability, as described in Methods. Data is shown as average absorbance + SEM. Statistical 
analysis was carried using a 1 way ANOVA, followed by post hoc Bonferroni’s correction for 
pair wise multiple analysis (** p< 0.01 for C6 cells, ** p < 0.01 for N2a cells). 
 
 
The dose response curve for C6 and N2a cells exposed to thimerosal for 48 hours 
(Figure 7.3.5) begins to decline after 0.1 µM in the N2a cell line. With C6 cells the 
decline is less steep and occurs in between 0.1 and 1 µM. Statistical analysis using a 1 
way ANOVA indicated that in the C6 cell line significant inhibition of MTT 
reduction did not occur until 10 and 100 µM. In the N2a cells line MTT reduction was 
significantly inhibited at 1 (p = 0.0231 µM). The EC50 value for C6 cells was 3.7x10-
6 and for N2a cells 9.9x10-6 M. 
 
 
The dose response curve in Figure 7.3.6 shows that MeHgCl begins to inhibit the N2a 
cells ability to reduce MTT between 0.1 and 1 µM. With C6 cells the curve begins to 
decline at the same range as N2a cells but less steeply. Statistical analysis using a 1 
way ANOVA indicates that in the C6 cell line there was significant inhibition of MTT 
reduction 10 and 100 µM (p = 0.002458 and 0.005674 respectively). In the N2a cell 
line significant inhibition occurred earlier at 1 µM (p = 0.03464). The EC50 value for 
C6 cells was 3.8x10-6 and for N2a cells 1.2x10-6.  
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Figure 3.7.4: Dose response curve showing C6 and N2a cells differentiated for 48 
hours in the presence and absence of mercury chloride. 
N2a and C6 cells were induced to differentiate in the presence and absence of mercury 
chloride for 48 hours, after which the MTT assay was performed as an assessment of cell 
viability, as described in Methods. Data is shown as average absorbance + SEM. Statistical 
analysis was carried using a 1 way ANOVA, followed by post hoc Bonferroni’s correction for 
pair wise multiple analysis (* p< 0.05, ** p< 0.01 for C6 cells, * p < 0.05, ** p < 0.01 for 
N2a cells). 
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Figure 3.7.5: Dose response curve showing C6 and N2a cells differentiated for 48 
hours in the presence and absence of thimerosal. 
N2a and C6 cells were induced to differentiate in the presence and absence of thimerosal for 
48 hours, after which the MTT assay was performed as an assessment of cell viability, as 
described in Methods. Data is shown as average absorbance + SEM. Statistical analysis was 
carried using a 1 way ANOVA, followed by post hoc Bonferroni’s correction for pair wise 
multiple analysis (** p< 0.01 for C6 cells, * p < 0.05, ** p < 0.01 for N2a cells). 
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Figure 3.7.6: Dose response curve showing C6 and N2a cells differentiated for 48 
hours in the presence and absence of methylmercury chloride. 
N2a and C6 cells were induced to differentiate in the presence and absence of methylmercury 
chloride for 48 hours, after which the MTT assay was performed as an assessment of cell 
viability, as described in Methods. Data is shown as average absorbance + SEM. Statistical 
analysis was carried using a 1 way ANOVA, followed by post hoc Bonferroni’s correction for 
pair wise multiple analysis (** p< 0.01 for C6 cells, * p < 0.05, ** p < 0.01 for N2a cells). 
 
 
3.8: Discussion 
 
              This chapter determined the lethal and sub-lethal concentrations of various 
heavy metal compounds and investigated their effects on the cell morphology of C6 
and N2a cell lines. There are no previous studies that have compared the toxicity of 
such a large number of heavy metal compounds in the same differentiating cell line. 
However previous studies have investigated smaller groups of compounds or 
individual metals (Monnet-Tschudi et al., 1996; Braekman et al., 1997; Allen et al., 
2001).   
          The cytotoxicity studies (section 3.1 - 3.6), determined that MeHgCl, 
thimerosal and cadmium chloride were the most toxic of the heavy metals and that 
they had the most profound effect on both MTT reduction and neurite outgrowth in 
both cell lines.  
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           Zinc chloride had no significant effects on MTT reduction or neurite outgrowth 
in either cell lines at any concentration used (Figure 3.1.1-3.1.5). Zinc is the only one 
of the heavy metals studied that is essential in the nervous system. Zinc is present in 
vesicles within excitatory nerve terminals and when released in a calcium dependent 
manner, can reach concentrations of 100 µM in the extra cellular space (Gee et al., 
2002). Synaptically released zinc can then modify the activity of certain proteins such 
as glutamate and γ-aminobutyric acid (GABA) receptors (Frederickson & Bush, 2001; 
Mathie et al., 2005). This may be why the toxicity seen with the other metals in this 
study was not apparent with zinc exposure of up to 100 µM. Our findings are in 
agreement with those of Park and Koh (1999), who treated mitotic primary cultures of 
neuronal and glial cells with concentrations of 300 µM zinc chloride before detecting 
a reduction in cell viability. In their study exposure to 100 µM zinc chloride had no 
significant effect on cell viability after 8 hours, unfortunately they did not extend the 
incubation time beyond 8 hours. Hence it is not possible to directly compare their 
results with the present study after 24 and 48 hours exposure. Park & Koh, (1999) 
observed no reduction in cell viability after 8 hours, which is consistent with the 4 
hour exposure time. Schwartz et al., (2000) found that in the human neuronal 
SHSY5Y cell line, neurite length remained unaltered in cells exposed to 50 µM zinc 
chloride. However the study did not use any higher concentrations of zinc to examine 
whether changes occurred above that concentration. Exposure to 100 µM zinc did not 
alter cell viability in PC12 cells. Following 24 hours of exposure to 250 µM zinc, cell 
viability was reduced in mitotic PC12 cells (Watjen, 2001). Thus, the lack of toxicity 
of zinc chloride in the experiments presented in this thesis is in good agreement with 
the findings of other workers. 
            Lead chloride induced significant changes only at the highest concentration of 
100 µM (Figures 3.2.1 - 3.2.6). MTT reduction assays showed an increase in the 
amount of MTT reduced by N2a and C6 cells at all time points (Figure 3.2.1). This 
increase in the metabolic activity of the cells may be a stress response to reduce lead 
toxicity. Lead can also have a proliferative effect on cells (Castiglioni, 1993), which 
would explain the increase in MTT reduction seen in both C6 and N2a cells treated 
with lead chloride. However, cells viewed with an inverted microscope did not show 
any evidence of increased proliferation (see Figure 3.2.3 and 3.2.5).  Cordova et al., 
(2004) found that concentrations of lead up to 10 µM had no significant effect on the 
viability of slices of rat brain when incubated for up to 3 hours. Whilst they did not 
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use as high a concentration as 100 µM lead. The effects of the lower doses do agree 
with the findings of the present study. Since the standard error of the mean for the 24 
hour exposure to lead chloride (see Figure 3.2.3 and 4) in both cell lines were bigger 
than the 4 hour exposure which may reflect differences in the batches of cells as the 
experiments were done at different times. The numbers of neurites were not the same 
in each individual experiment. Despite the differences in absolute values the trends 
remained the same. 
             It required a concentration of Cadmium chloride 10 µM or above to 
significantly decrease MTT reduction in both C6 and N2a cells (Figure 3.3.1). 
Watjen, (2001) found that exposure to 15 µM cadmium resulted in decreased cell 
viability after 24 hours of exposure in PC12 cells, an adrenal chromaffin cell line. 
This difference in lethal concentration could be due a greater susceptibility of C6 and 
N2a cells to the toxic effect of cadmium. Cadmium chloride was the only heavy metal 
that induced any significant effect in neurite outgrowth below 1 µM (see Figure 
3.3.5). A concentration of 0.1 µM cadmium chloride reduced neurite outgrowth in 
N2a cells by 40-50 % after 4 and 24 hours exposure. This reduction was not seen in 
C6 cells (Figure 3.3.3), indicting that glial cells are less susceptible than N2a cells to 
the neurite inhibitory effects of cadmium chloride. 
            Mercury chloride decreased MTT reduction and neurite outgrowth at 10 and 
100 µM (Figures 3.4.1 - 3.4.5). Unlike the organic mercury species, mercury chloride 
did not induce any sub-lethal alterations in neurite outgrowth, as inhibition of neurite 
number was seen only at concentrations that reduced cell viability. A study by 
Bonacker et al., (2004) found tubulin assembly to be inhibited by 10 µM mercury 
chloride in both a cell free system, and in V79 cells microtubule assembly was 
completely inhibited by treatment with 100 µM mercury chloride. Microtubules 
comprise part of the cytoskeleton within cells of the CNS and are a major component 
of the neurites produced by neuronal and glial cells. Thus, this inhibition of tubulin 
assembly could account for the neurite inhibition seen within this thesis. However, the 
study by Bonacker et al., (2004) made no mention of any inhibitory effects in the cell 
system below 100 µM, whereas the data presented in this thesis found neurite number 
to be reduced by approximately 50 % with 10 µM mercury chloride and 60-70 % with 
exposure to 100 µM mercury chloride. One possible explanation of this discrepancy is 
that exposure to 10 µM mercury chloride tends to retard the tubulin subunits within 
the neurites, rather than the cell body.  
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           Thimerosal and MeHgCl had a similar effect to each other on MTT reduction 
(Figures 3.5.1 and 3.6.1). Both organic mercury compounds caused a decrease in 
MTT reduction at 10 and 100 µM in C6 cells and 1, 10 and 100 µM in N2a cells. 
Sanfeliu et al., (2001) used mitotic cells and found that MeHgCl decreased cell 
viability at 5 µM in both primary neurons and SHSY5Y neuroblastoma cells and 10 
µM in primary glial cells. The viability of glial cells was also reduced by 50 % 
following 24 hours exposure to 9 µM  MeHg (Garg & Chang, 2006).  Crespo-López 
et al., (2006) found a 20 % decrease in the viability of neuroblastoma and 
glioblastoma cell lines treated with 0.1 and 1 µM MeHg for 24 hours. The present 
study did not find any significant decrease in MTT reduction with these 
concentrations, perhaps due to different cell lines used and the fact that they were 
mitotic during experimentation in the case of Crespo-López et al (2006). The two 
organic mercury compounds had an inhibitory effect on neurite outgrowth in both cell 
lines (Figures 3.5.3, 3.5.5, 3.6.3 and 3.6.5) at concentrations not inhibiting the 
reduction of MTT. This suggests that the changes in morphology observed were sub-
lethal events that were occurring before cell death. The reduction in the numbers of 
neurites may also be caused by changes in the cell volume. Research has shown that 
heavy metals can cause damage to cell membranes (Herdman et al., 2006), which may 
allow fluid to enter causing the cells to swell and increase in size causing the neurite 
to appear shorter. However during examination of cells with a light microscope there 
did not appear to be any in cell volume when compared to the control.             
                  Comparison of the three mercury compounds using MTT assays and 
neurite outgrowth shows that the inorganic compound (mercury chloride) is less toxic 
than the organic compounds (MeHgCl and thimerosal). A number of studies have 
noted the differences in the toxicity of inorganic and organic mercury (Chetty et al., 
1996; Monnet-Tschudi et al., 1996; Allen et al., 2001; Ochi, 2002). However, none of 
these studies have directly compared the lethal doses of the heavy metals.    
            Sanfeliu et al., (2001) found that neuronal cells were more sensitive to the 
effects of MeHgCl using the MTT reduction assay. The research showed that the 
lowest dose at which cytotoxicity was seen was 5 µM in neuroblastoma cells and 10 
µM in astrocytes. The work in the present study has found that exposure to thimerosal 
and MeHgCl appeared to be more debilitating to N2a cells after 48 hours of 
incubation with the organic mercury compounds. N2a cells are also more susceptible 
to the sub-lethal effects of cadmium chloride, as neurite outgrowth in N2a cells was 
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reduced at concentration 100 times less than the minimum concentration needed to 
reduce neurite outgrowth in C6 cells. Braekman et al., (1997) compared the toxicity 
of cadmium chloride, mercury chloride and MeHgCl on an insect cell line exposed to 
the different heavy metals for 3 hours. MeHgCl was found to be the most toxic of the 
three metals with sub-lethal concentrations of 2 µM and below. Unlike the current 
study, Braekman et al., (1997) found cadmium to be the least toxic of the metals 
tested, with lethal concentrations of 44 µM and above. This is a higher than the lethal 
concentration determined by the present work. But differences could be explained by 
the differences in cell lines used, incubation time and the cell viability assay used, as 
Braekman et al., (1997) used a propidium iodide cell exclusion test. A comparison of 
cell viability assays indicated that each assay provided slightly different results, 
making a comparison of toxicity difficult if a different assay was used (Bigl et al., 
2007).            
           The dose response curves contained in section 7.7 used the data obtained from 
MTT reduction assays and the EC50s are summarised in table 3.1. The re-plotting of 
the MTT reduction data using log concentrations enabled the EC50 values of the 
different compounds to be calculated and a comparison to be made. The EC50s 
clearly demonstrate that N2a cells are more sensitive than C6 cells particularly for the 
organic mercury compounds.      
 
                           
EC50 (M) Heavy Metal 
C6 N2a 
Lead chloride 1.5x10-5 1.1x10-5 
Cadmium chloride 4.7x10-6 3.6x10-6 
Mercury chloride 6.6x10-6 6.5x10-6 
Thimerosal 3.7x10-6 9.7x10-7 
Methylmercury chloride 3.8x10-6 1.2x10-6 
 
Table 3.1: EC50 derived from dose response curves of MTT reduction. 
          The EC50 represent 50 % of the metals effective concentration and were 
calculated by the graph pad prism program used to create the dose response curves.  
 94 
               From the initial cytotoxicity screening studies in this thesis, it was decided 
that the two organic mercury species thimerosal and MeHgCl would be studied in 
more detail. Both were highly toxic and in addition thimerosal as a potential source of 
mercury exposure is relevant and controversial at present due to its presence in 
vaccinations, the concerns about the health risks that it poses and because very little is 
known about its potential neurotoxicity.  
           The aim of the following chapters was to investigate sub-lethal events that 
preceded cell death. From the MTT reduction assays it was determined that 
concentrations of 10 µM thimerosal and MeHgCl and above were unsuitable because 
of the significant reductions in cell viability that they caused. The concentrations used 
for further work were 1 and 0.1 µM, as they caused no reduction in cell viability at 4 
and 24 hours but 1 µM affected on neurite outgrowth after 4 and 24 hours of 
exposure.  
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Chapter 4: Effects of organic mercury compounds on the neuronal and glial cell 
cytoskeleton 
 
 Introduction 
 
             The previous chapter demonstrated that organic mercury compounds had a 
detrimental effect upon the production of cellular processes. Major protein 
components of the processes formed by both neuronal and glial cells are various 
cytoskeletal proteins. Since changes in neurite length and number were observed in 
chapter 3, the aim of the work presented in this chapter was to determine whether the 
reduction in the number of processes was accompanied by molecular changes in the 
proteins that make up neuronal and glial cell processes.   
            The cytoskeletal network of the CNS is comprised of microtubules, 
microfilaments and intermediate filaments (i.e. neurofilaments in neuronal cells and 
glial fibrillary acidic protein in glial cells). Microtubules are comprised of 
alternatively arranged α and β tubulin sub-units, organised into protofilaments that 
form a cylindrical shape that is the microtubule structure (Hargreaves, 1997). 
Microtubules are dynamic structures that can polymerise and depolymerise; by post-
translational modification of the α-tubulin sub-unit, microtubules can become stable 
and resist depolymerisation (Dhamodharan & Wadsworth, 1995). Post-translational 
modifications include acetylation or detyrosination. Detyrosination involves the 
removal of a tyrosine residue from α-tubulin subunit though the action of the enzyme 
tubulin carboxypeptidase which releases the COOH terminal tyrosine. Detyrosination 
is a reversible modification and the subunit can be re-tyrosinated as it depolymerises 
from the microtubule. A tyrosine residue can be added to the same position by 
tubulin:tyrosine ligase (Sironi et al., 2000). Previous studies have shown that 
treatment with mercury disturbs microtubule formation and function (Stoiber et al., 
2004). Mercury has been shown to possess a high affinity for tubulin sulfhydryl 
groups (Sager et al., 1983; Vogel et al., 1985; Graff et al., 1997)  which may account 
for the disturbed formation and function of microtubules. Methylmercury can both 
prevent depolymerisation (Abe et al., 1975) of microtubules and inhibit assembly 
(Sager, 1998).   
             The effects of thimerosal and methylmercury chloride on tubulin levels, 
microtubule organisation and dynamics were investigated by measuring total α-
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tubulin, tyrosinated α-tubulin and total β-tubulin, Neuronal cells also contain an 
intermediate filament network known as neurofilaments (NFs) that is unique to this 
cell type. NFs confer strength and stability to axon like structures formed by neuronal 
cells. There are three main forms of the NF chain in animal cells, NFH, NFM and 
NFL (Yuan et al., 2006). The three forms of NF are distinguished by their molecular 
weight, which is due to differences in their head and tail domains (Ackerley et al., 
2003). This thesis looks at NFH rather than NFM and NFL as NFH is the most 
extensively phosphorylated form of the NFs and its phosphorylation is associated with 
axon stability and maturity (Williamson, 1996). NF phosphorylation also regulates 
transport within the cell, the more extensive the phosphorylation the slower the rate of 
transport (Yuan et al., 2006). Previous studies have noted the effect of mercury on 
axon outgrowth but have not looked at the cytoskeletal proteins that make up the axon 
(Gopal, 2002). Using antibodies that recognise these proteins, this chapter aimed to 
determine whether organic mercury compounds disrupted the cytoskeletal network 
within the differentiating cell lines.  
 
Methods 
 
         The previous chapter established that concentrations of 0.1 and 1 µM of 
thimerosal and methylmercury chloride were sub-lethal. The two organic mercury 
compounds were chosen due to their enhanced toxicity over inorganic mercury and 
the opportunity to compare the differences in the mechanisms of toxicity that the 
methyl and ethyl groups confer to the compounds. The cell lines were differentiated in 
the presence and absence of the organic mercury compounds. After the 4 and 24 hour 
incubation periods had lapsed the cell extracts were lysed by boiling 0.5 % SDS in 
TBS (Methods section 2.212). SDS-PAGE followed by western blotting was 
completed on 6 independent cell lysates for each antibody. SDS-PAGE was used to 
separate proteins by molecular weight and western blotting was used to probe lysed 
cell extracts with various antibodies. The antibodies used on western blots created 
from lysates of both cell lines were B512 (anti-total α-tubulin antibody), T1A2 (anti-
tyrosinated α-tubulin antibody) and Tub 1.2 (anti-total β-tubulin antibody). In 
addition, antibodies against N52 (anti-total NFH antibody), RT97 and SMI34 (anti-
phosphorylated NFH antibodies) were used to probe western blots created from N2a 
cell lysates.  These antibodies were chosen due to the high content of cytoskeletal 
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proteins within the nerve and glial cells and they were all well established within the 
lab. All antibodies were used at a dilution of 1/1000 in either 3 % BSA or Marvel. 
The resultant blots were quantified using AIDA software.  
           The same antibodies were also used for immunofluorescence staining of fixed 
cells at dilution of 1/200 with 3 % BSA. The secondary antibody was either 
conjugated with TRITZ which gives a red fluorescence under the microscope or FITZ 
which was green. Images of the stained cells were obtained using a confocal 
microscope at x600 magnification. In the results section the number of times the 
experiment was carried out using separate cell extracts was indicated by the n = x in 
the figure legend. The data shown is the average densitometric value for 6 western 
blots created from 6 gels of independent cell extracts. The lane on the blot labelled 0 
is the control extract with no added metal. For the thimerosal treated corresponding 
control sterile distilled water was added at the same volume as the metal in the treated 
cells and with MeHgCl DMSO was added at the same volume as with the treated cells 
as the MeHgCl was dissolved in DMSO due to poor solubility in distilled water. 
Statistical analysis was carried using 2 way ANOVA followed by Bonferroni’s post 
hoc correction for pair wise multiple analysis.   
 
4.1: Effects of organic mercury compounds on the levels and distribution of 
microtubule protein in differentiated C6 cells  
 
Densitometric analysis of the western blots created from lysed C6 cell extracts in 
Figure 4.1.1 showed that the levels of B512 reactivity were not significantly altered 
when compared to the control in cells treated with 0.1 or 1 µM thimerosal or 
MeHgCl. The average densitometric absorbance for the control cell extract was 
0.78359 and the average absorbance for the treated cells was in the range of 0.67849-
0.89496 (p = 0.077 - 0.65 for both concentrations of both heavy metals). After 24 
hours, there was a significant reduction (p<0.05) in the reactivity of B512 following 
exposure of cells to 1 µM concentrations of both thimerosal and methylmercury 
chloride. A 2 way ANOVA test followed by post hoc Bonferroni’s test confirmed 
significance (p = 0.0231 and 0.0364 for 1 µM thimerosal and 1 µM MeHgCl, 
respectively). Both compounds caused approximately a 75 % reduction in antibody 
reactivity. Thimerosal alone caused a significant reduction of around 35 % in 
antibody reactivity at the lower concentration of 0.1 µM. Statistical analysis of the 4 
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and 24 hour data showed that there were no significant differences between the 
incubation times with exposure to both concentrations of thimerosal and 1 µM 
MeHgCl (p = 0.9323 for 0.1 µM thimerosal).  
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Figure 4.1.1: Western blots of lysates from the differentiated glial C6 cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the B512 anti- total α-tubulin 
antibody. Quantification of the antibody reactivity was carried out using AIDA 
software.  
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated. The resultant western blots of cell extracts were then 
probed with the antibodies indicated. Data represent mean levels of antibody reactivity, 
expressed as a percentage of difference from the corresponding control + SEM (n = 6). 
Untreated cell extracts are indicated on the western blots by 0. Asterisks indicate statistical 
significance from the control (* p value <0.05). a, b, c and d indicates statistical significance 
between the 4 and the 24 hour data. Statistical significance was determined using a 2 way 
ANOVA test, followed by post hoc Bonferroni’s correction for pair wise multiple analysis. 
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Figure 4.1.2: Immunofluorescence images of C6 cells stained with the anti-total α-
tubulin antibody B512 
C6 cells were induced to differentiate for 24 hours in the absence (a) or presence (b-e) of 
thimerosal and MeHgCl, with 0.1 (b) or 1 µM (c) of thimerosal, 0.1 (d) and 1 µM (e) 
MeHgCl. Cells were then fixed on a slide and stained with B512, an anti-total α-tubulin 
antibody as described in Methods (n = 3). Green arrows indicate cellular processes and 
turquoise arrows indicate tubulin networks in the cell body. 
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Figure 4.1.2 a shows control C6 cells differentiated for 24 hours. The MT network 
was clearly visible in B512 stained cells and was in organised strands around the cell 
body, extending in to the cellular processes. In cells that had been exposed to 0.1 µM 
thimerosal for 24 hours (Figure 4.1.2 b), the MT network was still clearly visible, but 
it appeared less organised and the staining was less intense. Cellular processes were 
still brightly stained at this concentration of thimerosal. Cells treated with 1 µM 
thimerosal exhibited reduced staining with the B512 antibody (Figure 4.1.2. c). 
Fragmented strands of MTs were still visible in the cell body but the staining was less 
intense. There were no densely stained processes such as those observed in the control 
cells. The MT network was less organised when compared to the control in cells 
exposed to 0.1 µM MeHgCl (Figure 4.1.2. d). Intense staining was still apparent in the 
processes but in some cells the cytoskeleton was beginning to fragment. Cells 
exposed to 1 µM MeHgCl were still brightly stained, unlike the cells treated with the 
same concentration of thimerosal (Figure 4.1.2. e), where there were no stained 
processes and MT architecture was disrupted by the heavy metal (Figure 4.1.2. c) The 
difference in the colour of the green fluorescence seen in images d-e is due to the use 
of a FITZ conjugated secondary antibody. The TRITZ conjugated secondary antibody 
that gave red fluorescence was no longer available. The secondary antibodies were the 
same barring their fluorescent conjugate. 
 
The levels reactivity with the anti-tyrosinated α-tubulin antibody was not significantly 
altered after 4 hours of exposure to either thimerosal or MeHgCl (Figure 4.1.3). The 
average absorbance for antibody reactivity with the control cell extracts was 0.97332. 
Statistical analysis confirmed lack of statistical significance (p = 0.0876, 0.9654, 
0.7654 and 0.8743 for 0.1 and 1 µM of thimerosal and MeHgCl respectively). The 
average densitometric absorbance for these concentrations was 0.84563 and 0.91145 
respectively. After 24 hours of exposure, there was a significant reduction (p<0.05) of 
approximately 40 % in the reactivity of the anti-tyrosinated α-tubulin antibody with 
cells exposed both concentrations of thimerosal and MeHgCl. (p = 0.0234 and 0.0354 
for 1 µM thimerosal and MeHgCl respectively). Statistical analysis confirmed that 
there were significant differences between the 4 and 24 hour data (p = 0.0124 to 
0.0433).  
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Figure 4.1.3: Western blots of lysates from the differentiated glial C6 cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the T1A2 anti- tyrosinated α-
tubulin antibody. Quantification of the antibody reactivity was carried out using 
AIDA software.  
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated. The resultant Western blots of cell extracts were then 
probed with monoclonal antibody T1A2. Untreated cell extracts are indicated on the western 
blots by 0. Data represent mean levels of antibody reactivity, expressed as a percentage of the 
corresponding control + SEM (n = 6). Asterisks indicate statistical significance from the 
control (* p value <0.05). a, b, c and d indicates statistical significance between the 4 and the 
24 hour data. Statistical significance was determined using a 2 way ANOVA test, followed by 
post hoc Bonferroni’s correction for pair wise multiple analysis. 
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Figure 4.1.4: Immunofluorescence images of C6 cells stained with the anti-tyrosinated 
α-tubulin antibody T1A2 
C6 cells were induced to differentiate for 24 hours in the absence (a) or presense (b-e), of 0.1 
µM (b) and 1 µM (c) of thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with T1A2, an anti-tyrosinated α-tubulin antibody as described in Methods (n = 3). 
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Figure 4.1.4 a shows that control cells differentiated in the absence of thimerosal 
exhibited intense staining in the processes and the MT network in the cell body. In 
cells in exposed to 0.1 µM thimerosal (Figure 4.1.4 b), MT staining was less intense 
than that observed in control. The bright spot in the image (indicated by yellow 
arrow) is where the fluorescent secondary antibody had aggregated during storage. 
The secondary antibody was spun in a bench centrifuge but some aggregates 
remained. Figure 4.1.4 c shows cells treated with 1 µM thimerosal. There were no 
distinguishable staining processes and the MT network was disrupted. Cells exposed 
to 0.1 µM MeHgCl (Figure 4.1.4 d) were more intensely stained than control cells. 
Unlike cells exposed to the same concentration of thimerosal, there was no obvious 
fragmentation of the cytoskeleton. Certain cells (indicated by pink arrow) had very 
intense areas of staining within the cell body and the processes were brightly stained. 
In Figure 4.1.4 e (1 µM MeHgCl) there were no obvious changes in the intensity of 
the staining with the T1A2 antibody when compared to the control cells. The number 
of MT networks surrounding the cells was reduced after exposure to 1 µM MeHgCl. 
However, there did not appear to be the reduction in process staining that is seen with 
thimerosal. The images are representative of three separate experiments and reflect 
the trends seen in each individual experiment.  
 
Analysis of Western blots probed with Tub 2.1 indicated that after 4 hours exposure 
there were no significant changes in the reactivity of the antibody with the C6 cell 
lysates (Figure 4.1.5). Statistical tests confirmed the lack of significance (p = 0.2563 
to 0.8769). The average densitometric absorbance for the 4 hour control extracts was 
0.77859. After 24 hours exposure to 0.1 µM thimerosal had no effect upon reactivity 
(p = 0.7654) but 1 µM thimerosal decreased antibody binding by approximately 25 %. 
A 2 way ANOVA, followed by post hoc Bonferroni’s test indicated significance (p = 
0.0234). Both concentrations of MeHgCl significantly decreased antibody reactivity 
by 30-40 % at this time point. A two way ANOVA test showed that there were 
statistically significant differences between the 4 and 24 hour data, post hoc 
Bonferroni’s test indicated that the significant differences occurred with exposure to 
0.1 µM MeHgCl and both 1 µM thimerosal and MeHgCl (p = 0.02456, 0.04653 and 
0.01984 respectively).  
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Figure 4.1.5: Western blots of lysates from the differentiated glial C6 cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the Tub 2.1 anti- total β-
tubulin antibody. Quantification of the antibody reactivity was carried out using 
AIDA software.  
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated. The resultant Western blots were then probed with the 
antibodies indicated. Untreated cell extracts are indicated on the western blots by 0. Data 
represent mean levels of antibody reactivity, expressed as a percentage of the corresponding 
control + SEM (n = 5). Asterisks indicate statistical significance from the control (* p value 
<0.05). a, b and c indicates statistical significance between the 4 and the 24 hour data. 
Statistical significance was determined using a 2 way ANOVA test, followed by post hoc 
Bonferroni’s correction for pair wise multiple analysis. 
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4.2: Western blot analysis and immunofluorescent staining of microtubule and 
neurofilament proteins in N2a cells treated with thimerosal and methylmercury 
chloride 
 
Exposure to 0.1 µM thimerosal had no significant affect upon antibody binding at 
either 4 or 24 hours (p = 0.9354 and 0.3556) (Figure 4.2.1). The average 
densitometric absorbance for antibody reactivity with control N2a cell extracts was 
0.6438. Exposure to 1 µM thimerosal had no effect at 4 hours (p = 0.4534) but after 
24 hours incubation, antibody reactivity was significantly reduced by approximately 
78 % of control values. The average absorbance with this concentration was 0.2148. 
Neither MeHgCl concentration had an effect upon antibody reactivity at 4 hours (p 
values 0.45342 and 0.0786) but after 24 hours incubation, 0.1 µM and 1 µM MeHgCl 
significantly reduced band intensity by 46 % and 67 %, respectively (p = 0.0442 and 
0.0243). Statistical tests showed that there were significant differences in the effects 
seen at 4 and 24 hours with both concentrations of MeHgCl and the higher 
concentration of thimerosal 
 
 
Figure 4.2.2 (a) shows immunofluorescence staining of control cells differentiated for 
24 hours in the absence of thimerosal or MeHgCl. The cells displayed clear tubulin 
networks around the nucleus of the cell and in some cells, the microtubule organising 
centre can be visualised as an intense spot located near the nucleus (indicated by the 
yellow arrows). The axon-like processes were clearly visible and were intensely 
stained as areas with high levels of tubulin. Figure 4.2.2 (b) shows differentiating N2a 
cells exposed to 0.1 µM thimerosal. The axons were still visible and brightly stained, 
as was the microtubule organising centre. In some cells the MT network was losing 
organisation and spreading out. Figure 4.2.2 (c) shows cells exposed to 1 µM 
thimerosal. The staining was weak in both the cell body and the neurites. Microtubule 
organising centres were no longer clearly visible. 
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Figure 4.2.1: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the B512 anti- total α-tubulin 
antibody. Quantification of the antibody reactivity was carried out using AIDA 
software.  
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated, then separated by SDS PAGE and Western blotting as 
described in Methods. Untreated cell extracts are indicated on the western blots by 0. Data 
represents mean levels of antibody reactivity, expressed as a percentage of the corresponding 
control + SEM (n = 6). Asterisks indicate statistical significance from the control (* p value 
<0.05). a, b and c indicates statistical significance between the 4 and the 24 hour data. 
Statistical significance was determined using a 2 way ANOVA test, followed by post hoc 
Bonferroni’s correction for pair wise multiple analysis. 
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Figure 4.2.2: Immunofluorescence images of N2a cells stained with the anti-total α-
tubulin antibody B512 
N2a cells were induced to differentiate for 24 hours in the absence (a) or presence (b-e) of 0.1 
µM (b) and 1 µM (c) of thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with B512, an anti-total α-tubulin antibody as described in Methods (n = 3). 
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The cells incubated with 0.1 µM MeHgCl have stunted axon-like processes and the 
MT network appeared to randomly cover the whole cell (Figure 4.2.2. d). There were 
visible microtubule organising centres in the image as well as some areas of intense 
fluorescence, where there appeared to be high levels antibody staining. Cells exposed 
to 1 µM MeHgCl (Figure 4.2.2. e) have weaker staining than in the control (Figure 
2.2.a). There was patchy staining along the axon-like processes and in the cell body, 
where the MT network staining appeared to have fragmented. There was still some 
staining of microtubule organising centres in 2 of the cells (indicated by the yellow 
arrows). The images are representative of three separate experiments and reflect the 
major trends seen in each one. 
   
Densitometric analysis shown in Figure 4.2.3 shows that 0.1 µM thimerosal had no 
significant effect upon the reactivity of the anti-tyrosinated α-tubulin antibody at 
either 4 or 24 hours (p = 0.0678 and 0.9756 for 4 and 24 hours respectively). The 
average absorbance obtained from the densitometry was 0.799342 for the control 
extracts and 0.482618 for cell lysates exposed to 1 µM thimerosal for 4 hours. 
Exposure to 1 µM thimerosal caused a significant reduction (p<0.05) of 55 % in band 
intensity at 4 hours and a 46 % reduction after 24 hours. Exposure to 0.1 µM MeHgCl 
for 4 hours caused a significant reduction of 42- 44 % in antibody reactivity after 4 
hours (p = 0.0445) and 24 hours (p = 0.0265). Statistical analysis of the data obtained 
from the two incubation times indicated that there were no significant differences 
between the effects seen at 4 and 24 hours (p = 0.9756).  
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Figure 4.2.3: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the T1A2 anti-tyrosinated α-
tubulin antibody. Quantification of the antibody reactivity was carried out using 
AIDA software.  
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated, then separated by SDS PAGE and Western blotting as 
described in Methods. Untreated cell extracts are indicated on the western blots by 0. Data 
represents mean levels of antibody reactivity, expressed as a percentage of the corresponding 
control + SEM (n = 6). Asterisks indicate statistical significance from the control (* p value 
<0.05). Statistical significance was determined using a 2 way ANOVA test, followed by post 
hoc Bonferroni’s correction for pair wise multiple analysis. 
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Figure 4.2.4: Immunofluorescence images of N2a cells stained with the anti-
tyrosinated α-tubulin antibody T1A2 
N2a cells were induced to differentiate for 24 hours in the absence (a) or presence (b-e) of 0.1 
µM (b) and 1 µM (c) thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with T1A2, an anti-tyrosinated α-tubulin antibody as described in Methods (n = 3). 
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Figure 4.2.4 (a-e) shows immunofluorescence staining with the anti-tyrosinated α-
tubulin antibody T1A2. The images shown are representative of typical trends 
obtained from 3 separate experiments. Figure 4.2.2a shows control N2a cells 
differentiated for 24 hours in the absence of thimerosal or MeHgCl. The cells had 
clearly stained networks of tyrosinated α-tubulin within the cell body and densely 
stained long axon-like processes. The microtubule organising centre was clearly 
visible within the cell (indicated by green arrow). Figure 4.2.4 (b) shows cells treated 
with 0.1 µM thimerosal. Staining with T1A2 appeared less intense within the axon 
and the cell body compared to the control. The microtubule organising centre was no 
longer visible within the cells and the microtubule arrays were less defined. The cells 
in figure 4.2.4 (c) had been exposed to 1 µM thimerosal for 24 hours. Again, the 
staining was weaker than that seen in untreated cells (image a). Whilst axon-like 
processes were still visible they had patchy staining and appeared broken instead of a 
continuous strand. Cells exposed to 0.1 µM MeHgCl had less visibly stained strands 
of tyrosinated α-tubulin (Figure 4.2.4. d). The microtubule organising centre was not 
visible within the cells at this concentration of MeHgCl. The cells in Figure 4.2.4 (e) 
had been incubated with 1 µM MeHgCl for 24 hours. The tyrosinated α-tubulin 
network had disintegrated, there were no visible strands. There were some neurites 
that were weakly stained for tubulin but they were deformed when compared to the 
untreated cells in image (a). 
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Figure 4.2.5: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the Tub2.1 anti-total β-tubulin 
antibody. Quantification of the antibody reactivity was carried out using AIDA 
software.  
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated, then separated by SDS PAGE and Western blotting as 
described in Methods. Untreated cell extracts are indicated on the western blots by 0. Data 
represent mean levels of antibody reactivity, expressed as a percentage of the corresponding 
control + SEM (n = 6). Asterisks indicate statistical significance from the control (* p value 
<0.05). a, and b ndicates statistical significance between the 4 and the 24 hour data. Statistical 
significance was determined using a 2 way ANOVA test, followed by post hoc Bonferroni’s 
correction for pair wise multiple analysis. 
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Statistical analysis using a two way ANOVA test, followed by Bonferroni’s test 
indicated that there was a significance differences between the effect seen after 4 and 
24 hours of exposure to 1 µM of both thimerosal and MeHgCl (p = 0.032131and 
0.008956 for thimerosal and MeHgCl respectively).  
 
Figure 4.2.6 shows densitometric analysis of western blots probed for total NFH. The 
average absorbance obtained for the control extracts was 0.59527 and 0.58852 for 4 
and 24 hours respectively. The data indicated that after 4 hours incubation time with 
thimerosal and MeHgCl there was no alteration in the intensity of the bands when 
compared to the control. A 2 way ANOVA test confirmed the lack of statistical 
significance from the control (p = 0.78695). After 24 hours there was a reduction in 
the reactivity of the antibody with cells exposed to both thimerosal and MeHgCl. The 
band intensity was significantly reduced by around 35 % when treated with 
thimerosal. MeHgCl significantly reduced antibody reactivity by 32 - 40 %. Statistical 
analysis highlighted significant differences in the data obtained from the 4 and 24 
hour exposure times for all concentrations. A comparison of the data obtained from 
exposure to 1 µM of both thimerosal and MeHgCl (p = 0.002439 and 0.004543 
respectively).  
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Figure 4.2.6: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the N52 anti-total NFH 
antibody. Quantification of the antibody reactivity was carried out using AIDA 
software.  
N2a cells were induced to differentiate for 4 (a) and 24 (b) hours in the presence and absence 
of thimerosal and MeHgCl as indicated, then separated by SDS PAGE and Western blotting 
as described in Methods. Untreated cell extracts are indicated on the western blots by 0. Data 
represents mean levels of antibody reactivity, expressed as a percentage of the corresponding 
control + SEM (n = 6). Asterisks indicate statistical significance from the control (* p value 
<0.05). a, b, c and d indicates statistical significance between the 4 and the 24 hour data. 
Statistical significance was determined using a 2 way ANOVA test, followed by post hoc 
Bonferroni’s correction for pair wise multiple analysis. 
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Figure 4.2.7: Immunofluorescence images of N2a cells stained with the anti-total 
NFH antibody N52 
N2a cells were induced to differentiate for 24 hours in the absence (a) or presence (b-e) of 0.1 
µM (b) and 1 µM (c) thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with N52, an anti-total NFH antibody as described in Methods (n = 3). 
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Differentiated control N2a cells stained with an anti-total NFH antibody were heavily 
stained with the anti-total NFH antibody, as were certain areas within the cell body 
(Figure 4.2.7. a). After exposure to 0.1 µM thimerosal (Figure 4.2.7 b), intensely 
stained neurites were still visible but it appeared that the distribution of the staining 
had changed. The axon staining was fragmented and within the cell body there were 
areas where the antibody stain was more intense. Exposure to 1 µM thimerosal 
(Figure 4.2.7 c) reduced the staining within the neurites. The staining within the cells 
became widespread instead of being localised to certain areas as it was in control cells 
(a). After 24 hours of exposure to 0.1 µM MeHgCl (Figure 4.2.7 d) axon staining was 
still visible but they were more weakly stained than in the control cells. Also NFH 
staining filled the whole of the cell body instead of the discrete areas that were 
observed in the control cells. Figure 4.2.7 e shows cells treated with 1 µM MeHgCl. 
The cells were weakly stained and there were no visible axons. 
 
Densitometric analysis in Figure 4.2.8 of western blots prepared from N2a cell 
extracts and probed with the anti-phosphorylated NFH antibody RT97 showed that 
band intensity was unaffected by 0.1 µM thimerosal after 4 hours exposure (p = 
0.67534). The average densitometric absorbance for the control cells after 4 hours of 
differentiation was 0.720843. Exposure to 1 µM thimerosal and both concentrations 
of MeHgCl for 4 hours did significantly reduce antibody binding by 60-70 %. 
Statistical analysis confirmed significance (p = 0.02562- 0.04532). Exposure to both 
compounds for 24 hours significantly reduced antibody reactivity by 20-60 % at both 
concentrations. A 2 way ANOVA test comparing the 4 and 24 hour data confirmed 
that there significant differences in the data obtained from the 2 time points. Post hoc 
Bonferroni’s test confirmed that there were significant differences with the 0.1 µM 
data with both compounds (p = 0.02243 and 0.035422 for 0.1 µM thimerosal and 
MeHgCl respectively).  
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Figure 4.2.8: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the RT97 anti-phosphorylated 
NFH antibody. Quantification of the antibody reactivity was carried out using AIDA 
software.  
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated, then separated by SDS PAGE and Western blotting as 
described in Methods. Untreated cell extracts are indicated on the western blots by 0. Data 
represent mean levels of antibody reactivity, expressed as a percentage of the corresponding 
control + SEM (n = 6). Asterisks indicate statistical significance from the control (* p value 
<0.05). a and b indicates statistical significance between the 4 and the 24 hour data. Statistical 
significance was determined using a 2 way ANOVA test, followed by post hoc Bonferroni’s 
correction for pair wise multiple analysis. 
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Figure 4.2.9 (a) shows control cells differentiated for 24 hours in the absence of 
thimerosal or MeHgCl and stained with RT97. The cells were brightly stained for 
phosphorylated NFH in certain areas of the cell body and long stained axon-like 
processes extending from the cell body. Exposure to 0.1 µM thimerosal (Figure 4.2.9 
b) strengthened the intensity of the staining in the cell body. At this concentration the 
cells did not exhibit significant staining in long neurites. There was one extremely 
stunted outgrowth visible indicated by the yellow arrow. Incubation with 1 µM 
thimerosal (Figure 4.2.9c) dramatically reduced the visible staining within the cells 
and prevented staining of the axon-like processes. MeHgCl exposure caused patchy 
staining within the cell body at 0.1 µM (Figure 4.2.9 d). The cells produced a number 
of axon-like processes that were brightly stained for phosphorylated NFH and there 
was also evidence of aggregate staining within the cell body. Figure 4.2.9 e shows 
cells exposed to 1 µM MeHgCl, which inhibited axon production and staining within 
the cell body was patchy with areas of intense staining where the antibody has 
accumulated. The images are representative of the major trends seen with three 
separate experiments. 
 
The densitometric analysis contained in Figure 2.4.10 shows that 0.1 µM thimerosal 
had no effect on band intensity at 4 or 24 hours (p = 0.56748 and 0.09833 for 4 and 24 
hours respectively). However exposure to 1 µM thimerosal caused a significant 
reduction of approximately 30 % compared to the control at both 4 hours and 24 
hours. The average densitometric absorbance obtained for the reactivity of the 
antibody with control extracts for both 4 and 24 was 0.76851 and 0.89413 
respectively. Exposure to 0.1 µM MeHgCl caused approximately a 35-38 % reduction 
in antibody reactivity. Statistical analysis confirmed significance from the control (p = 
0.04542 and 0.01784 for 4 and 24 hours respectively). Exposure to 1 µM MeHgCl 
caused a 30 % reduction in band intensity after 4 hours and a 35 % reduction after 24 
hours.  A 2 way ANOVA test indicated that there were no significant differences 
between the 4 and 24 hour data (p = 0.95674).  
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Figure 4.2.9: Immunofluorescence images of N2a cells stained with the anti-
phosphorylated NFH antibody RT97 
N2a cells were induced to differentiate for 24 hours in the absence (a) or presence (b-e) of 0.1 
µM (b) and 1 µM (c) thimerosal and 0.1 µM (d) and 1 µM (e) methylmercury chloride. The 
cells were stained with RT97, an anti-phosphorylated NFH antibody as described in Methods 
(n = 3).             
a) 
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Figure 4.2.11 (a) shows N2a cells differentiated in the absence of thimerosal or 
MeHgCl. The cells were brightly stained with SMI 34 in both the cell body and within 
the long neurites. The image showed a number of long axon-like processes (indicated 
by green arrows) that had a greater intensity of staining than the majority of the cell 
bodies. There were also visible patches of very brightly stained areas within the cell 
body, highlighting areas that have a greater level of phosphorylated NFH (indicated 
by blue arrows). The cells in Figure 4.2.11 (b) were exposed to 0.1 µM thimerosal for 
24 hours. There was less neurite staining in Figure 4.2.11 (b) when compared to the 
control Figure 4.2.11 (a). The cell body also had more intense spots of fluorescence 
spread over the whole of the cell body instead of the patches seen in Figure 4.2.11 (a). 
Figure 4.2.11 (c) shows cells exposed to 1 µM thimerosal for 24 hours. There was 
only 1 visibly stained short neurite and there were a number of weakly stained cells 
that appeared to be fragmenting. In addition there were some intensely stained cells. 
Figure 4.2.11 (d) shows cells exposed to 0.1 µM MeHgCl for 24 hours. The axon-like 
processes in this image were malformed with clumps of fluorescence along the length 
of axon-like process. Within the cell body there were small areas of intense staining 
distinct from those in cells exposed to 0.1 µM thimerosal. Figure 4.2.11 (e) shows 
cells exposed to 1 µM MeHgCl for 24 hours. There were no visible neurites and the 
cells were weakly stained barring some bright areas. 
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Figure 4.2.10: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the SMI 34 anti-
phosphorylated NFH antibody. Quantification of the antibody reactivity was carried 
out using AIDA software.  
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated, then separated by SDS PAGE and Western blotting as 
described in Methods. Untreated cell extracts are indicated on the western blots by 0 and PS 
indicates the protein standards. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM (n = 6). Asterisks indicate statistical 
significance of difference from the control (* p value <0.05). Statistical analysis was carried 
out using a 2 way ANOVA test, followed by post hoc Bonferroni’s correction for pair wise 
multiple analysis. 
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Figure 4.2.11: Immunofluorescence images of N2a cells stained with the anti-
phosphorylated NFH antibody SMI 34 
N2a cells were induced to differentiate for 24 hours in the absence (a) or presence (b-e) of 0.1 
µM (b) and 1 µM (c) thimerosal and 0.1 µM (d) and 1 µM (e) methylmercury chloride. The 
cells were stained with SMI 34, an anti-phosphorylated NFH antibody as described in 
Methods (n = 3). 
a) b) 
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4.3 Discussion 
 
The reduction in neurite outgrowth caused by exposure to the organic mercury 
compounds, thimerosal and MeHgCl indicated that these two compounds had a 
detrimental effect upon the production of cellular processes by some unknown 
mechanism (Chapter 3). This chapter aimed to determine whether this unknown 
mechanism of inhibition was due to the ability of thimerosal and MeHgCl to interfere 
with cytoskeletal proteins, a major component of both the processes produced by C6 
cells and N2a cells.  
             Previous studies have determined that incubation with 5 µM MeHgCl for 3 
hours causes the complete disappearance of microtubules in mouse glioma cells and 
rat pheochromocytoma cells (Miura & Imura, 1989; Miura et al., 1999). Experiments 
in this chapter determined that lower concentrations of 0.1 and 1 µM of both MeHgCl 
and thimerosal caused disruption of the microtubule network in N2a and C6 cells 
without its complete disintegration. 
             Western blots of C6 cells probed with antibodies against total α-tubulin and 
tyrosinated α-tubulin have shown that after 4 hours there was no change in the levels 
of total α-tubulin (see Figure 4.1.1 (a) and 4.1.2), or tyrosinated α-tubulin (see Figure 
and 4.1.5). After exposing C6 cells to the organic mercury compounds for 24 hours 
western blot analysis indicated that there was a reduction in the levels of both total 
(see Figure 4.1.1 (b) and 4.1.2) and tyrosinated α-tubulin (see Figures 4.1.4 (b) and 
4.1.5.). Normally the levels of total α-tubulin would not change as the tubulin subunits 
are constantly being replenished to keep the pool of unpolymerised tubulin the same. 
However polymerisation of MTs does not occur if the levels of free tubulin drops too 
low (Hargreaves, 1997). The observed decrease in reactivity with antibodies against 
both total (B512) and tyrosinated (T1A2) α-tubulin indicated that there may be 
proteolytic degradation or reduced synthesis of tubulin at the later time point.  
            Confocal microscope images of cells incubated with anti-total α-tubulin, anti 
tyrosinated α-tubulin and the appropriate secondary antibody with a fluorescent label 
(see Figures 4.1.3 and 4.1.6) confirmed the disintegration of microtubules. The 
microtubule arrays within the cells treated with thimerosal and methylmercury 
chloride appear very different from the controls. In untreated cells the microtubule 
network was clearly visible within the cell body and the processes extending out from 
it. When exposed to thimerosal or methylmercury chloride there were less defined and 
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organised microtubule arrays. The disruption of the MT network became more 
marked as the concentration of the compound increased. In C6 cells, the levels of both 
tyrosinated α-tubulin and total α-tubulin were reduced after exposure to the organic 
mercury compounds. It would appear that tyrosinated MTs were more susceptible to 
thimerosal, as the disruption of tyrosinated tubulin seemed more apparent in the 
confocal images shown in Figure 4.1.6 (b and c). An independent study by Sager et 
al., (1983) found similar disruption of the microtubule network after 22 hours of 
exposure to 0.2 µM MeHg in fibroblast cells. Unfortunately, in the work presented in 
this thesis, confocal images could only be obtained after 24 hours of differentiation. 
The cells differentiated more slowly on the slides used for confocal imaging and after 
the 4 hour time point very few processes had developed.  
              The levels of β-tubulin remained unchanged from the control levels at 4 
hours. As with α-tubulin, the levels of reactivity with the anti-β-tubulin antibody 
decreased after 24 hours of exposure to both concentrations of MeHgCl and 1 µM 
thimerosal (Figure 4.2.5). The levels of β-tubulin should remain unchanged as β-
tubulin subunits are constantly synthesised to keep the pool of unpolymerised tubulin 
consistent. Thus the reduction in the levels of total β-tubulin at 24 hours may be 
caused by a proteolytic event that is targeting the microtubule network or the organic 
mercury compounds are affecting tubulin synthesis. Reactivity with the anti-β-tubulin 
antibody TUB 2.1 was less sensitive to thimerosal and MeHgCl exposure than that of 
the anti-α tubulin antibodies used in this thesis as less reduction in reactivity was 
observed with the β-tubulin at 24 hours. The difference antibody reactivity could 
indicate sensitivity differences in the two sub-units or it could reflect a less sensitive 
anti-β-tubulin antibody as the background on the anti-β-tubulin blots was higher. 
Reactivity with the Tub 2.1 antibody was not as clear as the anti-α-tubulin antibody 
B512. 
        As with C6 cells, total α and β-tubulin levels in N2a cells were not significantly 
altered after 4 hours exposure to both organic mercury compounds. However, 
tyrosinated α-tubulin levels were significantly reduced when cells were treated with 1 
µM thimerosal and both concentrations of MeHgCl. The detyrosination of the α-
tubulin subunit, along with various other post-translational modifications, is a 
mechanism by which microtubules resist depolymerisation and achieve stability. 
Tyrosinated tubulin is associated with labile microtubules (Graff et al., 1997) and the 
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changes in tubulin tyrosination may indicate that the mercury compounds affect 
microtubule dynamics at the earlier time point. A change in the tyrosination state of 
α-tubulin has also been recognised in an animal model (Ishida et al., 1997). These 
workers found that the levels of tyrosinated α-tubulin were reduced in rats exposed to 
10 mg/kg methylmercury per day. The observation that the tyrosination state of 
microtubules remained unaltered in the glial cell line at 4 hours, indicates that altered 
tubulin tyrosination may represent an early neuronal specific marker for toxicity. 
Confocal images of N2a cells stained for total and tyrosinated α-tubulin confirmed the 
reduction of tubulin levels determined by western blot analysis (Figure 4.2.12). 
(Hunter & Brown, 2000) also found that 2 hours exposure to 1 µM MeHgCl almost 
completely disrupted the α-tubulin network in mouse neuronal P19 cells.  
             Tyrosinated α-tubulin is more sensitive to the effects of the heavy metals than 
total α-tubulin (see Figure 4.2.15). Cells treated with 0.1 µM thimerosal have weaker 
staining within the axons and the cell bodies. Some of the axonal microtubule were 
fragmented, an effect that was not highlighted by the total α-tubulin antibody. 
Tyrosinated microtubules have been found to be the most susceptible form of MTs to 
the effects of MeHgCl (Graff et al., 1993; Graff et al., 1997). For example, exposure 
to 2 µM MeHgCl for 1 hour caused an almost complete disruption of tyrosinated 
MTs, while detyrosinated microtubules were less affected. The difference in 
incubation conditions probably accounts for the higher concentration needed to 
disrupt microtubules than which was determined by this investigation. However, the 
detrimental effect of MeHgCl upon the microtubule network was noted in both 
investigations.  
           In N2a cells the levels of β-tubulin remained unaffected after 4 hours of 
exposure to both concentrations of thimerosal and MeHgCl (Figure 4.2.10). After 24 
hours β-tubulin levels were not significantly altered by exposure to 0.1 µM thimerosal 
or MeHgCl but they were significantly reduced by the higher concentrations of both 
organic mercury compounds (Figure 4.2.10). The levels of α and β-tubulin should be 
equal as they have equal distribution within the microtubule structure. However 
densitometric analysis of western blots probed with anti-α and β-tubulin antibodies 
indicated that the two sub-units were not reduced to the same extent by MeHgCl 
treatment. The α-tubulin sub-unit was more susceptible to MeHgCl or thimerosal 
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exposure. The difference between α and β-tubulin could be caused by the differences 
in the sub-units’ sensitivities or the lesser reactivity of the β-tubulin antibody. 
            Wasteneys et al., (1988) found that treatment with MeHg for up to 2 hours 
caused a time and concentration dependant disassembly of MTs in embryonal 
carcinoma cells. Using immunofluorescence they discovered that concentrations of 
0.1 µM had no effect on microtubules. Exposure to 1 µM caused what they classed as 
slight disruption; in that the staining pattern observed was less intense than with 
untreated cells. Western blots using anti-total α and β-tubulin antibodies did not agree 
with this finding, as only tyrosinated α-tubulin was affected after 4 hours. However, 
as the study by Wasteneys et al., (1988) used immunofluorescence staining, it is 
possible that despite the slight disruption in staining of the microtubule network, the 
absolute levels of tubulin were unaltered. 
 
Heavy Metal 
Concentration (µM) 
N2a cells 
4 hours                      24 hours 
C6 Cells 
4 hours                        24 hours
  
0.1 µM Thimerosal 1:1 1:1 1:1 1:1 
1 µM Thimerosal 0.4:1 1.6:1 0.8:1 2:1 
0.1 µM MeHgCl 0.5:1 1:1 0.8:1 0.8:1 
1 µM MeHgCl 0.4:1 1:1 1:1 1.5:1 
 
Table 4.1: Table of α-tubulin tyrosination to total α-tubulin ratios for N2a and C6 cell 
lysates. 
Table 4.1 shows the ratio of tyrosinated α-tubulin to total α-tubulin in N2a and C6 cell 
extracts treated with thimerosal and MeHgCl for 4 and 24 hours. The ratios were 
obtained from the densitometric data contained in chapter 4. The tyrosination ratios 
were calculated for each individual extract using the equation: 
 
% relative to control tyrosinated α-tubulin 
% relative to control total α-tubulin 
The ratios were then averaged for each metal concentration and time point. The ratios 
enable a direct quantifiable comparison to be made about the changes in the levels of 
tyrosination. 
 
 The ratio of tyrosination confirms that at 4 hours reduced levels of tyrosinated α-
tubulin is restricted to N2a cells at the higher thimerosal concentration and both 
concentrations of MeHgCl. After 24 hours the higher concentrations of both 
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compounds actually increased the ratio of tyrosinated α-tubulin to total α-tubulin in 
C6 cells. Western blotting showed that levels of total α-tubulin were reduced. In N2a 
cells there is no difference in the ratio with 0.1 µM thimerosal exposure and both 
concentrations of MeHgCl but with 1 µM thimerosal the ratio shows that levels of 
tyrosinated α-tubulin is higher than total α-tubulin. This may highlight a difference in 
the way thimerosal disrupts the microtubule network in the cell lines.               
                  In addition to microtubules, N2a cells also contain the neuron specific 
class of intermediate filaments called neurofilaments (NFs). The neurofilament heavy 
chain (NFH) is the most phosphorylated of the three NFs and is important in the 
stabilisation and growth of the axon.  
  
Heavy Metal 
Concentration (µM) 
4 hours 24 hours 
0.1 µM Thimerosal 1:1 1:1 
1 µM Thimerosal 0.4:1 1.5:1 
0.1 µM MeHgCl 0.3:1 1:1 
1 µM MeHgCl 0.3:1 1:1 
 
4.2: Table of NF-H phosphorylation to total NF-H ratios for N2a cell lysates 
Table 4.2 shows the ratio of phosphorylated NFH to total NFH in N2a extracts treated 
with thimerosal and MeHgCl for 4 and 24 hours. The ratios were obtained from the 
densitometric data contained in chapter 4. The ratios were calculated for each 
individual extract using the equation: 
 
% relative to control Phosphorylated NFH 
% relative to corresponding control total NFH 
The ratios were then averaged for each metal concentration and time point. The ratios 
enable a direct quantifiable comparison to be made about the changes in the levels of 
NFH phosphorylation. 
 
       The ratio of Phosphorylated NFH to total NFH confirms that with exposure to 
organic mercury compounds the level of phosphorylated NFH was either less than or 
equal to total NFH. Only exposure to 1 µM thimerosal actually gave a ratio where 
phosphorylated NFH was greater than total NFH, indicted that the effect on NFs was 
dependant upon the type and concentration of the metal. 
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                  The levels of total NFH remains unaltered after 4 hours of incubation with 
thimerosal and MeHgCl (Figure 4.2.10), which in agreement with the study by 
Funchal et al., (2006). The levels of phosphorylated NFH (Figures 4.2.13, and 4.2.16) 
were significantly reduced after 4 hours of incubation with 1 µM thimerosal and 
exposure to MeHgCl significantly reduced levels of phosphorylated NFH at both 0.1 
and 1 µM. Two different neurofilament antibodies were used and gave a virtually 
identical result. The two phosphorylated NF-H antibodies (RT97 and SMI34) 
recognise different epitopes on the NFH chain, but both indicated a change in NFH 
stability. The phosphorylation of NFH is associated with the maturity and stability of 
the axon (Williamson, 1996). Since the axon has little protein synthesis machinery, 
these NF are synthesized in the cell bodies and preassembled as insoluble hetero-
oligomers and/or short filaments they are transported into and through axons by 
axonal transport. As stable synapses are established during postnatal development, 
neurofilaments accumulate in axons, which are accompanied by extensive 
phosphorylation on the carboxyl terminal tail domains of both NFH and NFM 
subunits and increased radial growth of axons. Phosphorylation at serine residues of 
multiple KSP repeat motifs along these tail domains is mediated by several proline-
directed protein kinases (Roy et al., 2000). The reduction NFH phosphorylation is 
indicative of the breakdown of NFH stability and thus axon stability. After 24 hours 
exposure to thimerosal and MeHgCl the levels of total NFH were reduced with both 
compounds and at both concentrations. As with tubulin, it seems that proteolysis is 
occurring after 24 hours of exposure time and, as both NF-H and tubulin are affected 
by this event, it appears that it may be targeting the cytoskeleton in general.  
            Confocal images of cells stained with anti-total and phosphorylated NF-H 
antibodies confirm that the cytoskeletal protein becomes more degraded as the 
concentration of thimerosal and MeHgCl increases. Braekman et al., (1997) found 
that 2 µM MeHg altered the length of axons after 3 hours of incubation. Presumably 
the axon shortening would have been accompanied by a change in NF levels but since 
the study only used a light microscope to view cell morphology this could not be 
confirmed. The slightly lower concentration found to affect neurite outgrowth in the 
present study could be due to a longer incubation time and the different cell line used.  
             The cytoskeleton of both N2a and C6 cells are equally vulnerable to the 
effects of the organic mercury compounds used after 24 hours of exposure. After just 
4 hours of thimerosal and MeHgCl treatment the integrity of the neuronal and glial 
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cell cytoskeleton was compromised but there were no significant changes in the 
tyrosination of α-tubulin in C6 cells.  This indicates that glial cells may be slightly 
more resistant than N2a cells or that the mechanism of organic mercury compound 
toxicity may be different in glial cells. Sager & Syversen, (1984) looked at the effects 
of MeHg on microtubule disassembly in neuronal, glial and fibroblast cells and found 
no differences in the MT staining of the three cells types at concentrations of 5 µM. 
At lower concentrations of 1 µM the MT network of the neuronal cell was more 
sensitive. Kim et al., (2002) found that exposure to 20 µM thimerosal for 1 hour 
produced changes in the cytoskeleton. Images of cells stained for f-actin showed 
reduced levels of actin fibres in serum starved HeLa cells, indicting that the disruption 
of the cytoskeleton occurs in all three of the major network types, NFs, microtubules 
and microfilaments. 
               The regulation of cytoskeletal proteins is controlled by various signalling 
pathways. The next stage in the investigation into thimerosal and methylmercury was 
to determine what effect the compounds had upon the MAPK signalling pathways. 
ERK1/2 is known to regulate the cell cycle and JNK and P38 are important in stress 
responses (Robinson & Cobb, 1997). Furthermore, ERK1/2 has a role in neurite 
outgrowth and neurofilament phosphorylation (Veeranna et al., 1998), both of which  
have been shown to be altered during exposure to organic mercury compounds.  
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Chapter 5: Effects of organic mercury compounds on cell signalling pathways in 
differentiating N2a and C6 cells 
 
Introduction 
 
          Previous chapters demonstrated that sub-lethal concentrations of both 
thimerosal and MeHgCl had an inhibitory effect on neurite formation. Chapter 4 
indicated that the inhibition was associated with disruption of microtubules and 
neurofilaments. Due to the changes highlighted by western blotting and 
immunofluorescence staining, it was decided to investigate cellular signalling 
mechanisms that are known to be linked with the cytoskeleton.  
       The cytoskeletal protein α-tubulin comprises 450 amino acid residues. The 
sequence contains areas abundant in serine and threonine residues targeted by 
activated ERK1/2. The COOH region of 66 residues are devoid of asparagine, 
glutamine, threonine, cysteine, proline, and isoleucine, and the last 40 positions have 
47 % acidic side chains, 16 glutamic and three aspartic, rendering this segment one of 
the most acidic part of the protein (Ponstingl et al., 1981). The NFH protein contains a 
region that has repeats of the motif lysine-serine-proline (KSP repeats). It is in this 
KSP region that the filament is phosphorylated by various kinases including ERK1/2 
(Ackerley et al., 2003). 
          The mitogen-activated protein kinase signalling cascades have roles in various 
cellular functions. They are serine/threonine kinases that are ubiquitous enzymes of 
signalling pathways. They are activated via reversible phosphorylation and are vital in 
connecting cell surface receptors to intracellular targets (Kaminska, 2005). The 
MAPK family consists of three main groups, the extra cellular signal related protein 
kinase (ERK 1/2), the stress activated protein kinases (SAPK) p38, and the SAPK, c-
jun N-terminal kinases (JNK). Each MAPK is activated by a specific mitogen 
activated protein kinase kinase (MAPKK), MEK1/2 activates ERK1/2. ERK1/2 has 
roles in cell cycle progression (Robinson & Cobb, 1997) and cytoskeletal organisation 
(Reszka et al., 1995). The ERK1/2 signalling pathway is also known to be important 
in neurite outgrowth and NFH phosphorylation (Veeranna et al., 1998), whereas  JNK 
and p38 are stress activated kinases (Wang et al., 1998). Activated ERK1/2 targets 
cytoskeletal proteins for phosphorylation such as NFs and Tau. ERK also 
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phosphorylates m-calpain at Ser50 both in vitro and in vivo even in the absence of 
millimolar concentrations of Ca2+ (Glading et al., 2001).  
          Previous studies have shown that heavy metals can affect the MAPK signalling 
pathway. Exposure to mercury has been to shown to both increase the activation of 
JNK (Matsuoka et al., 1999) and not alter the activation of the pathway (Barnes & 
Kircher, 2005). Mercury exposure has been shown to increase ERK activation 
initially after 2.5 minutes of exposure to methylmercury then cause levels to decrease 
(Parran et al., 2004). 
         Activated ERK1/2 targets serine and threonine residues for phosphorylation so it 
was of interest to the investigation to determine whether changes in ERK1/2 
activation were accompanied by changes in substrate phosphorylation levels in the 
neuronal and glial cell lines. It was anticipated that that these blots may highlight 
changes in protein phosphorylation in addition to the decreases seen in NFH 
phosphorylation, which could then be investigated in more depth. 
 
Methods 
             N2a and C6 cells were differentiated for 4 and 24 hours in 0.1 and 1 µM 
thimerosal and MeHgCl. Each incubation time had a separate control of differentiated 
cells untreated with the organic mercury compounds (Methods section 2.2.10). The 
cells were extracted in boiling 0.5 % SDS in TBS and lysed by a further 5 minutes of 
boiling. Lysed cell extracts were diluted in x2 concentrated Laemmli electrophoresis 
sample buffer (see Methods section 2.2.12 for detail) and loaded on to 10 % 
acrylamide gel at a protein concentration of 30 µM.  
           Levels of total ERK1/2, phosphorylated ERK, total JNK and phosphorylated 
JNK were investigated using western blots of N2a and C6 cell lysates probed with 
antibodies against total ERK1/2 (K-23), phosphorylated ERK (E-4), total JNK (D-2) 
and phosphorylated JNK (G-7). All antibodies were well established in the lab as 
effective with the cell lines used. In addition, the levels of phosphorylated serine and 
threonine levels were also investigated by western blotting analysis. Antibodies raised 
against phosphorylated serine (PSR-45) and phosphorylated threonine (PTR-8) were 
used to probe the western blots to determine whether the levels of the phosphorylation 
states indicate other protein kinase substrates were altered. All secondary antibodies 
were tested for non specific binding using a non primary control western blot. The 
resultant western blots were then probed with the antibodies indicated and the reactive 
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bands were scanned densitometrically using AIDA software. Each experiment was 
repeated at least 5 times with separate cell extracts. The number of times the 
experiment was carried out on individual cell extracts was indicated in the figure 
legend by n = x. Data represent mean levels of antibody reactivity, expressed as a 
percentage of the corresponding control + SEM. Statistical test used was initially a 2 
way ANOVA to highlight significance differences in dose and time data sets. Post hoc 
Bonferroni’s correction for pair wise analysis was used to establish significance 
between individual doses and times. Asterisks indicate statistical significance of 
differences from the control (* p value <0.05). The data shown is the average 
densitometric value for 6 western blots created from 5 gels of independent cell 
extracts. The lane on the blot labelled 0 is the control extract with no added metal. For 
the thimerosal treated corresponding control sterile distilled water was added at the 
same volume as the metal in the treated cells and with MeHgCl DMSO was added at 
the same volume as with the treated cells as the MeHgCl was dissolved in DMSO due 
to poor solubility in distilled water. 
 
 
5.1: The effect of thimerosal and methylmercury chloride on the levels and activation 
of ERK1/2 in C6 cells 
 
The densitometric analysis in figure 5.1.1 confirmed that, after 4 hours of incubation 
with thimerosal and MeHgCl there was no change in the anti-total ERK1/2 antibody 
reactivity with C6 cell lysates. The average densitometric absorbance obtained from 
the control was 0.823034 for cell lysates probed with ERK1/2 and 0.827393 for 
phosphorylated ERK1/2. Statistical analysis using a 2 way ANOVA test and post hoc 
Bonferroni’s test confirmed that there were no significant changes when compared the 
control (p ranged from 0.06944-0.4180). However, there was a 45-65 % increase in 
the reactivity of the anti-phosphorylated ERK antibody with cells exposed to 0.1 and 
1 µM thimerosal respectively. A 2 way ANOVA confirmed that the increase was 
statistically significant (p = 0.04678 and 0.02990 for 0.1 and 1 µM respectively). In 
contrast exposure to MeHgCl significantly decreased antibody reactivity by 
approximately 25-30 % (p<0.05). Statistical analysis confirmed that there were 
significant differences between the effects seen at 4 hours and those seen after 24 
hours (Figure 5.1.2) of incubation.  
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Figure 5.1.1: Western blots and densitometric analysis of lysed C6 cell extracts 
exposed to thimerosal and MeHgCl for 4 hours. The proteins were visualised with a 
1/1000 dilution of an anti-ERK1/2 and phosphorylated ERK1/2 antibody and 
compared with the corresponding control that was untreated with the organic mercury 
compounds. 
 
C6 cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and MeHgCl as indicated, then separated by SDS PAGE and western blotting as described in 
Methods section 2.2.10-12. Data represent mean levels of antibody reactivity, expressed as a 
percentage of the corresponding control + SEM (n = 6). Asterisks indicate statistical 
significance of differences from the control (* p value <0.05). Statistical significance was 
determined using a 2 way ANOVA test, followed by post hoc Bonferroni’s correction for pair 
wise multiple analysis. 
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After 24 hours of exposure to thimerosal and MeHgCl there was no significant 
(p<0.05) change in the reactivity of the anti- ERK1/2 antibody with C6 cell lysates 
(Figure 5.1.2). The average control absorbance obtained from densitometry of the 
phosphorylated ERK western blots was 0.946631 and for extracts exposed to 0.1 µM 
thimerosal 0.543821. After 24 hours the reactivity of the anti-phosphorylated ERK 
antibody was significantly reduced by 45-50 % with exposure to thimerosal. 
Statistical analysis confirmed the difference from the control as significant (p = 
0.03414). Exposure to 0.1 µM and 1 µM MeHgCl significantly reduced (p< 0.05) the 
binding of the anti-phosphorylated ERK antibody by around 38 % and 40 %, 
respectively. A statistical comparison of the 4 (Figure 5.1.1) and 24 hour data 
indicated that there was a significant time componant in the reactivity of the 
phosphorylated ERK1/2 antibody with exposure to both concentrations of thimerosal 
(p = 0.03428 and 0.02369 for 0.1 and 1 µM respectively), but not with exposure to 
MeHgCl.  
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Figure 5.1.2: Western blots and densitometric analysis of lysed C6 cell extracts 
exposed to thimerosal and MeHgCl for 24 hours. The proteins were visualised with a 
1/1000 dilution of an anti-ERK1/2 and phosphorylated ERK1/2 antibody and 
compared with the corresponding control that was untreated with the organic mercury 
compounds. 
C6 cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and MeHgCl as indicated, then separated by SDS PAGE and western blotting as described in 
Methods section 2.2-10-12. Data represent mean levels of antibody reactivity, expressed as a 
percentage of the corresponding control + SEM (n = 6). Asterisks indicate statistical 
significance of differences from the control (* p value <0.05). Statistical significance was 
determined using a 2 way ANOVA test, followed by post hoc Bonferroni’s correction for pair 
wise multiple analysis. 
 
 
 
 
Anti-phosphoERK1/2                               
 
           Thimerosal                         MeHgCl 
                          Concentration (µM) 
Antibody 
Reactivity 
(% of 
control) 
  0        0.1         1           0          0.1         1    
        Thimerosal                         MeHgCl  
                                 (µM) 
 
    0        0.1        1          0       0.1      1    
       Thimerosal                  MeHgCl  
                             (µM) 
 
* 
* * 
* 
 
 
 
 
ERK 1 (44 kD) 
ERK 2 (42 kD) 
Anti-ERK1/2 
 
 136 
5.2: The effect of thimerosal and methylmercury chloride on ERK and phosphorylated 
ERK in N2a cells 
 
After 4 hours there were no significant changes in the levels of bound anti-ERK1/2 
antibody to the N2a cell lysates with either thimerosal or MeHgCl (Figure 5.2.1). 
Statistical analysis using a 2 way ANOVA and post hoc Bonferroni’s test showed p to 
be in the range of 0.05446-0.92251. The average densitometric absorbance obtained 
for cells extracts probed with the anti-ERK1/2 antibody was 0.729491 at 4 hours and 
0.945816 with the western blot of the 24 hour differentiated cells. By contrast, 
exposure to both concentrations of thimerosal and MeHgCl caused approximately a 
40 % decrease in the reactivity of the anti-phosphorylated ERK antibody, which was 
statistically significant (p = 0.015529-0.043316).  
 
 
Figure 5.2.2 shows that after 24 hours there were no significant changes in the levels 
of bound anti-total ERK1/2 antibody to the N2a cell lysates treated with either 
thimerosal or MeHgCl (p = 0.744719).. Densitometric analysis of the western blots 
gave an average absorbance of 0.773096 for the control cells reacted with the anti-
phosphorylated ERK1/2 antibody and 0.438926 for extracts exposed to 0.1 µM 
thimerosal. After 24 hours exposure to 0.1 µM thimerosal the anti-phosphorylated 
ERK reactivity was significantly reduced by 45 % (p = 0.003425). Exposure to 1 µM 
thimerosal caused also caused around a 48 % decrease in antibody reactivity. 
Exposure to MeHgCl significantly reduced the intensity of the anti-phosphorylated 
ERK antibody by 38-50 % (p = 0.03528 and 0.26281 for 0.1 and 1 µM respectively). 
A statistical comparison of the 4 and 24 hour data showed that there were significant 
differences between both compounds and concentrations (p = 0.19567-0.38461).  
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Figure 5.2.1: Western blots and densitometric analysis of lysed N2a cell extracts 
exposed to thimerosal and MeHgCl for 4 hours. The proteins were visualised with a 
1/1000 dilution of an anti-ERK1/2 and phosphorylated ERK1/2 antibody and 
compared with the corresponding control that was untreated with the organic mercury 
compounds. 
N2a cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and MeHgCl as indicated, then separated by SDS PAGE and western blotting as described in 
Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed as a 
percentage of the corresponding control + SEM (n = 5). Asterisks indicate statistical 
significance of difference from the control (* p value <0.05). Statistical significance was 
determined using a 2 way ANOVA test, followed by post hoc Bonferroni’s correction for pair 
wise multiple analysis. 
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Figure 5.2.2: Western blots and densitometric analysis of lysed N2a cell extracts 
exposed to thimerosal and MeHgCl for 24 hours. The proteins were visualised with a 
1/1000 dilution of an anti-ERK1/2 and phosphorylated ERK1/2 antibody and 
compared with the corresponding control that was untreated with the organic mercury 
compounds. 
N2a cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and MeHgCl as indicated, then separated by SDS PAGE and western blotting as described in 
Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed as a 
percentage of the corresponding control + SEM (n = 5). Asterisks indicate statistical 
significance of difference from the control (* p value <0.05). Statistical significance was 
determined using a 2 way ANOVA test, followed by post hoc Bonferroni’s correction for pair 
wise multiple analysis. 
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5.3: Effects of thimerosal and methylmercury chloride on the levels of 
phosphorylation in serine and threonine residues 
 
Figure 5.3.1 shows that there was a complex pattern of reactivity reflecting the 
multitude of proteins with serine residues that could potentially be phosphorylated by 
activated ERK. The cell extracts exposed to 1 µM thimerosal appears to have caused a 
reduction in antibody reactivity. However statistical analysis did not highlight the 
reduction as significant (p = 0.06692 and 0.14826 for 4 and 24 hours respectively). 
There were changes in the pattern of reactivity of the phosphorylated serine antibody 
with C6 cells differentiated for 4 and 24 hours. After 24 hours of differentiation the 
highest molecular weight band of 230 kD evident in the 4 hour incubation was no 
longer visible the highest molecular weight protein was 100 kD. The 80 kD band 
visible at 4 hours was not evident after 24 hours of incubation and there were bands of 
74 and 60 kD that were not there after 4 hours. However, there were no obvious or 
consistent differences in reactivity between the control and the organic mercury 
treated cells for individual time points or treatments. The pattern was considered too 
complex to perform detailed quantitative analysis.  
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Figure 5.3.1: Western blots of lysates from the differentiated glial C6 cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the PSR-45 anti-
phosphorylated serine antibody. Quantification of the antibody reactivity was carried 
out using AIDA software.  
C6 cells were induced to differentiate for 4 (a) and 24 (b) hours in the presence and absence 
of thimerosal and MeHgCl as indicated and extracts were separated by SDS PAGE and 
western blotted as described in Methods section 2.2.12. The blots were probed with an anti-
phosphorylated serine residue antibody. Molecular weight markers are in lane S. 
 
 
Molecular weight of band (kD) Heavy metal 
concentration 
(µM) 230 100 80 70 25 
0.1µM thimerosal 
 
 
99+25.1 99+19.2 105+23.1 124+24.9 104+18.5 
1 µM thimerosal  
 
 
78+27.1 89+14.1 104+22.4 99+18.9 98+24.3 
0.1 µM MeHgCl  
 
 
137+12.6 96+29.2 113+17.5 123+15.3 96+19.8 
1 µM MeHgCl  
 
 
94+23.0 103+26.7 83+32.3 105+31.7 107+14.0 
 
Table 5.3.1: Densitometric analysis of the effects of thimerosal and MeHgCl on the 
levels of phosphorylated serine in C6 cells differentiated for 4 hours. 
C6 cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM.  
 
b) 
 
100kD 
74kD 
70kD 
60kD 
25kD 
15kD 
10kD 
230kD 
        S     0     0.1    1     0    0.1    1    
               Thimerosal     MeHgCl  
                               (µM) 
 
        S    0    0.1    1     0    0.1     1    
             Thimerosal     MeHgCl  
                             (µM) 
 
a) 
 
100kD 
80kD 
70kD 
25kD 
10kD 
15kD 
 141 
Molecular weight of band (kD) Heavy metal 
concentration 
(µM) 
100 74 70 60 25 15 10 
0.1µM 
thimerosal 
103+18.0 104+23.5 98+19.0 123+33.3 126+12.3 105+23.6 108+29.6 
1 µM thimerosal 
 
 
123+13.1 86+18.2 97+21.1 105+17.6 135+18.6 103+12.4 97+30.3 
0.1 µM MeHgCl 
 
 
106+28.4 123+31.8 104+30.1 87+19.1 95+18.5 114+22.5 122+17.9 
1 µM MeHgCl 98+21.2 104+12.6 123+10.9 139+20.1 98+18.9 103+24.1 110+19.1 
 
 
Table 5.3.2: Densitometric analysis of the effects of thimerosal and MeHgCl on the 
levels of phosphorylated serine in C6 cells differentiated for 24 hours 
C6 cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM. 
 
Tables 5.3.1 and 2 shows that there was no change in band intensity at any molecular 
weight with C6 cell extracts incubated with the organic mercury compound for 4 and 
24 hours (p = 0.0798 and 0.5621 for 4 and 24 hours respectively). 
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Figure 5.3.2: Western blots of lysates from the differentiated glial C6 cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the PTR-8 anti-
phosphorylated threonine antibody. Quantification of the antibody reactivity was 
carried out using AIDA software.  
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl as indicated and extracts were separated by SDS PAGE and western 
blotted as described in Methods section 2.2.12. The blots were probed with an anti-
phosphorylated threonine antibody for 4 hours (a) and 24 hours (b). Molecular weight 
markers are in lane S. 
 
Figure 5.3.2 shows that, as with the phosphorylated serine antibody, probing the 
western blot with an anti-phosphorylated threonine antibody produced a very 
complicated pattern of reactivity. After incubating the C6 cells with thimerosal and 
MeHgCl for 4 hours, there were no statistically significant changes reactivity of the 
antibody.  The pattern of reactivity became less complex after 24 hours of treatment 
with the organic mercury compounds. Some of the bands visible at 4 hours incubation 
were no longer visible after 24 hours, the 52, 64, 109 and 150 kD bands were all 
absent from the western blot of the 24 hours cell lysates. There were no significant 
changes in the levels of reactivity after 4 or 24 hours of exposure with either 
compound. As with the phosphorylated serine western blot, quantification was only 
carried out on the major bands.  
 
 
 
  
              S   0    0.1   1       0     0.1    1    
                   Thimerosal       MeHgCl  
                                    (µM) 
 
              S     0     0.1     1      0    0.1    1    
                     Thimerosal         MeHgCl  
                                       (µM) 
 
b) 
 
150kD 
100kD 
64kD 
52kD 
15kD 
10kD 
100kD 
80kD 
15kD 
10kD 
a) 
 
109kD 
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Molecular weight of band (kD)  Heavy metal 
concentration 
(µM) 
150 109 100 64 52 15 10 
0.1µM thimerosal 91+17.6 87+19.7 108+11.9 89+24.8 92+12.4 129+18.3 134+14.3 
1 µM 
thimerosal 
 
124+28.4 94+12.6 86+34.2 96+27.5 83+18.7 123+22.8 103+27.7 
0.1 µM MeHgCl 
 
103+19.1 91+20.6 97+25.3 95+19.1 89+19.6 105+31.6 118+13.8 
1 µM MeHgCl 
 
109+28.4 97+13.9 95+16.9 116+29.3 95+29.1 103+21.9 95+25.9 
 
Table 5.3.3: Densitometric analysis of the effects of thimerosal and MeHgCl on the 
levels of phosphorylated threonine in C6 cells differentiated for 4 hours. 
C6 cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM (n = 5). 
 
 
 
Molecular weight of band (kD) Heavy metal concentration 
(µM) 
100 64 15 10 
0.1µM thimerosal 94+29.9 89+22.2 87+18.1 108+30.3 
1 µM thimerosal  
 
102+26.2 104+17.2 98+18.5 133+28.6 
0.1 µM MeHgCl  
 
107+15.1 98+22.8 102+17.1 113+30.3 
1 µM MeHgCl  
 
115+25.8 86+19.8 98+28.6 119+27.1 
 
Table 5.3.4: Densitometric analysis of the effects of thimerosal and MeHgCl on the 
levels of phosphorylated threonine in C6 cells differentiated for 24 hours 
C6 cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM (n = 5). 
 
 
Tables 5.3.3 and 4 shows that there was no statistically significant change in band 
intensity at any molecular weight with C6 cell extracts incubated with the organic 
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mercury compound for 4 and 24 hours (p = 06887 and 0.9735 for 4 and 24 hours 
respectively). 
 
Figure 5.3.3 shows that after 4 (a) and 24 (b) hours of differentiation in the absence 
and presence of the organic mercury compounds, the anti-phosphorylated serine 
antibody reacted with numerous proteins of varying molecular weight. The pattern of 
reactivity did not alter after treatment with either thimerosal or MeHgCl after 4 or 24 
hours of exposure. Statistical analysis of the densitometric data showed that neither 4 
nor 24 hours of exposure caused significant changes from the control (p = 0.518329 
and 0.802471 for 4 and 24 hours respectively). However the molecular weight of the 
proteins recognised by the antibody changed with the different differentiation times 
(Table 3.3.3-4). After 24 hours of differentiation the bands seen at 200 and 50 kD 
after 4 hours of differentiation were no longer visible. There were bands visible at 79 
and 55 kD that were not seen with the western blot created from cell extracts 
differentiated for 4 hours. As with C6 cells the pattern of reactivity was considered to 
complex to perform detailed quantification.  
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Figure 5.3.3: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the PSR-45 anti-
phosphorylated serine antibody. Quantification of the antibody reactivity was carried 
out using AIDA software.  
 
N2a cells were induced to differentiate for 4 (a) and 24 (b) hours in the presence and absence 
of thimerosal and methylmercury chloride and extracts were separated by SDS PAGE and 
western blotted as described in Methods section 2.2.12. The blots were probed with an anti-
phosphorylated serine residue antibody. Molecular weight markers are in lane S. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
 
150kD 
200kD 
100kD 
90kD 
65kD 
50kD 
25kD 
15kD 
10kD 
150kD 
100kD 
90kD 
65kD 
55kD 
25kD 
10kD 
15kD 
          S     0      0.1   1     0    0.1     1    
                 Thimerosal       MeHgCl  
                                  (µM) 
 
S       0    0.1   1      0      0.1    1    
        Thimerosal        MeHgCl   
                          (µM) 
 
b) 
 
79kD 
 146 
 
Molecular weight of band (kD) Heavy metal 
concentration 
(µM) 
200 150 100 90 65 50 25 15 10 
0.1µM 
thimerosal 
96+16.4 96+14.02 112+14.2 98+12.9 104+18.8 124+20.9 103+17.8 103+11.5 75+14.3 
1 µM 
thimerosal  
110+11.7 104+16.9 86+14.4 95+22.2 97+16.1 95+18.2 124+14.7 87+28.1 87+18.5 
0.1 µM  
       MeHgCl  
91+18.4 108+15.9 104+29.2 106+14.1 111+14.3 103+23.0 104+14.6 94+18.8 96+16.9 
1 µM MeHgCl 86+13.2 94+29.2 112+37.6 114+33.7 109+26.4 92+14.6 115+21.5 74+12.6 104+20.7 
 
Table 5.3.5: Densitometric analysis of the effects of thimerosal and MeHgCl on the 
levels of phosphorylated serine in N2a cells differentiated for 4 hours 
N2a cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM (n = 5). 
 
Heavy metal 
concentration 
(µM) 
Molecular weight of band (kD)  
 
150 100 90 79 65 55 25 15 10 
0.1µM 
thimerosal 
104+22.2 104+15.5 88+16.2 109+18.2 92+18.3 105+31.3 117+28.2 102+27.3 102+12.8 
1 µM 
thimerosal 
 
102+12.0 89+15.2 97+15.6 123+12.1 102+21.2 117+18.9 104+21.3 113+16.2 109+19.6 
0.1 µM 
MeHgCl  
 
115+21.8 78+19.5 103+12.3 98+16.4 114+28.5 99+41.6 122+35.9 98+29.4 93+10.7 
1 µM 
MeHgCl 
 
92+24.2 108+16.6 120+13.6 88+17.0 122+20.5 90+22.2 97+17.6 87+35.5 112+9.3 
 
Table 5.3.6: Densitometric analysis of the effects of thimerosal and MeHgCl on the 
levels of phosphorylated threonine in N2a cells differentiated for 24 hours 
N2a cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM (n = 5). 
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Tables 5.3.5 and 6 shows that there is no change in antibody reactivity with C6 cell 
lysates incubated with thimerosal and MeHgCl for 4 and 24 hours (p = 0.0688 and 
0.1358 for 4 and 24 hours respectively).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.4: Western blots of lysates from the differentiated neuronal N2a cell line 
following exposure to either thimerosal and methylmercury chloride for 4 or 24 hours. 
The proteins were visualised using a 1/1000 dilution of the PTR-8 anti-
phosphorylated threonine antibody. Quantification of the antibody reactivity was 
carried out using AIDA software. 
N2a cells were induced to differentiate for 4 (a) and 24 (b) hours in the presence and absence 
of thimerosal and MeHgCl as indicated, and the extracts were separated by SDS PAGE and 
western blotted as described in Methods section 2.2.12. The blots were probed with an anti-
phosphorylated threonine residue antibody. Molecular weight markers are in lane S 
 
Figure 5.3.4 indicates that that the reactivity of the anti-phosphorylated threonine 
antibody did not alter when cell extracts were exposed to either thimerosal or 
MeHgCl. As with the anti-phosphorylated serine antibody, the pattern of reactivity 
appeared to change with the different differentiation times. The numbers of proteins 
recognised by this antibody were not as numerous as with the anti-phosphorylated 
serine antibody, but the pattern of reactivity was still fairly complex. There no 
significant reduction in antibody reactivity with exposure to the organic mercury 
compounds. Unlike the phosphorylated serine antibody the molecular weights of the 
phosphorylated proteins did not appear to change with the incubation times. The 
images show evidence of a number of bands that were considered too faint to obtain 
accurate quantification.  
 
a) 
 
150kD 
110kD 
95kD 
65kD 
55kD 
15kD 
150kD 
100kD 
65kD 
55kD 
15kD 
      S       0       0.1    1     0   0.1 1    
                Thimerosal     MeHgCl  
                                 (µM) 
 
  S   0    0.1   1       0     0.1    1    
       Thimerosal        MeHgCl  
                         (µM) 
 
b) 
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Molecular weight of band (kD) Heavy metal 
concentration 
(µM) 100 64 52 15 10 
0.1µM 
thimerosal 
101+23.1 110+18.6 98+16.3 94+15.5 102+16.6 
1 µM thimerosal  
 
108+18.3 98+23.4 96+19.5 96+18.5 118+16.3 
0.1 µM MeHgCl 
 
117+19.3 103+13.6 89+17.4 108+22.1 98+18.9 
1 µM  MeHgCl 
 
95+20.3 129+10.8 111+9.3 116+20.6 105+21.1 
 
Table 5.3.7: Densitometric analysis of the effects of thimerosal and methylmercury 
chloride on the levels of phosphorylated threonine in N2a cells differentiated for 4 
hours 
N2a cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM (n = 5). 
 
 
Molecular weight of band (kD) Heavy metal 
concentration 
(µM) 
100 64 52 15 10 
0.1µM thimerosal 101+23.1 110+18.6 98+16.3 94+15.5 102+16.6 
1 µM thimerosal  
 
108+18.3 98+23.4 96+19.5 96+18.5 118+16.3 
0.1 µM MeHgCl 
 
117+19.3 103+13.6 89+17.4 108+22.1 98+18.9 
1 µM  MeHgCl 
 
95+20.3 129+10.8 111+9.3 116+20.6 105+21.1 
 
Table 5.3.8: Densitometric analysis of the effects of thimerosal and methylmercury 
chloride on the levels of phosphorylated threonine in N2a cells differentiated for 24 
hours 
N2a cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed 
as a percentage of the corresponding control + SEM (n = 5). 
 
Tables 5.3.7 and 8 show that there was no change in band intensity at any molecular 
weight with N2a cell extracts incubated with the organic mercury compound for 4 and 
24 hours (p = 0.4526 and 0.7206 for 4 and 24 hours respectively). 
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5.5: Discussion 
 
             One possible signalling cascade that is involved in both cytoskeletal 
organisation and cell death is the MAPK pathway. ERK has been shown to 
phosphorylate cytoskeletal proteins such as NFH (Veeranna et al., 1998; Perron & 
Bixby, 1999; Pant et al., 2000) and Tau (Robinson & Cobb, 1997). Tau is a MAP, 
which confers stability to microtubules by binding along the length of the structure. 
The data in chapter 5 shows that the activation of ERK was inhibited by the organic 
mercury compounds thimerosal and MeHgCl, whilst levels of total ERK1/2 were 
unaffected. 
               Until recently it was thought that ERK activation opposed cell death whilst 
JNK and p38 activated it (Subramaniam & Unsicker, 2006).  However, it has been 
discovered that ERK may also have a death-promoting role in neuronal cells under 
various conditions, such as glutamate-induced cell death and ROS-induced death 
(Chin et al., 2004).  In this study ERK activation (phosphorylation) increased after 4 
hours exposure of differentiating C6 cells to both thimerosal concentrations and 
decreased with MeHgCl exposure, indicating a different mechanism of toxicity for the 
organic mercury compounds (Figures 5.1.1(b) and 5.1.2). It could be that cells 
exposed to MeHgCl are beginning the apoptotic process, as it has been noted that in 
many conditions leading to apoptosis, ERK activity is suppressed (Wang et al., 1998). 
However, MTT reduction assays in chapter 3 did not find any evidence of decreased 
cell viability or changes in cell morphology with the lower concentration of 0.1 µM. 
Another possibility is that the transient increase in ERK activation, as seen with 
thimerosal exposure occurred earlier in C6 cells exposed to MeHgCl and would not 
be detected at 4 hours. Work carried out by Parran et al., (2004) showed that ERK 
activation and inhibition changes throughout the course of mercury exposure, thus the 
pattern of ERK inhibition could be different for the two compounds. Further work 
needs to be carried out on apoptotic markers such as caspase activation to clarify this. 
The increase in ERK activation seen with thimerosal could also be indicative of 
cellular damage as ERK has been found to be activated in certain stressful conditions, 
such as insult from ROS (Robinson & Cobb, 1997; Wang et al., 1998). Previous 
studies have shown that mercury exposure does increase levels of ROS in cells 
(Burlando et al., 1997; Dare et al., 2000), which may account for this increase. MTT 
reduction assays in chapter 3 did not find cell viability to be decreased, so it is 
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unlikely that ERK activation has a death promoting role in this instance. The rate 
constant for ERK phosphorylation is 0.75s-1 and the maximal rate for ERK 
dephosphorylation is 10-9-10-6 Ms-1 (Maly et al., 2004). As organic mercury 
compounds inhibit ERK activation it would be expected that they would decrease the 
rates of phosphorylation and dephosphorylation. 
 
Heavy Metal 
Concentration (µM) 
N2a cells 
4 hours                      24 hours 
C6 Cells 
4 hours                        24 hours
  
0.1 µM Thimerosal 0.5:1 0.5:1 1.7:1 0.4:1 
1 µM Thimerosal 0.5:1 0.46:1 1.5:1 0.5:1 
0.1 µM MeHgCl 0.52:1 0.5:1 0.6:1 0.55:1 
1 µM MeHgCl 0.46:1 0.5:1 0.8:1 0.56:1 
 
Table 5.9: Ratios of phosphorylated ERK to total ERK in C6 and N2a cells. 
Table 5.9 shows the ratio of phosphorylated ERK1/2 to total ERK1/2 in N2a and C6 
cell extracts treated with thimerosal and MeHgCl for 4 and 24 hours. The ratios were 
obtained from the densitometric data contained in chapter 5. The ratios were 
calculated for each individual extract using the equation: 
 
% relative to control Phosphorylated ERK1/2 
% relative to control total ERK1/2 
The ratios were then averaged for each metal concentration and time point. The ratios 
enable a direct quantifiable comparison to be made about the changes in the levels of 
phosphorylation. 
 
The ratios show that apart from 4 hour thimerosal treatment in C6 cells, exposure to 
organic mercury compounds causes the levels of phosphorylated ERK to decrease in 
comparison to the levels of total ERK. This confirms the western blots and 
Quantiscan data. This decrease in the activity of ERK1/2 corresponds to the decrease 
in NFH phosphorylation seen in chapter 4. 
                 Exposing N2a cells to MeHgCl for 4 hours had a similar effect of inhibiting  
ERK phosphorylation as was seen with C6 cells at the same time point (see Figure 
5.2.1 b and 5.2.2). ERK activation decreased with both concentrations of MeHgCl. 
However, both concentrations of thimerosal caused a decrease in activated ERK in 
N2a cells as opposed to the increase in the levels of phosphorylated ERK seen with 
the same concentration and time point in C6 cells. This perhaps highlights a possible 
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difference in the toxicity of thimerosal in the two cell types, either at the level of 
sensitivity in the cell lines or differences in the time course of response in the actual 
mechanism of toxicity in the two cell lines. 
               After 24 hours of exposure in C6 cells the levels of activated ERK remained 
reduced with both concentrations of MeHgCl. Both concentrations caused a reduction 
in activation in contrast to the transient increase seen at 4 hours. After 24 hours levels 
of activated ERK were decreased with both concentrations of thimerosal and MeHgCl 
in N2a cells (see Figure 5.2.3 (b) and 5.2.4). Thus, in the neuronal cell line ERK 
inhibition was a sustained event. Parran et al., (2004) looked at ERK activation in 
PC12 cells and found that total ERK remained at control levels throughout treatment 
with mercury for 1 hour,  the present study indicated that the levels of total ERK 
remained unchanged at both 4 and 24 hours in both cell lines, with both 
concentrations of the organic mercury compounds. 
          Generally ERK signalling was inhibited by the addition of organic mercury 
compounds; there was only a transient increase in C6 cells at the 4 hour time point. 
Sustained ERK activation is known to be essential for the promotion of neurite 
outgrowth and stabilisation, as is NFH phosphorylation (Veeranna et al., 1998). 
Decreased ERK activity coincides with a decrease in NFH phosphorylation (see 
chapter 4), which occurs during neurite outgrowth. A relative decrease in the 
reactivity with the anti-phosphorylated ERK antibody may mean decreased activation, 
but it is not conclusive evidence in itself. However, similarly altered phosphorylation 
of a known substrate (also known to be important in neurite outgrowth), is supporting 
evidence of an effect on the ERK1/2 signalling cascade. A similar study using 2.5 µM 
phenyl saligenin phosphate (PSP) found ERK activation to be increased during 
exposure to the organophosphate in N2a cells. This increased activation in the 
signalling pathway was accompanied by an increase in the phosphorylation of NFH 
(Hargreaves et al., 2006). Thus, PSP had the opposite effect on NFH phosphorylation 
and ERK1/2 signalling to the organic mercury compounds used in the present study.                                      
            Cordova et al., (2004) found that inhibiting ERK activation protected cells 
from lead induced cell death. Hence the inhibition of ERK activation seen in this 
study could be a protective mechanism employed by the cells.  
         In contrast to the study by Cordova et al., (2004) other investigations have 
shown that the activation of ERK can also confer a survival advantage to cells (Xia et 
al., 1995; Guyton et al., 1996; Wang et al., 1998). Thus the activation of ERK at 4 
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hours might give the glial cells a survival advantage in response to thimerosal that is 
not possible after the longer exposure time. It would of interest for further work if a 
larger range of concentrations and more incubation times between time 0 and 4 hours 
were used to monitor the activation or suppression of the ERK1/2 pathway.            
           Ziemba et al., (2006) found ERK activation was prevented in T-cells by the 
failure of Ras to become properly activated after exposure to non-lethal 
concentrations of mercury. An investigation into the effect of MeHg on protein kinase 
C (PKC) activity showed that exposure to organic and inorganic mercury inhibited 
PKC activity in purified extracts from rat brain (Rajanna et al., 1995). PKC is 
involved in a G-protein mediated pathway to ERK activation. PKC becomes activated 
by a G-protein and phosphorylates the Raf kinase inhibitory protein (RKIP) causing it 
to disassociate from Raf allowing ERK signalling to occur (Werry et al., 2005). If 
mercury disrupts PKC in the N2a and C6 cells lines it may cause the inhibition of 
ERK1/2 signalling pathway seen in this thesis. Parran et al., (2004) found levels of 
phosphorylated ERK to be reduced in differentiated PC12 cells after 2.5 minutes of 
exposure to 0.1-0.3 µM MeHgCl, then activation of ERK increased rapidly and 
peaked at 5 minutes before falling, indicating that MeHgCl treatment produces earlier 
transient signalling events. The time course did not exceed 1 hour so it can not be 
determined whether the activity of ERK would continue to fall to levels below the 
control as with the N2a cells in the present study.                
           Studies into the effects of other heavy metals on ERK activation indicate that 
responses are varied. Exposure to 300 µM zinc elevated levels of phosphorylated 
ERK in a mixed culture of neuronal and glial cells for up to 8 hours (Park & Koh, 
1999). A separate study attributed this increase in ERK activity to damaged caused by 
ROS (Seo et al., 2001). Exposure to mercury caused no alteration in the activation of 
ERK but caused an increase in the levels of activated p38, highlighting the difference 
in toxicity between the organic and the inorganic mercury species (Kim & Sharma, 
2005). Cadmium can both inhibit and activate the ERK pathway depending on the 
concentration. Low levels of cadmium inhibit ERK activation, whilst high 
concentrations activate ERK signalling (Pulido & Parrish, 2003).  
              Activated ERK phosphorylates a variety of different substrates such as NFH 
(Veeranna et al., 1998), Tau and calpain (Subramaniam & Unsicker, 2006). ERK 
targets serine and threonine residues for phosphorylation. Western blots of C6 cell 
lysates probed for phosphorylated serine and threonine residues (Figures 5.3.1 and 
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5.3.2) show no changes in the gross levels of phosphorylated serine or threonine with 
either concentration of thimerosal or MeHgCl. This is to be expected if there was an 
inhibition in ERK activity as with MeHgCl. However ERK activity increased in C6 
cells after 4 hours incubation with both concentrations of thimerosal, but the increase 
does not correspond to a rise in substrate levels as would be expected. It is possible 
that the affected proteins were in too low abundance to be detected by the antibody. 
As with C6 cells there were no alterations in the levels of phosphorylated serine and 
threonine residues in N2a cells (Figures 5.3.3 and 5.3.4). This result suggests that the 
change in substrate phosphorylation involves a lower abundance protein that shows 
lower specificity for the anti-phosphoserine and threonine antibodies. As the numbers 
of phosphorylated proteins within cells is so high it was unlikely that the western blots 
would pick up the proteins such as NFH that are targeted by ERK1/2. However an 
attempt was considered to be worth while on the off chance that it presented any 
interesting data. Future investigations could involve the use of 2D gels to provide 
better separation of proteins.  
         Attempts to investigate the effect of organic mercury compounds on the JNK 
pathway are shown in the appendix. Unfortunately the reactivity of the antibody was 
rather poor under the conditions used in this project. Further work needs to be carried 
out to optimise the procedures for this antibody. However, Quantiscan analysis was 
completed on the western blots and indicated that there was an increase in JNK 
activation with both concentrations of the organic mercury compounds, but reactivity 
was to low to allow for a confident conclusion (see appendix). 
           Investigations into the effect of organic mercury compounds on the p38 
pathway were unsuccessful despite numerous attempts. There antibody displayed very 
low reactivity with both C6 and N2a cell lysates. 
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Chapter 6: The effect of thimerosal and methylmercury chloride on the organisation 
of the cell and calpain activity 
 
Introduction 
 
             It has been shown in previous chapters that the cytoskeletal organisation of 
C6 and N2a cells was disturbed following exposure to thimerosal and MeHgCl. Given 
that the endomembrane system, which is dependent on MT integrity (Waterman-
Storer & Salmon, 1998), houses intracellular Ca2+ stores; it was of interest to this 
investigation to determine whether the organisation of cell organelles were affected 
by the exposure to organic mercury compounds. Using a bodipy labelled probe to 
recognise the endoplasmic reticulum (ER) and an antibody against a Golgi apparatus 
protein called GRASP 65, confocal microscopy was carried out to visualise any 
disruptions caused by the mercury compounds.  
          Both the ER and the Golgi apparatus depend upon MTs for their positioning 
within a cell and MT based motors such as kinesin and dynein are involved in 
membrane trafficking (Presley et al., 1997). The Golgi apparatus of mammalian cells 
is organised into stacks of cisternae. Each stack contains an average of 4–8 cisternae, 
and about 40–80 such stacks are attached to each other and anchored in the 
pericentriolar region. When mammalian cells enter mitosis, the pericentriolar stacks 
of Golgi cisternae undergo extensive fragmentation, and the fragments are dispersed 
throughout the cytosol. This process is mediated by mitogen-activated protein kinase 
kinase 1 (MEK1). GRASP 65 (Golgi reassembly stacking protein of 65 kDa) is a 
Golgi associated protein that is required for mitotic Golgi fragmentation (Sutterlin et 
al., 2002).  
              Changes in intracellular calcium concentrations disrupt calcium dependent 
signalling mechanisms and enzyme activity. The ryanodine receptor mediates the 
release of calcium from ER stores and is activated by raised levels of cytosolic 
calcium of around 100 µM in a process known as Ca2+ induced Ca2+ release (Fabiato, 
1985). The ER is an important organelle in the maintenance of calcium homeostasis in 
both neuronal and glial cells. Previous work has shown that disrupting the ER hinders 
the cells ability to maintain intracellular concentrations (Doutheil et al., 1997; Lee et 
al., 2006). Calcium is removed from the intracellular matrix by a variety of 
mechanisms. These include SERCA; an energy dependent pump that sequesters 
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calcium within the ER. SERCA is important in the regulation of intracellular calcium 
as research has shown that overexpression of SERCA decreases the time period of a 
calcium wave (Falcke et al., 2003). Thapsigargin is a plant derivative that binds to 
SERCA; using fluorescently labelled bodipy thapsigargin and bodipy ryanodine 
allowed the capture of images showing the distribution of SERCA and ryanodine 
receptors within cells. In this chapter experiments were carried to determine whether 
the addition of thimerosal or MeHgCl changed the distribution of the ryanodine 
receptors and SERCA within differentiating C6 and N2a cells.                 
           One possible consequence of raised intracellular calcium levels is the 
activation of calpains. Calpains are calcium activated enzymes that are known to 
target cytoskeletal proteins (Huang & Wang, 2001). There are two main forms of 
calpains in vertebrate cells; calpain 1 and 2 and they are distinguished by their 
calcium requirements for activation. Calpain 1 requires concentrations of 5-50 µM 
and calpain 2 requires concentrations of 200-1000 µM for activation (Wang, 2000). 
Calpains are known to be involved in the formation of processes and cells adhesion, 
they are also known to degrade various MAPs. MAPs are important in the 
stabilisation of MTs and their degradation by calpain may have an adverse affect on 
MT stability (Sorimachi et al., 1997). Due to the degradation of the cytoskeletal 
network seen in chapter 4, it was of interest to the study to determine if the addition of 
the organic mercury compounds affected the activation of calpain 1, as changes in 
activity may indicate a possible role for calpain in organic mercury induced disruption 
of the cytoskeleton. 
 
Methods 
         The concentrations of thimerosal and MeHgCl used for the western blotting and 
confocal microscopy in this chapter were the same as previous chapters 0.1 and 1 µM. 
Cells were seeded into an 8 well chamber slide (see Methods section 2.2.14-15), there 
were 2 wells for the control and each concentration of the organic mercury 
compounds (0.1 and 1 µM). Each experiment was repeated a minimum of 3 times and 
the images contained in the chapter represent what was seen in each individual 
experiment.  All antibodies and probes were diluted in 3 % BSA (see Methods for 
detail). The calpain 1 antibody (sc-7530) was used at a dilution of 1/1000 and the 
secondary anti-goat antibody was used at 1/2000. The dilution factor for the anti-golgi 
antibody was 1/200; Bodipy thapsigargin was diluted to 10 µM and the final 
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concentration of Bodipy ryanodine was 1 µM. Each experiment was completed in 
triplicate using different batches of cells.  
       For the calpain assay the cells were seeded at the normal density in T25 flasks 
and then extracted in the homogenisation buffer described in the methods section with 
a cell scraper. The cell suspension was kept on ice to minimise enzyme activity and 
sonicated for 5 minutes. A mini-Lowry protein estimation was carried out on the 
sonicates so that the activity could be corrected for protein concentration. The lane on 
the blots labelled 0 is the control extract with no added metal. For the thimerosal 
treated corresponding control sterile distilled water was added at the same volume as 
the metal in the treated cells and with MeHgCl DMSO was added at the same volume 
as with the treated cells as the MeHgCl was dissolved in DMSO due to poor solubility 
in distilled water. 
 
 
Figure 6.1 (a) shows control cells differentiated for 24 hours without the addition of 
heavy metals. The probe bodipy thapsigargin stained cell bodies and outgrowths in a 
punctate manner. The brightest staining was located around the nucleus of the cell, 
where the highest concentration of ER would be expected. Figure 6.1 (b) shows cells 
differentiated for 24 hours in the presence of 0.1 µM thimerosal. The cells exhibited a 
relatively diffuse staining pattern. In some cells the bright area of staining circling the 
nucleus was no longer visible, although the processes were still visibly stained at this 
concentration. The cells exposed to 1 µM thimerosal for 24 hours (figure 6.1 c), 
exhibited very intense punctate staining and little or no staining of neurites. The 
perinuclear organisation was no longer visible. Figure 6.1 (d) shows cells exposed to 
0.1 µM MeHgCl. There was little difference between the cells in this image and those 
treated with the same concentration of thimerosal. The cells still had stained processes 
and the bright area around the nucleus was either less intense or had become 
disrupted. Cells exposed to 1 µM MeHgCl for 24 hours, no longer displayed visibly 
stained processes, but the nuclei were more discernable than in the image of cells 
treated with the same concentration of thimerosal. The images are representative of 3 
separate experiments and reflect the major trends seen in each one. 
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Figure 6.1: The effect of thimerosal and MeHgCl on the distribution of SERCA in C6 
cells 
C6 cells were induced to differentiate for 24 hours in the absence of thimerosal (a), with 0.1 
(b) and 1 µM (c) of thimerosal and 0.1 (d) and 1 µM (e) methylmercury chloride. The cells 
were stained with bodipy thapsigargin, which binds to SERCA as described in Methods 
section 2.2.15 (n = 3). 
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Figure 6.2 (a) shows N2a cells differentiated for 24 hours in the absence of thimerosal 
and MeHgCl. The cells were stained in neurite outgrowths but the strongest of the 
staining was observed on one side of the nucleus. Bodipy thapsigargin appeared to 
have stained N2a cells in a less punctate manner than that observed in C6 cells. Figure 
6.2 (b) shows cells exposed to 0.1 µM thimerosal for 24 hours. The cells were stained 
more weakly with the bodipy thapsigargin but the most intense staining was still 
localised around the nucleus of the cell but still detectable in neurites. Cells exposed 
to 1 µM thimerosal for 24 hours, exhibited no visible neurite staining and the staining 
within the cell body was punctate and relatively disperse. Figure 6.2 (d) shows cells 
incubated with 0.1 µM MeHgCl for 24 hours. The cells were weakly stained in 
comparison to the control cell, but still exhibited fluorescent staining in cell bodies 
and neurites. In the vast majority of cells, the strongest staining was still around the 
nucleus, but in one cell the bodipy thapsigargin covered the whole cell.  
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Figure 6.2: The effect of thimerosal and MeHgCl on the distribution of SERCA in 
N2a cells 
N2a cells were induced to differentiate for 24 hours in the absence of thimerosal (a), with 0.1 
(b) and 1 µM (c) of thimerosal and 0.1 (d) and 1 µM (e) methylmercury chloride. The cells 
were stained with bodipy thapsigargin, which binds to SERCA as described in Methods 
section 2.2.15 (n = 3). 
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e) 
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 160 
In figure 6.2 (e) the cells have been treated with 1 µM MeHgCl for 24 hours and like 
the cells exposed to the same concentration of thimerosal, there was no visible neurite 
staining and staining in the cell body was more diffuse than in the control. The images 
shown are representative of three separate experiments and reflect the changes seen in 
each one. 
 
Figure 6.3 (a) shows that bodipy ryanodine staining of C6 cells differentiated for 24 
hours without the addition of thimerosal or MeHgCl was detected throughout the cell 
body and extended into the processes in a punctate manner. In cells exposed to 0.1 
µM thimerosal for 24 hours (figure 6.3 (b)), the staining did not appear as intense as 
with the control cells but the distribution of the ryanodine receptor staining was 
similar to that of untreated cells. The cells in figure 6.3 (c) have been exposed to 1 
µM thimerosal for 24 hours. At this concentration there were very few weakly stained 
processes and the distribution of the ryanodine receptor within the cell body had 
changed when compared to control cells. There was no longer a defined nucleus due 
to the disperse staining pattern. The punctate staining visible within control cell was 
no longer evident. Cells exposed to 0.1 µM MeHgCl for 24 hours show that there is 
little difference from the control apart from the intensity of the staining. The cells in 
figure 6.3 (e) have been exposed to 1 µM MeHgCl for 24 hours. There were no 
visible processes in the image and the nucleus was not as clearly defined as with 
control cells. The images shown are representative of three separate experiments and 
reflect the major changes seen in each individual experiment. 
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Figure 6.3: The effect of thimerosal and methylmercury chloride on the distribution of 
ryanodine receptors in C6 cells 
C6 cells were induced to differentiate for 24 hours in the absence (a) and presence (b-e) of   
0.1 µM (b) and 1 µM (c) of thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with bodipy ryanodine, which binds to ryanodine receptors as described in Methods 
section 2.2.15 (n = 3). 
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Figure 6.4 (a) shows that N2a cells differentiated for 24 hours without thimerosal or 
MeHgCl exhibited ryanodine receptor staining in the cell body with the greatest 
intensity around the nucleus, and also staining within the neurites. The staining 
pattern appeared punctate. The cells in figure 6.4 (b) have been exposed to 0.1 µM 
thimerosal for 24 hours. The cells in the image did not appear different from the 
control. The neurites were still visible and the pattern of staining within the cell body 
appeared unaltered from the control cells. Figure 6.4 (c) shows cells incubated with 1 
µM thimerosal for 24 hours. The cells had no visibly stained neurites and the staining 
pattern was different from the control in that there was a disperse distribution of 
staining such that the nucleus was no longer discernable.  Figure 6.4 (d) did not 
appear radically different from the control cells, there was still a visible nucleus 
within the cell body and the staining was quite granular. However in agreement with 
neurite outgrowth in chapter 3, neurites were generally more stunted but the pattern of 
staining was similar to controls. Cells incubated with 1 µM MeHgCl for 24 hours 
(figure 6.4 (e)), displayed very few visibly stained axons and they were extremely 
stunted. There did appear to be a redistribution of ryanodine receptor staining with 
this concentration in that there appeared to be an accumulation of the receptor staining 
on the edge of the nucleus. The images shown are representative of three separate 
experiments and reflect the changes seen in each one. 
 
 
Figure 6.5 (a) shows C6 cells differentiated for 24 hours in the absence of thimerosal 
and MeHgCl. The cells had been incubated with an ER tracker. The distribution of the 
ER in C6 cells appeared to be cell wide. Figure 6.5 (b) shows N2a cells differentiated 
for 24 hours without the addition of heavy metals. ER staining was localised to the 
area surrounding the nucleus and to a lesser extent, in neurites. When the cells were 
differentiated in the presence of the organic mercury compounds the fluorescence 
staining was too weak to be captured on digital image. Staining with the ER tracker 
was attempted on three separate occasions and each time staining only occurred in the 
control cells without the presence of thimerosal and MeHgCl. 
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Figure 6.4: The effect of thimerosal and methylmercury chloride on the distribution of 
ryanodine receptors in N2a cells 
N2a cells were induced to differentiate for 24 hours in the absence (a) and presence (b-e) of   
0.1 µM (b) and 1 µM (c) of thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with bodipy ryanodine, which binds to ryanodine receptors as described in Methods 
section 2.2.15 (n = 3). 
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Figure 6.5: The distribution of ER in C6 and N2a cells untreated with organic 
mercury compounds. 
N2a and C6 cells were induced to differentiate for 24 hours in the absence of thimerosal and 
methylmercury chloride. Cells were then stained with ER tracker and fixed with ice cold 
methanol as described in Methods section 2.2.15 (n = 3). 
 
 
Figure 6.6 (a) shows control C6 cells differentiated for 24 hours in the absence of 
thimerosal and MeHgCl. The anti-Golgi apparatus antibody was punctate throughout 
the cell body and was particularly intense in the cell processes. The widespread 
staining pattern indicated that the antibody had reacted with other cellular components 
as well as the Golgi apparatus. Figure 6.6 (b) shows cells exposed to 0.1 µM 
thimerosal for 24 hours. Treatment did not appear to cause disruption when compared 
to the control. In cells incubated with 1 µM thimerosal for 24 hours (figure 6.6 (c)), 
the organisation of the cell appeared different to that of the control. With the higher 
concentration there appeared to be minor disruption in the cell body staining. Figure 
6.6 (d) shows cells exposed to 0.1 µM MeHgCl for 24 hours. There did not appear to 
be any radical changes to the antibody staining, but there does seem to be a slight 
disruption in the cell body staining. Figure 6.6 (e) shows cell incubated with 1 µM 
MeHgCl for 24 hours. The organisation of the cells appeared very different from the 
control. The cells contained some intensely stained areas indicating a breakdown in 
cellular organisation. The images shown are representative of three separate 
experiments and reflect the changes seen in each one. 
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Figure 6.6: The effect of thimerosal and methylmercury chloride on antibody staining 
of the Golgi apparatus in differentiating C6 cells 
C6 cells were induced to differentiate for 24 hours in the absence (a) and presence (b-e) of   
0.1 µM (b) and 1 µM (c) of thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with N-20, an anti-Golgi apparatus antibody as described in Methods section 2.2.15 (n 
= 3). 
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Figure 6.7 (a) shows control N2a cells differentiated for 24 hours in the absence of 
thimerosal and MeHgCl. Anti-Golgi apparatus antibody staining was distributed 
around the cell body, with an intense perinuclear spot and into the neurites. The 
antibody may be binding to other proteins apart from the GRASP 65 protein in the 
Golgi apparatus membrane as normally the organelle would be located near the 
nucleus and would not cover the whole cell as the binding of this antibody suggests. 
Figure 6.7 (b) shows cells exposed to 0.1 µM thimerosal for 24 hours. The 
distribution of the Golgi apparatus and other proteins being detected by the antibody 
had altered with the addition of thimerosal. The area of staining had become much 
more disperse than control staining. There was still visible staining within the axon-
like processes. Figure 6.7 (c) shows cells treated with 1 µM thimerosal for 24 hours. 
Here the cells showed a different staining pattern from the control. Staining was more 
punctate and disperse throughout the cell body and no neurite staining was observed. 
The cells in figure 6.7 (d) have been exposed to 0.1 µM MeHgCl for 24 hours. As 
with the same concentration of thimerosal, the staining was more punctate and 
disperse in a proportion of cells and neurite staining, though present was less intense. 
Figure 6.7 (e) shows cells incubated with 1 µM MeHgCl for 24 hours. There was no 
visible neurite staining in this image and the staining within the cell body was much 
weaker than that seen in the control. The images shown are representative of three 
separate experiments and reflect the major trends seen in each individual experiment. 
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Figure 6.7: The effect of thimerosal and methylmercury chloride on the antibody 
staining of the Golgi apparatus in N2a cells 
N2a cells were induced to differentiate for 24 hours in the absence (a) and presence (b-e) of   
0.1 µM (b) and 1 µM (c) of thimerosal and 0.1 µM (d) and 1 µM (e) MeHgCl. The cells were 
stained with N-20, an anti-Golgi apparatus antibody as described in Methods section 2.2.15 (n 
= 3).  
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Figure 6.8: The effect of thimerosal and methylmercury chloride on the levels of 
calpain 1 in C6 cells  
C6 cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl, then separated by SDS PAGE and western blotting as described in 
Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed as a 
percentage of the corresponding control + SEM (n = 5). Asterisks indicated statistical 
significance of differences from the control (*p<0.05, **p<0.001). The 2 way ANOVA test 
was used for statistical analysis, followed by post hoc Bonferroni’s correction for pair wise 
multiple analysis. 
 
Figure 6.8 shows that at both 4 and 24 hours, both concentrations of thimerosal and 
MeHgCl significantly increased the reactivity of the anti-calpain 1 antibody with C6 
cell lysates. The average densitometric absorbance from control cell lysates probed 
with anti-calpain 1 antibody was 0.95823 for 4 hour extracts and 0.93795 for 24 
hours. After 4 hours incubation with thimerosal antibody reactivity was increased by 
around 23 % - 46 % when compared to the reactivity of the control extracts. Statistical 
analysis using a 2 way ANOVA test indicated that there was a significant difference 
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in the 4 hour data (p = 0.02439). Post hoc tests confirmed that the 0.1 and 1 µM 
concentrations were significantly different from the control (p = 0.03281 and 
0.004562 for 0.1 and 1 µM respectively). Exposure to 0.1 µM and 1 µM MeHgCl 
increased antibody reactivity by 19 - 57 %. Statistical analysis of the data confirmed 
significance (p = 0.04332 for 0.1 µM and 0.00674 for 1 µM). After 24 hours of 
exposure, thimerosal significantly increased band intensity by 29 %- 75 %. Twenty 
four hours exposure to 0.1 µM and 1 µM MeHgCl increased the reactivity of the anti-
calpain antibody by 21 % and 56 % (p range of 0.00253-0.00643). The 2 way 
ANOVA test indicated a significant difference in the 4 and 24 hour data (p = 
0.04543), the post hoc Bonferroni’s test confirmed that the data obtained from 
exposure to 1 µM thimerosal was significantly different but a comparison of the other 
concentrations did not highlight any significant differences between the two 
incubation times.  
 
 
Figure 6.9 shows that at both 4 and 24 hours, both concentrations of thimerosal and 
MeHgCl significantly increased the reactivity of the anti-calpain 1 antibody with N2a 
cell lysates. After 4 hours incubation with 0.1 µM thimerosal antibody reactivity was 
increased by around 33 %. Exposure to 1 µM caused a significant 62 % increase in 
band intensity when compared to the control. Exposure to 0.1 µM and 1 µM MeHgCl 
increased antibody reactivity by 24 % and 75 % respectively. Statistical analysis using 
a 2 way ANOVA test indicated significance differences (p = 0.04786 for the 4 hour 
data set). A post hoc Bonferroni’s test confirmed that all both concentrations of both 
compounds were significantly different from the control with p ranging from 0.04859-
0.00348. After 24 hours of exposure 0.1 µM thimerosal increased band intensity by 
38 % and 1 µM caused a 67 % increase in antibody reactivity. Exposure to 0.1 µM 
and 1 µM MeHgCl for 24 hours increased the reactivity of the anti-calpain antibody 
by 40 % (p = 0.002435) and 80 % (p = 0.008987) respectively. Statistical analysis 
using a 2 way ANOVA did not highlight any significant differences between the 4 
and 24 hour data, (p = 0.07865).  
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Figure 6.9: The effect of thimerosal and methylmercury chloride on the levels of 
calpain 1 in N2a cells 
N2a cells were induced to differentiate for 4 and 24 hours in the presence and absence of 
thimerosal and MeHgCl, then separated by SDS PAGE and western blotting as described in 
Methods section 2.2.10-12. Data represents mean levels of antibody reactivity, expressed as a 
percentage of the corresponding control + SEM (n = 5). Asterisks indicated statistical 
significance of differences from the corresponding control (*p<0.05, **p<0.01). The 2 way 
ANOVA test was used for statistical analysis, followed by post hoc Bonferroni’s correction 
for pair wise multiple analysis. 
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Figure 6.10: The effect of thimerosal and methylmercury chloride on the activity of 
calpain in differentiating C6 cells 
C6 cells were induced to differentiate for 4 (a) and 24 (b) hours in the presence and absence 
of thimerosal and MeHgCl as indicated. Cells were lysed by sonication and the extracts were 
used to measure calpain activity as described in Methods section 2.2.16. Data represents mean 
levels of calpain activity expressed as a percentage of the corresponding control + SEM (n = 
4).  Asterisks indicate statistical significance of difference from the control (*p<0.05). The 2 
way ANOVA test was used for statistical analysis, followed by post hoc Bonferroni’s 
correction for pair wise multiple analysis. 
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Figure 6.10 indicates that there was a concentration dependent increase in calpain 
activity compared to the controls in sonicated C6 cell extracts differentiated in the 
presence of thimerosal and MeHgCl for both 4 and 24 hours. Activity increased by 
approximately 25-43 % in cells exposed to both concentrations of the organic mercury 
compounds after 4 hours (Figure 6.10 a). Statistical analysis confirmed significance 
with p ranging from 0.01639-0.3629. Actual activity in absorbance change/mg 
protein/hour was 14.5 and 18.6 for 0.1 and 1 µM thimerosal and 16.8 and 22.3 for 
MeHgCl. After 24 hours (Figure 6.10 b) the activity of calpains was greater with a 70 
% increase with exposure to the higher concentrations of the mercury compounds and 
around a 24-35 % increase in activity with the lower concentration of 0.1 µM. 
Statistical analysis using a 2 way ANOVA confirmed that there was a significant 
difference from the control (p = 0.02441). Post hoc Bonferroni’s test indicated that 
both concentrations and both compounds were significantly different from the control 
(p = 0.02329, 0.00119, 0.01163, and 0.00803 for 0.1, 1 µM thimerosal and 0.1, 1 µM 
MeHgCl respectively). Actual enzyme activity expressed as change in absorbance/mg 
protein/hour was 25.2 and 89.7 for 0.1 and 1 µM thimerosal and 21.2 and 83.1 for 
MeHgCl. Statistical analysis also confirmed significant differences in the effects seen 
with the different incubation times (p < 0.05).  
 
 
Figure 6.11 (a) shows that after 4 hours incubation both concentrations of thimerosal 
and MeHgCl significantly increased calpain activity (p<0.05) by 25-36 %. A 2 way 
ANOVA (p = 0.03471), indicting that there were significant differences within the 4 
hour treatment. Further analysis using post hoc Bonferroni’s test confirmed that both 
concentrations of thimerosal and MeHgCl were significantly different from the 
control. Actual enzyme activity expressed as change in absorbance/mg protein/hour 
was 19.6 and 21.4 after exposure to 0.1 and 1 µM thimerosal and 20.9 and 24.8 for 
MeHgCl. After 24 hours (Figure 6.11 b) treatment with 0.1 µM of both compounds 
increased activity by 25-30 % (p = 0.04931 and 0.02798 for thimerosal and MeHgCl 
respectively). Exposure to 1 µM thimerosal and MeHgCl significantly increased 
calpain activity by approximately 60-70 %. Actual enzyme activity expressed as 
change in absorbance/mg protein/hour was 28.7 and 97.6 following exposure to 0.1 
and 1 µM thimerosal and 22.3 and 88.4 for MeHgCl. 
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Figure 6.11: The affect of thimerosal and methylmercury chloride on the activity of 
calpain in N2a cells  
N2a cells were induced to differentiate for 4 (a) and 24 (b) hours in the presence and absence 
of thimerosal and methylmercury chloride. Cells were lysed via sonication and the extracts 
were used to measure calpain activity as described in Methods section 2.2.16. Data represents 
mean levels of calpain activity expressed as a percentage of the corresponding control + SEM 
(n = 5).  Asterisks indicate statistical significance (*p<0.05). The 2 way ANOVA test was 
used for statistical analysis, followed by post hoc Bonferroni’s correction for pair wise 
multiple analysis. 
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Figure 6.12: The affect of a calpain inhibitor on calpain activation in N2a and C6 cells 
 
  
C6 and N2a cells were induced to differentiate for 24 hours in the absence of thimerosal and 
MeHgCl. Cells were lysed via sonication and the extracts were used to measure calpain 
activity with a calpain inhibitor added as described in Methods section 2.2.16. Data represents 
mean levels of calpain activity expressed as a percentage of the corresponding control + SEM 
(n = 4).  Asterisks indicate statistical significance of differences from the corresponding 
control (*p<0.05). The 2 way ANOVA test was used for statistical analysis, followed by post 
hoc Bonferroni’s correction for pair wise multiple analysis. 
 
Figure 6.12 shows the effect that a calpain inhibitor had on the activity of calpains 1 
and 2 in N2a and C6 cells. Calpain activity was significantly reduced in both cell lines 
by the addition of the inhibitor. In C6 cells activity was reduced by 70 % and in N2a 
cells activity was reduced by 63 %. Statistical analysis confirmed significance (p = 
0.016296 and 0.27193 for C6 and N2a cells respectively). Actual enzyme activity 
expressed as absorbance change/protein/hour was 27. 
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Chapter 6 Discussion 
 
              The aim of chapter 6 was to determine whether thimerosal and MeHgCl had 
any effect upon cellular organisation and calpain activation. Previous studies have 
noted that both thimerosal and MeHgCl increase intracellular calcium concentrations 
(Leonhardt et al., 1996; Burlando et al., 1997; Elferink, 1999; Marchi et al., 2000). 
The previous chapter has already demonstrated that ERK activation is either elevated 
or inhibited during exposure to the organic mercury compounds. The ERK signalling 
cascade can be activated by elevations in intracellular calcium (Subramaniam & 
Unsicker, 2006). PKC activity is known to be inhibited by the addition of mercury 
(Rajanna et al., 1995). The inositol triphosphate receptor is sensitised by thimerosal 
treatment, leading to unregulated release of calcium from the ER (Bootman et al., 
1992; Hilly et al., 1993; Sayers et al., 1993; Thrower et al., 1996). Other important 
calcium dependent enzymes within the cell are the calpains. The regulation of theses 
enzymes are control by calcium concentrations and calpain inhibitors. Calpain has 
also been identified as a downstream target of ERK (Subramaniam & Unsicker, 
2006). 
               SERCA is responsible for the removal of calcium from the cell cytoplasm 
into the ER for storage. The results in this chapter suggest that exposure to thimerosal 
and MeHgCl affects the distribution of SERCA in C6 cells (see figures 6.1 (a-e)). 
Bodipy thapsigargin staining showed that both thimerosal and MeHgCl affected the 
organisation of SERCA in a concentration dependant manner. The change in 
organisation observed was consistent with a major disruption in the endomembrane 
and that of the MT network (observed in chapter 4), on which the ER is dependent for 
its organisation (Waterman-Storer & Salmon, 1998). Heavy metals such as the two 
organic mercury compounds chosen for further investigation in this study have a high 
affinity for sulphydryl groups. By attacking proteins within the calcium pump the cell 
would be unable to sequester calcium, leading to sustained elevations in the calcium 
concentration. Sayers et al., (1993) found that calcium uptake was inhibited by the 
addition of thimerosal in a concentration dependant manner. At 2 µM calcium uptake 
was completely halted. The study hypothesised that the inhibition could be due to the 
metals high affinity for sulphydryl groups on SERCA.    
            The redistribution of SERCA was less apparent in N2a cells exposed to the 
lower concentration of both thimerosal and MeHgCl, but major distribution was 
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apparent at 1 µM of both organic mercury compounds, suggesting that major changes 
in the organisation of the endomembrane system occurred in the neuronal cell line as 
well.  SERCA within N2a cells appear to be less susceptible than within C6 cells as 
the lower concentrations of the organic mercury compounds produced a more 
noticeable change on the distribution in the C6 cell line. The Kd of SERCA is 
between 0.136-0.164 µM (Falcke et al., 2003).  
               Staining for the ryanodine receptor produced images very similar in 
appearance to SERCA staining, which is unsurprising as both probes recognise pumps 
and channels on the ER (compare Figures 3.3 and 6.4 with Figures 6.1 and 6.2). The 
lower concentration of each compound caused minor changes in the staining pattern 
compared to controls, whereas major disruption to punctate disperse distribution 
mainly in the cell bodies was observed at the higher concentration. This is consistent 
with a major distribution of the ER network housing both SERCA and ryanodine 
receptors. Changes in the distribution or conformation of the ryanodine receptor could 
lead to sustained calcium release or complete inhibition of calcium release. 
Micromolar concentrations of thimerosal have been shown to stimulate calcium 
release from ER stores via the ryanodine receptor by altering the receptors affinity 
(Abramson et al., 1995).  The ryanodine receptor has a quarterfoil shape with a pore 
in the centre, thought to be the channel for calcium movement. The pore is blocked by 
a mass thought to be the method of channel regulation (Zucchi & Ronca-Testoni, 
1997).  The Kd for the ryanodine receptor is 9.6 nm (Pessah et al., 1986). 
               As with C6 cells fluorescent staining for the ryanodine receptor (see Figure 
6.4) in N2a cells indicated major disruption in the distribution of the ryanodine 
receptor at the higher concentration of the heavy metals, which taken together with 
the SERCA staining points to a disruption of the endomenbrane system. The exact 
mechanism by which heavy metals cause the opening of the ryanodine receptor is not 
yet known but previous work has shown that the addition of an SH reducing 
compound such as dithiothreitol or glutathione prevents the calcium release caused by 
mercurial compounds (Brunder et al., 1988). Indicating that damage to the proteins 
within the channel is important. It could be that the calcium influx seen with the 
addition of mercury compounds bypasses the receptor completely as other studies 
have indicated that although the target of the metals was SH groups. Those SH groups 
were within the membrane rather than the receptor. Either by binding directly to the 
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SH group or by causing oxidation mercury caused the membrane of the SR to become 
more permeable to calcium (Abramson et al., 1983).  
               Both SERCA and the ryanodine receptor are located on the ER, so by using 
an ER tracker it could be determined if the disruption in the SERCA and the 
ryanodine receptor was coupled with a disruption in the ER. The fact that ER staining 
could only be seen in control cells is consistent with the possibility that the ER 
network was disperse or damaged in organic mercury treated cells.  However the 
possibility that the presence of the heavy metal in the cell culture medium rendered 
the tracker ineffective can not be ruled out. The ER stain in C6 cells covers the cells 
(see figure 6.7 a); while in N2a cells the majority of the staining is in the cell body 
and less intensely in neurites. This would be expected as ER is generally distributed 
through out the cell. 
           Inhibition of calcium release via the ryanodine receptor provided minor relief 
from calcium rises, indicating that the receptor may play a small role in the inhibition 
of calcium homeostasis caused by MeHg (Bearrs et al., 2001). The changes seen in 
the distribution of the SERCA and the ryanodine receptor may be down to the heavy 
metals affinity for thiol groups within proteins or non-specific lipid peroxidation 
(Limke et al., 2004) 
           The antibody used to stain for the Golgi apparatus was not as specific as hoped. 
The huge target area for the antibody indicates that the antibody binds to other 
proteins, in addition to GRASP 65 with the Golgi membrane or that the Golgi protein 
GRASP 65 is also a component of Golgi vesicles and the enzyme track them 
throughout the cells. Despite its non-specificity the antibody is additional 
conformation of cellular reorganisation. There was evidence of redistribution at the 
higher concentrations of the organic mercury compounds in both the neuronal and 
glial cell lines. 
                              Calpains have various targets within the cell and the apparent 
degradation of tubulin and NFH staining observed in chapter 4 could be due to 
increased activity of calpains. The Kd for calpain 1 is 240 nm (Guttmann et al., 1997). 
In both differentiating cell lines calpain activity was significantly increased with both 
concentrations of thimerosal and MeHgCl at both 4 and 24 hours (see Figure 6.12 a 
and b). The calpain assay detected both calpain 1 or 2, so the specific calpain 
responsible could not be determined by assay alone. However, western blotting using 
an anti-calpain 1 antibody showed that levels of activated calpain 1 significantly 
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increased in both cell lines after exposure to both organic mercury compounds. 
(Figures 6.9 and Figure 6.11). The predominant calpain in the CNS is calpain 1 which 
explains why the anti-calpain 2 antibody did not react with either C6 or N2a cells. The 
increased activation of calpain corresponds to decreased levels of tubulin and NFH, 
indicating that degradation by calpain may be at least partly responsible for the 
changes in the levels of NFH and tubulin seen at the 24 hour time point in chapter 4. 
The addition of a calpain inhibitor to cell sonicates reduced activity by 65-70 % in 
both cell lines (figure 6.14), indicating that the majority of the activity being 
measured by the assay was down to calpains. However the possibility that other 
proteases were affected can not be ruled out. Proteases such as pronase which is 
activated by calcium concentrations of 5-10 mM and has a Kd value of 2.99x10-7 M 
(Kramer et al., 1979) and metalloproteases such MP-112 which becomes activated by 
calcium concentrations ranging from 25-100 µM (Nelson & Siman, 1989). 
ADAMT13 cleaves Von Willebrand units and is activated by 4.8 µM calcium and has 
a dissociation constant of 15nM with the Von Willebrand units (Anderson et al., 
2006). The metalloproteases would become activated before calpain 1 and may also 
contribute to the degradation of the cytoskeleton in conjunction with calpain 1.  
Calpain 1 would be activated before pronase and the calcium concentration needed for 
the activation of pronase would be unlikely to occur within cells of the CNS. The 
activation of lipases such as phospholipase C (PLC) may also contribute to cellular 
degradation. PLC activity increases at calcium concentrations of 29-160 nM (Renard 
et al.) and has a dissociation constant of 100-200 µM for lipids (James et al., 1995). 
Phospholipase A2s (PLA2s) specifically hydrolyse the sn-2 fatty acid acyl bond of 
phospholipids, producing a free fatty acid and a lyso-phospholipid. The dissociation 
constant for calcium is 2 mM and the lipase requires 0.25 mM of calcium for 
activation (Lathrop & Biltonen, 1992).  
          Sakaue et al., (2005) measured the cleavage of calpain substrates tau and α-
fodrin in neuronal cells. It was found that the cleavage products increased at 0.3 µM 
MeHg, pointing to an increase in calpain activity. 0.3 µM is in between the two 
concentrations used in this thesis. The study by Sakaue et al., (2005) did not use lower 
concentrations.                 
           Zhang et al., (2003) found that calpain 1 was increased in rats exposed to 10 
mg/kg MeHg per day. It increased gradually during the 7 days of treatment and did 
not decrease until 3 days after the last dose. Addition of a calpain inhibitor reduced 
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activity by 65 %, once again confirming that the majority of the activity was down to 
calpains. Western blots were attempted to look at levels of calpain 2 in both cell line 
but were unsuccessful. It could be that there was insufficient substrate concentration 
for the antibody to detect as calpain 1 is the most prominent form of calpain in the 
CNS (Subramaniam & Unsicker, 2006). 
           In summary the results presented in this chapter support the degradation of the 
cytoskeleton seen in chapter 4, in that sub-lethal concentrations of thimerosal and 
MeHgCl induce major reorganisation of the architecture of the cell. The increased 
activation of calpain 1 and possibly other proteases may have been responsible for the 
decreased levels of tubulin and NFH observed following 24 hour exposure of 
differentiating cells to the mercury compounds. 
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Chapter 7: General Discussion 
            
          Heavy metals are extremely toxic compounds that cause numerous health 
problems and although widespread cases of poison heavy metal poisoning are rare in 
modern society, individuals remain at risk through the consumption of contaminated 
food (Atchison, 2005), exposure through the work place (Papanikolaou et al., 2005) 
and cigarette smoke (Waisberg et al., 2003). The symptoms of heavy metals can 
affect various organs within the body including the kidney, central nervous system 
and liver (Rajanna et al., 1995). At a cellular level heavy metals are thought to 
produce their effect via several different mechanisms, such as the formation of free 
radicals (Yee & Choi, 1996; Dare et al., 2000), interaction with the cytoskeleton 
(Graff et al., 1997; Miura et al., 1999)  and the disruption of calcium homeostasis 
(McNulty & Taylor, 1999; Marchi et al., 2000). 
         Various researchers have shown that heavy metal exposure affects the CNS in 
both adults and in children (Kim et al., 2000; Castoldi et al., 2001). The developing 
CNS is extremely susceptible to heavy metal toxicity, probably due to the intense 
proliferation and differentiation that occurs during the formation of a mature CNS 
(Bertossi et al., 2004). Children are at risk from developmental problems when 
exposed to concentrations as low as 0.1 µM of lead and mercury (Crumpton et al., 
2001; Heidemann et al., 2001). Both lead and mercury can also cross the placental 
barrier and impair foetal development (Miura & Imura, 1989; Papanikolaou et al., 
2005).  
          The aim of the study was to initially investigate the relative toxicity of several 
heavy metals before selection for further study. Following the determination of non-
lethal concentrations, the sub-lethal effects of thimerosal and methylmercury chloride 
on differentiating neuronal and glial cells was investigated. 
               
7.1: Cytotoxicity and cell differentiation assays 
 
              Cytotoxicity studies were carried out on the 6 different metals to determine 
their sub-lethal concentrations and neurite inhibitory concentrations. The investigation 
showed that zinc had no effect upon MTT reduction or neurite outgrowth. This is 
perhaps not surprising, as zinc is the second most prevalent metal in the body, and can 
reach concentrations in excess of 100 µM during synaptic transmission. Previous 
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studies used very high concentrations of zinc before an effect was noted (Park & Koh, 
1999; Watjen, 2001). Exposure to lead resulted in increased MTT reduction and 
reduced neurite number at 100 µM but had no effect at lower concentrations. A study 
using brain slices found no affect on the viability of the brain tissue at concentrations 
of up to 10 µM (Cordova et al., 2004), which agrees with the findings in this thesis 
using cell lines. MTT reduction assays and neurite counts highlighted the difference 
in the toxicity of inorganic and organic mercury compounds. Inorganic mercury was 
shown to be less toxic to the cell line than the organic mercury species. This 
difference in toxicity may be related to the organic properties of thimerosal and 
methylmercury chloride, as they more readily penetrate cell membranes. Cadmium 
was the only compound that caused a significant reduction in neurite outgrowth after 
4 hours of exposure to 0.1 µM indicating that it was the most toxic of the compounds 
investigated.             
                MTT reduction and neurite outgrowth assays showed that, superficially, the 
two organic mercury compounds had a similar level of toxicity. Further investigation 
into the biochemical and molecular effects would determine whether the similarity 
continued.  Initial studies also highlighted the higher sensitivity of the neuronal cell 
line compared to differentiating glial cells. After 48 hours, MTT reduction was 
depressed only in N2a cells incubated with 1 µM MeHgCl. The lower sensitivity of 
the C6 cells may reflect the fact that in vivo glial cells are thought to protect the 
central nervous system from the trace amounts of heavy metals that are found 
normally, since they have higher levels of metallothioniens and anti-oxidants, thus 
enabling them to deal with metals more efficiently than neurons (Castiglioni & Qian, 
2001).     
 
 
7.2: Cytoskeletal studies 
 
 
             Total and tyrosinated α-tubulin levels remained unchanged after 4 hours in C6 
cells, in contrast to N2a cell which displayed decreased levels of tyrosinated α-tubulin 
indicates an interesting difference in the response of the two cell types to organic 
mercury exposure. Hence, the fall in tubulin tyrosination may be a neuron specific 
marker for the toxicity of organic mercury compounds. Tyrosinated α-tubulin sub-
units are enriched in labile microtubules, thus the change in tubulin levels may 
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indicate that both thimerosal and MeHgCl affect microtubule dynamics in the N2a 
cell line. The decreased tyrosination seen in N2a cells may indicate that organic 
mercury compounds have an inhibitory effect on the enzyme responsible for 
detyrosination of the α-tubulin subunit. Alternatively tubulin-tyrosine ligase, which 
adds tyrosine to the c terminus of tubulin, could be inhibited by organic mercury 
compounds. Hence the net effect of thimerosal and MeHgCl on tubulin tyrosination 
would depend on the degree to which the addition or removal steps are inhibited. It 
may be of interest to measure the activity of tyrosine carboxypeptidase after exposure 
to MeHgCl and thimerosal to determine if the changes in tubulin tyrosination are due 
to the heavy metals affecting the enzyme activity rather than directly interacting with 
the tubulin subunit. After 24 hours exposure there was an overall reduction in both 
total and tyrosinated tubulin in both cell lines, indicating that thimerosal and MeHgCl 
causes some proteolytic degradation or reduced synthesis of tubulin subunits. As 
microtubules are composed of obligate heterodimers of α and β subunits, the levels of 
each one should remain equal. The consistent reduction in reactivity with anti α and β-
tubulin antibodies after 24 h exposure indicates a reduction in the levels of tubulin 
compared to controls. This could be due to decreased expression of tubulin genes 
and/or increased turnover (i.e. proteolysis) of both subunits in mercury compound-
treated cells compared to controls. Immunofluorescence imaging confirmed that the 
organic mercury compounds caused major disruption in the MT network in 
comparison to controls.  
            The reduction in the levels of phosphorylated NFH that occurred after 4 hours 
of exposure to the compounds may indicate a change in neurofilament organisation or 
its interaction with other macromolecules in the axon, as the phosphorylation of 
neurofilaments is known to be associated with axon stability and maturity 
(Williamson, 1996). This was further confirmed by the observation of similar patterns 
of reactivity to SMI 34 a different anti-NFH antibody. The smaller changes observed 
with SMI 34 reactivity may reflect specificity differences between the two antibodies. 
The reduction of phosphorylated NFH levels was accompanied by a reduction in the 
levels of phosphorylated ERK1/2. ERK1/2 is one of the kinases responsible for the 
phosphorylation of NFH, so its mirrored decrease adds further evidence to the 
argument that organic mercury compounds cause hypophosphorylation of NFH. A 
similar study using organophosphates found NFH phosphorylation to be increased in 
N2a cells exposed to PSP but neurite outgrowth was also inhibited (Hargreaves et al., 
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2006), indicating that the levels and alterations in the phosphorylation state of NFH 
are useful markers of neurotoxicity, although not specific for any one compound. 
          The observed decreases in reactivity with all anti-NFH antibodies after 24 hours 
exposure to both thimerosal and MeHgCl indicated that there may be a reduction in 
the overall levels of NFH at this time point. This could be due to reduced synthesis or 
increased turnover of NFH. This reorganisation of the cytoskeleton may affect ERK 
activation if its association with the cytoskeleton were disrupted; this could 
potentially be examined using anti-ERK in dual fluorescence staining with either anti-
tubulin or anti-NFH antibodies. It has been shown that cytoskeletal proteins such as 
actin modulate the plasma membrane Ca2+ pump (PMCAs) via direct binding to the 
enzyme (Vanagas et al., 2007). Evidence in this thesis suggests that mercury 
compounds disrupt the cytoskeleton, which may in turn impair cellular ability to 
maintain calcium homeostasis 
 
7.3: Cell signalling studies 
     
                In C6 cells there was transient ERK activation at 4 hours with both 
concentrations of thimerosal and decreases with both concentrations of MeHgCl, 
suggesting either a different mechanism of toxicity for the two compounds or 
differences in the timing of the mechanisms in these cell lines. The possibility that an 
increase occurred earlier in MeHgCl treated cells can not be ruled out, as activation 
has been described within minutes in PC12 cells (Parran et al., 2004). After 24 hours 
the levels of activated ERK fell with both concentrations of thimerosal and MeHgCl.   
              In N2a cells ERK activity decreased on exposure to both concentrations of 
the mercury compounds, the initial increase seen with C6 cells was not evident in 
neuronal cells. It may be that a transient increase in ERK1/2 phosphorylation occurred 
earlier in the neuronal cell line. ERK activity remained suppressed at both 4 and 24 
hours. NF-H is a substrate of ERK 1 / 2 during axon development and ERK activation 
is known to play a central role in axonal outgrowth (Jin et al., 2002). ERK plays a role 
in NFH phosphorylation, an event that was also suppressed by thimerosal and 
MeHgCl. Thus the decrease in ERK activity may be responsible for the reduction in 
NFH phosphorylation, and contribute to the degradation of the microtubule network. 
As ERK activation is now known to have a duel role in cell survival (Subramaniam & 
Unsicker, 2006), further investigation would be needed to determine if the changes in 
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activity are protective or the beginning of cell death. One way to investigate this 
would be to perform experiments in the presence of ERK inhibitors, such as ERK 
activation inhibitors 1 (SteMEK113) and 2 (MTPTATG-MEK113). Both inhibitors are 
cell permeable and prevent the activation of the ERK pathway by inhibiting the 
phosphorylation of MEK1/2; the upstream activator of ERK1/2. As over-activation of 
ERK is also associated with inhibition of neurite outgrowth the optimum 
concentration for the inhibitors in the two cell lines used in this thesis must be 
elucidated initially. Indeed, the finding of increased activation in the case of 
organophosphate toxicity (Hargreaves et al., 2006) does suggest that there is a very 
fine balance between the activation state of ERK 1/2 and the phosphorylation of key 
substrates of importance to neurite outgrowth such as neurofilaments. The majority of 
ERK in cells are bound the cytoskeleton indicating a role closely associated with the 
cytoskeletal organisation (Robinson & Cobb, 1997). Thus, the deviations from normal 
activity in MeHgCl and thimerosal treated cells may be associated with the disruption 
of the tubulin network. The exact mechanism by which organic mercury compounds 
alter ERK activity is still not clear. It could be due to the disruption of the 
cytoskeleton but it may also involve changes in the upstream activators of ERK1/2 
such as MEK. Future work could look at upstream regulators of the ERK cascade, 
using antibodies against MEK and phosphorylated MEK. 
             ERK targets serine and threonine residues on substrate proteins when 
activated. Western blotting analysis with anti-phospho-serine and anti-phospho-
threonine antibodies suggested that neither target showed altered phosphorylation 
when compared to the control in either cell line. However, it is likely that the 
antibodies have only revealed the target proteins of highest abundance, which may not 
necessarily be the key targets in terms of sub-lethal toxicity. Future studies could use 
2-D gel electrophoresis which would be more likely to reveal depression in the 
phosphorylation of minor proteins than the currant studies. ERK is just one of many 
protein kinases and phosphatase that regulate the phosphorylation of thousands of 
proteins within the cell. Although western blotting analysis suggested that JNK 
activity increased in both cell lines, the level of reactivity was very close to 
background and it would therefore be advisable to repeat this work in order to 
improve the signal to noise ration.  
 
 
 185 
7.4: Ca2+ homeostasis and calpain activity 
 
               Changes in calcium homeostasis are known to play a role in the toxicity of 
the two organic mercury compounds. Calcium is also known to be an upstream 
regulator of the ERK signalling pathway (Subramaniam & Unsicker, 2006), which 
has been shown to be inhibited by the addition of organic mercury compounds. 
Calcium can act as either an inhibitor or activator of the ERK1/2 signalling pathway. 
Other important targets of ERK1/2 are calpains 1 and 2. Activated ERK 
phosphorylates calpain 2 at Ser50 even in the absence of milimolar calcium 
concentrations (Glading et al., 2001)  
         Confocal microscopy studies showed that thimerosal and MeHgCl exposure 
alter the distribution of SERCA within both neuronal and glial cells. Changes in either 
the distribution or the configuration of this energy dependent pump, could lead to 
sustained elevations in calcium concentrations within the cell (Sayers et al., 1993) 
found that 2 µM thimerosal exposure inhibited calcium uptake completely, via the 
interaction with sulphydryl groups in SERCA. The distribution of the ryanodine 
receptor was also affected by the organic mercury compounds. The ryanodine 
receptor is responsible for the release of calcium from ER stores and any changes in 
its distribution could lead to unregulated release and further disruption to calcium 
homeostasis (Abramson et al., 1995). The change in the positioning of both SERCA 
and the ryanodine receptor indicates that there may be disruption of the ER within the 
cell, which houses these two Ca2+ regulatory proteins. However, the ER tracker dye 
used in the present work was not detectable in MeHgCl and thimerosal treated cells, 
this may indicate dispersal of the tubular network in treated cells but further staining, 
for example with anti-ER protein antibodies could give a more conclusive result.  
          The disperse pattern of staining seen with the anti-Golgi apparatus antibody 
could be due to the antibody recognising a membrane protein that is also part of the 
Golgi vesicles used for transport round the cell. Though not specific for Golgi 
apparatus-like structures within the cells, the staining pattern with the anti-Golgi 
apparatus antibody did further supported the view that disruption of the 
endomembrane system occurred, at least at the higher concentrations of both 
compounds. Furthermore, since ER distribution is known to be dependent on the 
integrity of the microtubule network (Waterman-Storer & Salmon, 1998), this 
indicates that the major disruption of MTs seen in immunofluorescence staining 
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analysis would be expected to cause major ER disruption, as ER tubules depend upon 
MTs for localisation via association along the length of the MT or by binding to the 
tip of the MT (Waterman-Storer & Salmon, 1998). 
            Calpain activity increased in neuronal and glial cells with both concentrations 
of the organic mercury compounds at both 4 and 24 hours. The increase in activity is 
a strong indication that calcium concentrations are elevated in both cell lines, as the 
calpains are calcium dependent enzymes (Sorimachi et al., 1997). Furthermore, as the 
calpains are known to target cytoskeletal proteins, the increased activity may in part 
explain the degradation seen in the levels of both NFH and tubulin following 4 and 24 
hours exposure to MeHgCl and thimerosal. Previous studies have shown that 
increases in intracellular calcium causes a reduction in the phosphorylation of 
ERK1/2 (Millar et al., 2007), which further supports the argument that organic 
mercury compounds causes increases in intracellular calcium as ERK1/2 
phosphorylation was seen to be decreased in this thesis.  
            
          In conclusion, this thesis has achieved most of the aims set out at the beginning 
of the work. Figure 7.1 gives an overview of the effects of thimerosal and MeHgCl 
had upon neuronal and glial cells. 
 
• The sub-lethal and neurite inhibitory concentrations have been identified for 
the 6 heavy metals chosen at the beginning of the project. 
 
Sub-lethal neurite outgrowth inhibitory concentrations of MeHgCl and thimerosal are 
associated with: 
 
• Inhibition of neurite outgrowth, accompanied by changes in the levels, 
distribution and posttranslational modification of tubulin in C6 and N2a cells 
and NFH in N2a cells. 
 
• Alteration of the cell signalling pathways associated with the control of the 
cytoskeleton. ERK activity was inhibited in both cell lines after 24 hours. 
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• Measurement of calcium homeostasis was attempted but a suitable 
environment for the determination of intracellular calcium concentrations 
could not be established within the limited time scale. It has been shown that 
organic mercury compounds caused an increase in levels and activity of 
calpain in N2a and C6 cells after exposure to 4 and 24 hours of both 
concentrations of thimerosal and MeHgCl, which suggests that calcium levels  
are increased by thimerosal and MeHgCl. 
 
• Addition of organic mercury compounds altered distribution of SERCA and 
ryanodine receptors in both cell lines. The anti-GRASP 65 antibody was 
further conformation of the disruption of the cells architecture. 
 
 
Figure 7.1: Summary diagram of some of the possible routes by which an organic 
mercury compound may exert its toxic effect. 
Figure 7.1 summarises a possible route of toxicity uncovered by the work in this thesis for 
organic mercury compounds. Once inside the cell, thimerosal and MeHgCl causes inhibition 
of the ERK1/2 signalling pathway, leading to hypophosphorylation of NFs and the reduction 
of axon outgrowth in neuronal cells. Organic mercury compounds have also been shown to 
increase the activity of calcium dependant enzymes called calpains. Calpains are generally 
activated by raises in calcium concentrations but they have also been shown to become 
activated through phosphorylation by ERK1/2. The inhibition of ERK1/2 indicates that the 
intracellular calcium concentration rose sufficiently to activate calpain 1. The activity of the 
calpain may be responsible for the degradation of the cytoskeleton seen in both neuronal and 
glial cells. 
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7.5: FUTURE WORK  
 
              With hindsight it would have been of use to measure the concentration of 
free metal within the media in order to establish how much of the compound had 
bound to organic matter within the media. It would have also been of interest to the 
thesis if the concentration of metal had been measured within the cell lysates after the 
different incubation times to determine how much of the compound added to the 
media actually entered the cell. The concentrations could be determined using an 
atomic absorption spectrophotometer equipped with a HGA-300 graphite furnace and 
calibrated with known metal concentrations. Whilst information on the actual amount 
taken up is lacking, organic mercury compounds elicit a variety of responses in N2a 
and C6 cells. 
          The confocal microscopy work on the cytoskeleton in chapter 4 would be 
further enhanced by electron microscope images of the cells to view cytoskeletal 
changes in more detail. The same antibodies would be used for visualisation of the 
neuronal and glial cell cytoskeleton. The cause of the reduction could be investigated 
to identify whether it is a result of the inhibition of the enzyme that detyrosinates α-
tubulin. The activity of the enzyme tubulin carboxypeptidase can be measured by 
assay developed by (Sironi et al., 2000) that uses [14C] labelled tubulin as a substrate 
for the enzyme. The assay would use purified tubulin from the cell lysates obtained 
from centrifugation at 100,000 g for 60 minutes at 2-4oC.  
               In chapter 4 this study looked at tyrosination; one form of post-translational 
modification for tubulin sub-units. Experiments showed that the addition of organic 
mercury compounds caused the levels of tyrosination to fall. However detyrosination 
of MTs is only one way that the MT network is stabilised. Acetylation of α-tubulin is 
another form of post-translational modification and future studies could determine if it 
responded in the way as tyrosinated α-tubulin to the organic mercury compounds 
using the same techniques of western blotting and immunofluorescence but with an 
anti-acetylated tubulin antibody.      
                Future work is required on the measurement of intracellular calcium 
concentrations. Initial experiments were unsuccessful in measuring calcium changes 
using fura-2 in a spectrofluorimeter. There was a low signal to noise ratio, which 
prevented accurate determination of changes in calcium concentrations in the 
fluorimeter. Intracellular calcium concentrations steadily increased even in the control 
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cells, indicating that the cells were not in a suitable environment. Further experiments 
are needed to determine a suitable medium that allows the cells to survive in non-
stressed state that does not interfere with calcium measurements. Once the cells are 
stabilised under these conditions experiments to determine the instantaneous effect 
that the addition of thimerosal and MeHgCl to the cells had upon calcium 
mobilisation could be carried out, as well as looking at calcium changes within cells 
pre-treated with the organic mercury compounds. Using calcium free medium would 
determine whether calcium was mobilised from intracellular stores or from outside 
the cell. SERCA pump inhibiters such as thapsigargin, which binds to irreversible to 
SERCA causing inactivation would determine the importance of intracellular calcium 
stores to the rises in calcium concentrations. 
          The work on calcium receptors and SERCA could be expanded by looking at 
the distribution of IP3 receptors in the cell lines, using an anti-IP3 receptor antibody 
(C-20).  
           Studies of the changes in cellular organisation in chapter 6 need to be expanded 
to other organelles such as the mitochondria which are important intracellular calcium 
stores (Dietmer et al., 1998). MeHg is known to affect mitochondrial calcium release 
and uptake leading to the induction of apoptosis (Levesque et al., 1988). Using the 
Mitosox Red mitochondrial superoxide indicator, would elucidate the effect of the 
organic mercury compounds on the organisation of organelles within the cell. In 
addition it may also indicate if the mitochondrial calcium store is partly responsible 
for the rises in intracellular calcium, which have been found to accompany exposure 
to thimerosal and MeHg (Abramson et al., 1983; Bearrs et al., 2001).  
            Western blotting analysis and calpain activity assays have shown an increase 
in the levels of calpain I and its activity in MeHgCl and thimerosal treated cells. It 
would therefore be of interest to add membrane-permeable calpain inhibitors to living 
cells incubated with the organic mercury compounds to determine whether calpain 
inhibition provides any protection from the toxic effects of these agents. Using the 
established antibodies used throughout this thesis, western blotting and confocal 
microscope may highlight any protective effects that the calpain inhibitors had upon 
the degradation of the cytoskeleton. 
            Chapter 5 indicated that ERK1/2 signalling was inhibited by the addition of 
organic mercury compounds. Western blots with cell lysates prepared under the same 
conditions as in this study may be used to look at the levels and activation of the 
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upstream activators of ERK1/2 such as MEK. The importance of the changes ERK1/2 
signalling can be expanded upon by using cell permeable ERK inhibitors prior to 
either the lysing of the cells for western blotting or fixing for immunofluorescence.  
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Appendix 
 
A.1: The effect of thimerosal and methylmercury chloride on the levels of JNK and 
phosphorylated JNK in C6 cells 
 
Figure A.1.1: The effect of thimerosal and methylmercury chloride on the levels of 
total JNK and phosphorylated in 4 hour differentiated C6 cells 
 
 
 
 
 
 
 
 
C6 cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride and extracts were separated by SDS PAGE and western blotted 
as described in Methods. The blots were probed with anti-total JNK (a) and phosphorylated 
JNK (b) antibodies. 
 
Figure A.1.1 shows that there was no apparent change in the reactivity of the total 
JNK antibody after 4 hours of exposure to thimerosal and MeHgCl. After 4 hours it 
seems that there is a slight increase in the reactivity of the phosphorylated JNK 
antibody with 0.1 µM of thimerosal and MeHgCl but a decrease in antibody reactivity 
with 1 µM thimerosal and MeHgCl. 
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Figure A.1.2: Densitometric analysis of the effects of thimerosal and methylmercury 
chloride on total and phosphorylated JNK 
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C6 cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods. The resultant western blots were then probed with the antibodies indicated and 
the reactive bands were scanned densitometrically using Quantiscan software. Data represents 
mean levels of antibody reactivity, expressed as a percentage of the corresponding control + 
SEM. Asterisks indicate statistical significance (* p value <0.05). 
 
Figure A.1.2 shows that the reactivity of the anti-total JNK antibody was not 
significantly altered (p<0.05) with C6 cell extracts that had been exposed to either 
concentration of thimerosal or MeHgCl. However the reactivity of the anti-
phosphorylated JNK antibody was significantly increased by around 45 % with cell 
lysates exposed to 1 µM thimerosal and 40% with 1 µM MeHgCl. 0.1 µM of both 
heavy metals caused no significant alterations in the anti-phosphorylated JNK 
antibody reactivity. 
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Figure A.1.3: The effect of thimerosal and methylmercury chloride on the levels of 
total JNK and phosphorylated JNK in 24 hour differentiated C6 cells 
 
 
 
 
 
 
C6 cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride and extracts were separated by SDS PAGE and western blotted 
as described in Methods. The blots were probed with anti-total JNK (a) and phosphorylated 
JNK (b) antibodies. 
 
Figure A.1.3 shows that there was no apparent change in the reactivity of the total 
JNK antibody after 24 hours of exposure to thimerosal and MeHgCl. After 24 hours 
of exposure to both concentrations of thimerosal it appears that the reactivity of the 
phosphorylated JNK antibody increases. There is no obvious change in the reactivity 
of the phosphorylated JNK antibody with either concentration of MeHgCl. 
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Figure A.1.4: Densitometric analysis of the effects of thimerosal and methylmercury 
chloride on total and phosphorylated JNK 
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C6 cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods. The resultant western blots were then probed with the antibodies indicated and 
the reactive bands were scanned densitometrically using Quantiscan software. Data represents 
mean levels of antibody reactivity, expressed as a percentage of the corresponding control + 
SEM. Asterisks indicate statistical significance (* p value <0.05). 
 
Figure A.1.4 shows that the reactivity of the anti-total JNK antibody was not 
significantly altered (p<0.05) with C6 cell extracts that had been exposed to either 
concentration of thimerosal or MeHgCl for 24 hours. The reactivity of the anti-
phosphorylated JNK antibody was also unaffected in cell lysates exposed to both 
concentrations of MeHgCl. In cell extracts exposed to 0.1 µM thimerosal, there was a 
statistically significant 40 % increase in the binding of the antibody and a 48% 
increase with 1 µM thimerosal. 
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A.2: The effect of thimerosal and methylmercury chloride on the levels of total JNK 
and phosphorylated JNK in differentiated N2a cells 
 
 
Figure A.2.1: The effect of thimerosal and methylmercury chloride on the levels of 
total JNK and phosphorylated JNK in 4 hour differentiated N2a cells 
 
 
 
 
 
 
 
 
N2a cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride and extracts were separated by SDS PAGE and western blotted 
as described in Methods. The blots were probed with anti-total JNK (a) and phosphorylated 
JNK (b) antibodies. 
 
Figure A.2.1 shows that there was no apparent change in the reactivity of the total 
JNK antibody after 4 hours of exposure to thimerosal and MeHgCl. The reactivity of 
the phosphorylated JNK antibody appears to increase with both concentrations of 
thimerosal and decrease when exposed to both 0.1 and 1 µM MeHgCl. 
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Figure A.2.2: Densitometric analysis of the effects of thimerosal and methylmercury 
chloride on total and phosphorylated JNK 
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N2a cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods. The resultant western blots were then probed with the antibodies indicated and 
the reactive bands were scanned densitometrically using Quantiscan software. Data represents 
mean levels of antibody reactivity, expressed as a percentage of the corresponding control + 
SEM. Asterisks indicate statistical significance (* p value <0.05) 
 
Figure A.2.2 shows that the reactivity of the anti-total JNK antibody was not 
significantly altered (p<0.05) with N2a cell extracts that had been exposed to either 
concentration of thimerosal or MeHgCl for 4 hours. The binding of the anti-
phosphorylated JNK antibody was not affected in N2a cells exposed to either 
concentration of MeHgCl. But exposure to 0.1 µM thimerosal caused a significant 
increase of around 40 %. Exposure to 1 µM thimerosal increased the reactivity of the 
anti-phosphorylated JNK antibody by 58 %. 
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Figure A.2.3: The effect of thimerosal and methylmercury chloride on the levels of 
total JNK and phosphorylated JNK in 24 hour differentiated N2a cells 
 
 
 
 
 
 
 
 
 
N2a cells were induced to differentiate for 4 hours in the presence and absence of thimerosal 
and methylmercury chloride and extracts were separated by SDS PAGE and western blotted 
as described in Methods. The blots were probed with anti-total JNK (a) and phosphorylated 
JNK (b) antibodies. 
 
Figure A.2.3 shows that there was no apparent change in the reactivity of the total 
JNK antibody after 24 hours of exposure to thimerosal and MeHgCl. Image b 
indicates that as with the 4 hour exposure the reactivity of the phosphorylated JNK 
antibody increases with cell lysates incubated with both 0.1 and 1 µM thimerosal and 
decreases with both concentrations of MeHgCl.  
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Figure A.2.4: Densitometric analysis of the effects of thimerosal and methylmercury 
chloride on total and phosphorylated JNK 
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N2a cells were induced to differentiate for 24 hours in the presence and absence of thimerosal 
and methylmercury chloride, then separated by SDS PAGE and western blotting as described 
in Methods. The resultant western blots were then probed with the antibodies indicated and 
the reactive bands were scanned densitometrically using Quantiscan software. Data represents 
mean levels of antibody reactivity, expressed as a percentage of the corresponding control + 
SEM. Asterisks indicate statistical significance (* p value <0.05). 
 
Figure A.2.4 shows that the reactivity of the anti-total JNK antibody was not 
significantly altered (p<0.05) with N2a cell extracts that had been exposed to either 
concentration of thimerosal or MeHgCl for 24 hours. Reactivity of the anti-
phosphorylated JNK antibody remained unaltered when compared to the control in 
N2a cell lysates exposed to 0.1 and 1 µM MeHgCl. Antibody binding was 
significantly increased by 50 % with cell extracts exposed to 0.1 µM and 60 % with 
cells exposed to 1 µM. 
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